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1. Introduction 
Research in the field of aging and dementia is a main concern as the population of elderly 
people is growing continuously due to increasing life expectancy and thus an accumulative 
number of people who live well beyond 65 years of age run a risk of developing age-
associated neurodegenerative disorders of cognitive function, such as Alzheimer‟s disease 
(AD), emerging as a major health problem. Rising rates of prevalence and incidence with age 
(Bickel, 2000; Gao, Hendrie, Hall, & Hui, 1998; Hebert, Beckett, Scherr, & Evans, 2001; Ku-
kull et al., 2002) are countered by prospects of effective therapies that, at least, might be able 
to slow or delay the progression to AD and the course of AD, respectively. Based on the as-
sumption that earlier identification of people at risk of AD will lead to better cognitive out-
come by e.g. medical interventions, research has focused on methods to identify cognitive 
disorders at the prodromal stage of the illness, the stage of mild cognitive impairment (MCI; 
Petersen et al., 1999). In particular, the amnestic form of MCI is generally considered a transi-
tional stage between normal ageing and a diagnosis of clinically probable AD (Petersen, 
2000) and therefore a subject of intense investigation.  
The present work is based on growing evidence that deficits in visual selective attention occur 
early in the progression to AD (Foldi, Lobosco, & Schaefer, 2002) and therefore might be 
present as the first non-memory deficits (Perry & Hodges, 1999) at the early prodromal MCI 
stage. Despite intensive research done in this field (Amieva, Phillips, Della Sala, & Henry, 
2004b; Bäckman et al., 2004; Balota & Faust, 2002; Parasuraman & Haxby, 1993; Perry & 
Hodges, 1999) there is still ongoing debate as to whether certain aspects of visual selective at-
tention are particularly vulnerable or preserved, especially at the stage of MCI, and whether 
attentional functioning might be qualitatively and/ or quantitatively different from attentional 
performance at the AD stage on the one hand or normal functioning on the other hand. To 
date, a huge variety of studies presented results on visual attentional functions in MCI and/ or 
AD patients which are heterogeneous due to several reasons: 
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a) Heterogeneity in the etiology and application of clinical criteria especially with regard to 
the various concepts of MCI lead to difficulties in gathering from results of different studies. 
b) Furthermore, results derived from different paradigms for attentional assessment are not 
highly comparable when they varied with respect to task, task difficulty, stimuli, stimuli pres-
entation conditions, automation (e.g. manual versus computerized tests), or response mea-
surement (e.g. reaction time (RT) or error rate). 
c) Cognitive impairment in general and cognitive slowing in particular are predominantly as-
sociated with deceleration in motor response and therefore often measured by manual re-
sponse times like it is done, for example, in the established clinical diagnostic tool „Test for 
Attentional Performance‟ (TAP; Zimmermann & Fimm, 1993). With the application of such a 
motor response dependent tool, it has to be taken into account that general cognitive slowing 
might lead to a distortion of the evaluation of other cognitive functions like short-term memo-
ry capacity or top-down control, which would undermine the theoretical independence of at-
tentional functions. Reversely, even selective deficits in motor speed would not unambiguous-
ly point to reduced processing capacity as the underlying cause might be due to predominant-
ly prevailing motor disturbances. Therefore, attentional assessment in elderly healthy subjects 
as well as in patients suffering from cognitive degeneration like AD should preferably be 
based on theoretically and empirically independent attentional components.  
d) As even patients in the early stage of AD show remarkable cognitive and memory impair-
ment, the application of exclusively easy and intuitive tasks including simple instructions 
would allow comparing attentional functions of distinct stages in the course of AD. In TAP 
subtests like the „Go/No-go‟ or the „Working memory‟ task (Zimmermann & Fimm, 1993) in-
structions would presumably be too difficult to follow for probable AD patients or contrari-
wise, the experimenter could hardly control for comprehension of the task. 
To overcome these shortcomings, this present work was designed to investigate selective vis-
ual attentional functions in MCI and AD patients compared to healthy control subjects based 
1. Introduction 14 
on Bundesen‟s theory of visual attention (TVA; Bundesen, 1990, 1998). This theoretical 
framework allows the assessment of several latent, mathematically independent and quantita-
tive parameter estimates which are derived from two highly comparable paradigms – compu-
terized whole report and partial report of briefly presented visual letter arrays.  
Before describing the theoretical and mathematical framework of TVA in more detail, a short 
overview of the studies presented in the chapters 4 to 6 is provided in the next section. 
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2. Synopsis 
In the following sections, English summaries of the three studies presented in this dissertation 
are given. For a detailed German synopsis of the present work, see chapter 8 (pp. 118 et 
seqq.). 
Research in the field of aging and dementia is a main concern as the population of elderly 
people is growing continuously due to increasing life expectancy and thus, an accumulative 
number of people who live well beyond 65 years of age run a risk of developing age-
associated neurodegenerative disorders of cognitive function, such as Alzheimer‟s disease 
(AD), emerging as a major health problem. 
The present work is based on growing evidence that deficits in visual selective attention occur 
early in the progression to AD (Foldi et al., 2002) and therefore might be present as the first 
non-memory deficits (Perry & Hodges, 1999) at the early prodromal stage of mild cognitive 
impairment (MCI; Petersen et al., 1999). The present dissertation was performed to contribute 
to the still ongoing debate as to whether certain aspects of visual selective attention are par-
ticularly vulnerable or preserved, especially at the stage of MCI, and whether attentional func-
tioning might be qualitatively and/ or quantitatively different from attentional performance at 
the AD stage on the one hand or normal functioning on the other hand. 
As theoretical basis, Bundesen‟s theory of visual attention (TVA; Bundesen, 1990, 1998) was 
employed to assess several latent, mathematically independent and quantitative parameter es-
timates which are derived from two highly comparable paradigms – computerized whole re-
port and partial report of briefly presented visual letter arrays. Central conclusions arising out 
of TVA-based investigations (e.g., Bublak et al., 2005; Bublak, Redel, & Finke, 2006; Dun-
can et al., 1999; Duncan et al., 2003; Finke et al., 2006; Gerlach, Marstrand, Habekost, & 
Gade, 2005; Habekost & Bundesen, 2003; Habekost & Rostrup, 2006; Peers et al., 2005) 
point at four central strengths of this tool for attentional assessment – the quality criteria sen-
sitivity, specificity, reliability and validity. 
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2.1. Study 1 
In AD, the amyloid cascade hypothesis (Hardy & Selkoe, 2002) assumes that rising plaque 
and tangle burden invokes loss of nerve cells through direct and indirect effects on synaptic, 
neuronal and neuritic function (see e.g. Cirrito et al., 2005), resulting in progressive intellec-
tual decline. Thus, sensitive biomarkers loading functionally on the neural alterations invoked 
by AD from early on, might improve the possibility to identify at risk subjects in time, provid-
ing a chance for effective treatment (Shah et al., 2008). The first study (see chapter 4, pp. 31 
et seqq.) examined whether cognitive parameters for estimating the capacity of visual atten-
tion might serve that purpose. 
Based on Bundesen‟s (1990) TVA, visual information uptake was analyzed in 18 subjects 
with probable AD, 18 subjects with amnestic MCI, and 18 healthy elderly control subjects. 
Groups were matched for gender, age, and education. From a whole report task requiring ver-
bal report of briefly presented letters, four parameters were derived, characterizing different 
aspects of visual processing capacity: perceptual threshold t0, iconic memory μ, processing 
speed C, and visual short-term memory (VSTM) storage capacity K.  
Comparison of these attentional parameters between groups revealed an elevation of the per-
ceptual threshold already in MCI subjects, while processing speed and VSTM storage capaci-
ty showed a significant decline for AD patients, only. AD patients on medication with acetyl-
choline esterase inhibitors had higher processing speed, but were still below the level of MCI 
patients. Perceptual threshold values were significantly correlated with disease duration, but 
not with cognitive measures. Conversely, speed and VSTM were significantly related to cog-
nitive scores, but not to disease duration. In particular, VSTM storage was related to neurop-
sychological tasks applying visual material (picture naming and visuo-construction), while 
speed showed an additional relationship also to measures of verbal memory. 
These results indicate a staged pattern of deficits affecting pre-attentive visual processing in 
MCI, and attentive processing in AD. They fit into the amyloid cascade hypothesis according 
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to which the neuropathology of AD is characterized by a net accumulation and deposition of 
β-amyloid (Aβ) in the initial phase, giving rise to neuronal and neuritic dysfunction. Later, 
gradual neuronal loss and transmitter disturbances finally cause the increasing intellectual de-
cline during further progression of the disease. A threshold elevation may thus be considered 
as a possible index of impaired neuronal functioning prior to cell death, while speed and 
VSTM deficits may be indicative already of a substantial loss of neuronal cell assemblies and 
a degeneration of neurotransmitter systems. 
2.2. Study 2 
AD is the most frequent form of dementia which appears both as a familial and a sporadic va-
riant. In the by far more frequent sporadic form, a genetic risk factor is also implicated, in that 
carriers of the apolipoprotein E ε4 allele (ApoE4) have a 3 to 15 times higher risk of develop-
ing the disease, compared to non-carriers (Blennow, de Leon, & Zetterberg, 2006). Using an 
identical TVA-based partial report paradigm as in the present study, Finke et al. (2006) had 
found a close relationship between the severity of the underlying genetic pathology in another 
neurodegenerative, namely Huntington‟s, disease and the direction and degree of spatial atten-
tional weighting. Sensitive tools for assessing selective visual attention might serve as early 
cognitive markers in the course of AD and therefore enhance the identification rate of at-risk 
subjects at the MCI stage (Shah et al., 2008) as well as of subjects with underlying genetic 
risk (ApoE4). The second study (see chapter 5, pp. 60 et seqq.) aimed at examining whether 
attentional parameters of visuospatial and task-related selection are appropriate means for that 
purpose. 
Visual selective attention was investigated in 32 patients with amnestic MCI, 16 patients with 
probable AD, and 36 healthy elderly control subjects. Groups were matched for age, gender 
and educational level. In combination with Bundesen‟s (1990) TVA, two mathematically in-
dependent and quantitative parameter estimates were derived from a partial report of briefly 
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presented letter arrays: top-down control of attentional selection, representing task-related at-
tentional weighting for prioritizing relevant visual objects, and spatial distribution of atten-
tional weights across the left and right visual hemifield.  
Compared to controls, MCI patients showed significantly reduced top-down controlled selec-
tion which further deteriorated in AD subjects. Moreover, attentional weighting was signifi-
cantly unbalanced across hemifields in MCI and tended to be more lateralized in AD. The ma-
jority of patients was biased to the left. Across MCI and AD patients, ApoE4 carriers revealed 
a leftward spatial bias. The leftward bias was the more pronounced the younger the ApoE4-
positive patients and the earlier disease onset. ApoE4-negative subjects showed balanced at-
tentional weighting.  
These results indicate that impaired top-down control may be linked to early dysfunction of 
cortico-cortical networks connecting parietal and frontal lobes. Accompanying, an early inter-
hemispheric asymmetry in temporo-parietal cortical interactions might cause a pathological 
spatial bias. As the inheritance of ApoE4 is associated with an interhemispheric imbalance in 
parietal cortical interactions, a pathological spatial bias may function as early cognitive mark-
er for detecting subjects at risk for probable AD. 
2.3. Study 3 
In the latter study, the TVA-based partial report paradigm proved to be a sensitive tool for ve-
rifying that both, deficits in task-related selection and a pathological attentional imbalance, 
are already present at the early stage of amnestic MCI and increase further at the AD stage 
(see second study, chapter 5, pp. 60 et seqq.). It was hypothesized that these deficiencies in 
selective attention may result from an early disconnection syndrome and an interhemispheric 
imbalance in cortical interactions, respectively, in the fronto-parietal attention network, before 
gradual neuronal loss leads to further decline in selective attentional and intellectual functions 
at later stages. 
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In the third study (see chapter 6, pp. 93 et seqq.), these hypotheses were tested by investigat-
ing the relationship of both partial report parameters, top-down control α and especially the 
laterality index of attentional weighting wλ, to regional glucose metabolism measured by rest-
ing-state positron emission tomography (PET) in a sample of 30 amnestic MCI or mild AD 
patients.  
Hypometabolism across all patients was slightly increased in the left hemisphere. Interesting-
ly, the more reduced the metabolism in the left temporo-parietal junction (TPJ) the more pro-
nounced was the top-down control deficit. Accordingly, hypometabolism in the left TPJ pre-
dicted the magnitude of the spatial bias. Furthermore, relative hypometabolism in the left TPJ 
and left inferior parietal lobe (IPL) as compared to the right TPJ and right IPL, respectively, 
was correlated with direction and degree of spatial bias. 
Taken together, PET imaging results support the hypotheses that, one the one hand, early def-
icits in task-related weighting may result from a fronto-parietal disconnection syndrome al-
ready at the stage of MCI. On the other hand, very early AD seems to be also associated with 
an interhemispheric imbalance of metabolism, particularly in the temporo-parietal cortices, 
resulting in a correspondingly directed and distinctive visuo-spatial attentional bias. 
2.4. Conclusions and outlook 
This dissertation intended to investigate the probable valuable contribution of the whole and 
partial report of briefly presented letter arrays based on Bundesen‟s theory of visual attention 
(TVA; Bundesen, 1990, 1998; Bundesen, Habekost, & Kyllingsbaek, 2005) in assessing am-
nestic MCI and AD patients in comparison to healthy elderly control subjects. 
The results of the three presented studies suggest a staging model of visual selective atten-
tional impairments in MCI and AD. Deficits of pre-attentive processing (perceptual threshold 
t0), task-related (top-down control α) and spatial weighting (laterality index of attentional 
weighting wλ) were already detectable in MCI patients, while aspects of processing capacity 
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(perceptual processing speed C and VSTM storage capacity K) were still intact. At a later 
stage of the disease, further deterioration of top-down control α and increasing lateralization 
of spatial weighting wλ accompanied impairments in perceptual processing speed C and 
VSTM storage capacity K.  
In conclusion, the TVA-based assessment of selective visual attention proved to be a sensitive 
diagnostic tool for revealing subtle deficits already at the stage of MCI which might exhibit 
the capability of an early cognitive marker for the identification of subjects at risk of AD. To 
address this question, this survey needs to be complemented by longitudinal studies. 
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3. Theory of visual attention (TVA) 
The theory of visual attention (TVA) by Claus Bundesen (Bundesen, 1990, 1992, 1998; Bun-
desen et al., 2005) is a formal computational theory integrating both, aspects of early (e.g., fil-
ter theory by Broadbent, 1958; feature integration theory by Treisman & Gelade, 1980) and 
late visual attentional selection (Deutsch & Deutsch, 1963) into one unified mechanism of 
visual recognition and attentional selection. Accordingly, in TVA, selection and recognition 
are assumed to characterize the same processing operation and therefore occur at the same 
time. As a result, an object in the visual field is selected when it is recognized, and vice versa. 
As TVA was developed from Luce‟s (1959) choice model (see also Bundesen, Pedersen, & 
Larsen, 1984; Bundesen, Shibuya, & Larsen, 1985), which was integrated in the framework of 
the race model (Bundesen, 1987) on the one hand, and from a fixed-capacity four-parameter 
independent race model (FIRM; Shibuya & Bundesen, 1988), these models will not be dis-
cussed here. TVA is a mathematical model with strong relations to the biased competition ac-
count of attentional selection proposed by Desimone and Duncan (Desimone, 1998; Desi-
mone & Duncan, 1995; Duncan, Humphreys, & Ward, 1997). For a detailed mathematical de-
scription of TVA, see Bundesen (1990, 1998), Duncan et al. (1999), or Kyllingsbæk (2006). 
3.1. Basic assumptions and equations 
Perceptual categorizations are at the basis of visual recognition and attentional selection in 
TVA. Visual information intake is a process by which evidence is accumulated that a visual 
perceptual unit in the visual field, object x, belongs to a certain perceptual category i (the class 
of all objects that exhibit a certain common feature) and is characterized by a certain percep-
tual feature j (e.g. a specific color, shape, movement, or spatial location). According to that, a 
set of red objects would be indicative of a perceptual categorization with regard to color; in 
view of shape, a letter set of the character Z could be exemplified.  
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The probability that a specific categorization is selected is dependent on both, the strength of 
the sensory evidence that object x belongs to a particular category i and the strength of the 
sensory evidence that x bears a certain perceptual feature j. The representation of relatively 
weaker or stronger sensory evidence is not on equality with conscious recognition and atten-
tional selection. Decisions on the affiliation of an object to a specific perceptual category are 
computed before the start of the selection process. As a consequence, the object x can only be 
identified or selected (which is synonymous in TVA) as belonging to category i, when it is 
encoded into a capacity-limited visual short-term memory (VSTM) store. To consider this 
matter from another angle, an object x is assumed to be represented in the VSTM store when 
some categorization of object x entered this store. 
According to TVA, objects in the visual field are processed in parallel and compete for selec-
tion, that is, „conscious‟ representation within the information processing system. The selec-
tion mechanism is temporally restricted so that only those objects may be reported from a 
briefly presented visual display which sampled categorizations are completely encoded into 
VSTM, before the decay of the sensory representation of the visual stimulus array and before 
the VSTM is completely filled with other elements. If the perceptual categorization of object 
x is not completely processed/ sampled or if it was sampled but the VSTM store is filled up 
with K other elements, not containing a representation of object x, the categorization of object 
x will be lost. Thus, object x won‟t be selected into VSTM and won‟t be identified unless 
there are less than K elements represented in VSTM store. Parameter K, an estimation of 
VSTM storage capacity, represents the maximum number of objects that can be consciously 
maintained in parallel in VSTM (expressed in number of elements). Typically, parameter K 
reaches between three to four elements in healthy subjects (Bundesen et al., 1984; Bundesen 
et al., 1985; Finke et al., 2005). Objects (i.e. targets) that entered the VSTM store are correct-
ly identified with a probability close to 100% regardless of whether other elements in the vis-
ual field are encoded or not. Thus, the maximum number of elements represented in VSTM 
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store, parameter K, is independent of display size (Bundesen et al., 1984; Bundesen et al., 
1985). 
It is important to differentiate between the limited capacity of the VSTM store with regard to 
the number of objects, K, that might be represented at the maximum, and the non-limited 
amount of object categorizations, provided the following prerequisites are established: a) ca-
tegorizations of object x can always enter the VSTM as long as the corresponding object is al-
ready encoded into VSTM (irrespective of whether it is filled completely with K elements) 
and therefore represented with one or various categorizations; b) the categorization of object x 
can be sampled and represented in VSTM in case of less than K encoded elements. These as-
sumptions are in line with a study by Luck and Vogel (1997) who were able to demonstrate 
that VSTM capacity must be interpreted as integrated objects bearing e.g. several features or 
categorizations that are bound together and related to one single object representation instead 
of individual unconnected features.  
3.1.1. Single stimulus identification 
When a single object is considered, the probability of correct object identification is a func-
tion of exposure duration. It can be modeled by an exponential growth function originating 
from a threshold value t0, beneath which nothing is perceived, rising steeply with increasing 
presentation time, and approaching an asymptote when additional presentation time does not 
yield any further effect on report probability. The slope of this function at its origin reflects 
processing speed which is determined by the available capacity of attention (see Kyl-
lingsbaek, 2006, for a mathematical description). An illustration of this process is given in the 
second study of this dissertation (see Figure 4, p. 44). 
Given that x is the only object in the visual display, this single element‟s processing rate vx de-
termines the speed of the object‟s race towards VSTM and equals the basic sensory effective-
ness of object x, denoted sx (Bundesen, 1990, 1998) The sensory effectiveness of an object sx 
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is determined by several influences such as stimulus discriminability, contrast and spatial lo-
cation in relation to fixation (see also section 5.3.3.3, pp. 72 et seq.). 
3.1.2. Selection from multi-element displays 
In the case of multiple objects present in the visual field, two limiting factors emerge: a) the 
amount of the attentional capacity available and b) the capacity of the VSTM store (about 
four objects in healthy young subjects; see Cowan, 2001). The first constraint implies alloca-
tion of attention across all objects, which reduces the capacity each object receives and there-
by decreases the processing speed for each object. The second constraint relates to the termi-
nation of the selection process, which occurs when the VSTM store is completely filled.  
Thus, according to TVA, which considers the competition between multiple objects for selec-
tion as a race towards VSTM, the efficiency of visual processing is primarily characterized by 
two components: visual processing speed and the VSTM storage capacity. These components 
can be assessed by a whole report task, in which letter arrays are briefly presented, either 
masked or unmasked, and subjects have to report as many letters as possible. A subject‟s per-
formance can then be modeled by four parameters: perceptual processing speed C (i.e. the 
slope of the exponential growth function), VSTM storage capacity K (i.e. the asymptote of the 
function), a perceptual threshold t0, and an estimation of iconic memory µ (or visual persis-
tence) derived from unmasked displays (Kyllingsbaek, 2006). For a detailed illustration of the 
exponential growth function see Figure 4 (p. 44). 
3.1.2.1. Equation 1 – rate equation 
As the selection of a visual object is synonymous with its encoding into a VSTM store with 
limited capacity, the probability of selection is determined a) by an object‟s processing rate v, 
which depends on the attentional weight w it receives, and b) by the capacity of the VSTM 
store (if the store is filled, the selection process terminates). When an object is presented in 
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the visual field and is assigned to a certain perceptual category i, the hazard function of this 
process is assumed to be: 𝑣 𝑥, 𝑖 =  η(𝑥, 𝑖)β𝑖
𝑤𝑥
 𝑤𝑧𝑧∈𝑆
 (equation 1; Bundesen, 1990). 
The strength of the sensory evidence that element x belongs to category i is represented by 
η(x,i), βi is a perceptual decision bias associated with category i (0 ≤ βi ≤ 1), and wx and wz are 
attentional weights of elements x and z, respectively. S is the set of all elements in the visual 
field. The denominator of the third factor represents the relative attentional weight of object x 
(in reference to the sum of attentional weights for all elements in the visual field). Conse-
quently, the third factor of the rate equation indicates the portion of the total available capaci-
ty that is allocated to object x (e.g. Bundesen, 1990). 
With regard to central TVA parameters, it should be mentioned that perceptual processing 
speed C is defined as the sum of v values across all perceptual categorizations of all elements 
in the visual field while VSTM storage capacity K corresponds to the asymptote of the 
growths function relating mean number of reported visual objects to exposure duration. Para-
meter K represents the maximum number of reported elements on any single trial at any expo-
sure duration (e.g. Duncan et al., 1999). Further details are provided in chapter 4.3.3 (pp. 42 et 
seq.) of the second study. 
3.1.2.2. Equation 2 – weight equation 
Due to the limitation of VSTM capacity to K distinct elements, the resulting parallel race for 
selection (see also the 'biased competition model' by Desimone & Duncan, 1995) among ob-
jects in the visual display can be biased such that some objects are favored for selection/ en-
coding into VSTM, especially if display elements outnumber VSTM capacity K. According to 
the TVA model, to each element in the visual field a corresponding attentional weight w is as-
signed. The probability of a non-selected visual object to be encoded into VSTM depends on 
the relative attentional weight of that specific object in relation to the summed attentional 
weights of all other non-selected objects in the visual display (see equation 1; Bundesen, 
1990). Attentional weights are derived from pertinence values, πj (Bundesen, 1998; Kyl-
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lingsbaek, 2006). Every perceptual category j is assigned a pertinence value πj, which is a 
measure reflecting the current importance of attending to elements that belong to category j. 
The attentional weight of every object x in the visual field is determined by the second central 
equation of TVA: 𝑤𝑥 =  η(x, j)𝑗∈𝑅 𝜋𝑗  (equation 2; Bundesen, 1990). 
R is the set of all perceptual categories, η(x,j) is the strength of the sensory evidence that ele-
ment x belongs to category j, and πj is the pertinence value of category j (Bundesen, 1990). 
Importantly, further central TVA-based parameters are derived from attentional weights w, 
which are estimated separately for each object in the visual display. Parameter top-down con-
trol α, reflecting task-related weighting for prioritizing relevant visual objects for processing, 
indicates whether attentional weights for targets (T) are greater than the weights for distrac-
tors (D) and is defined as the ratio wD / wT. The spatial distribution of attentional weights 
across the left and right hemifields, parameter wλ, is derived from separate attentional weights 
for the left (wleft) and the right visual hemifield (wright). Parameter wλ is defined as the ratio 
wleft / (wleft + wright). See chapter 5.3.3 (pp. 70 et seqq.) for additional information. 
3.2. A neural theory of visual attention (NTVA) 
TVA (Bundesen, 1990) is able to account for a broad range of data from the experimental 
psychological literature on visual selective attention. The neural theory of visual attention 
(NTVA; Bundesen et al., 2005) also bridges the gap to neurophysiology by explaining a wide 
range of attentional effects derived from single cell recordings, and by making explicit as-
sumptions about a neural interpretation of its parameters. For example, processing speed is 
assumed to reflect the number and activation of cortical neurons representing visual objects, 
while VSTM storage is thought to represent the function of neuronal populations arranged in 
a feedback circuitry to actively maintain object representations (Bundesen et al., 2005).  
Parameter top-down control α and the spatial distribution of attention wλ are both derived 
from attentional weights that are computed for each element in the visual display. In terms of 
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NTVA (Bundesen et al., 2005), attentional weights are assumed to be represented as cortical 
activation in a saliency map which may be located in the widely interconnected pulvinar nuc-
leus of the thalamus. Via attentional weights, the reallocation of attention is controlled by dy-
namic remapping of receptive fields of cortical neurons. The higher the attentional weight of a 
visual object, the more neurons are assigned to that object. Consequently, selective processing 
of a prioritized object results from the amount of processing capacity allocated to this element 
which is dependent on the attentional weight of that object (Bundesen et al., 2005). In healthy 
subjects, more processing resources are dedicated to important objects, i.e. targets in contrast 
to distractors, indicating intact top-down control α (Desimone & Duncan, 1995). Accordingly, 
the parameter spatial distribution of attentional weights wλ might reflect the distribution of in-
terhemispheric cortical activity (Desimone & Duncan, 1995; Peers et al., 2005). 
3.3. TVA-based attentional assessment 
The whole report paradigm as well as the partial report paradigm are the central experimental 
applications of Bundesen‟s TVA (Bundesen, 1990) in the studies of the present dissertation. 
3.3.1. Whole and partial report paradigms 
A) 
 
B) 
 
Figure 1:  Schematic illustration of the TVA-based (A) whole and (B) partial report para-
digms 
(A): Different trial types with presentation of five equidistant letters (either red or green, respectively) in columns 
on the left or the right of the fixation cross are shown. (B): 16 different trial types were presented: 4 single target 
(depicted as „T‟, always red), 8 target plus distractor (depicted as „D‟, always green) and 4 dual target condi-
tions. 
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We used a whole report task (Figure 1 A), in which letter arrays are briefly presented, either 
masked or unmasked, and subjects have to report as many letters as possible (for the exact 
whole report instructions, see Instruction 1 and Instruction 2, p. 126). The whole report task, 
procedure, stimuli and apparatus are described in detail in the first study of this dissertation 
(see chapter 4.3.2, pp. 39 et seqq.).  
The whole report task was combined with Bundesen‟s TVA (see e.g. Bundesen, 1990) in or-
der to assess four mathematically independent and quantitative parameter estimates describing 
facets of visual information intake in general and specific aspects of processing capacity: a) 
parameter t0 (expressed in milliseconds), the estimated threshold value (minimum presenta-
tion time) beneath which nothing is perceived; b) parameter μ (also expressed in millise-
conds), the iconic memory buffer estimated from the difference in accuracy between un-
masked and masked displays; c) parameter C, an estimation of visual perceptual processing 
speed reflecting the rate of information uptake during visual processing (expressed in num-
bers of elements processed per second); and d) parameter K, an estimation of VSTM storage 
capacity representing the maximum number of objects that can be consciously maintained in 
parallel in VSTM (expressed in number of elements; see also chapter 4.3.3, pp. 42, et seq.). 
Besides the whole report task, a task was employed requiring partial report of briefly pre-
sented letters, based on Bundesen‟s (1990) TVA (see Figure 1 B). Subjects were instructed to 
report only pre-defined target letters while ignoring green distractor letters. For detailed in-
formation on test instructions, see Instruction 3 and Instruction 4 (p. 127). Details on the par-
tial report assessment (task, procedure, stimuli and apparatus) are provided in the second 
study of this dissertation (see chapter 5.3.2, pp. 68 et seqq.).  
The partial report paradigm allowed deriving two independent quantitative parameter esti-
mates for characterizing specific aspects of attentional weighting, such as task-related weight-
ing for prioritizing relevant visual objects for processing (top-down control α) and the spatial 
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distribution of attentional weights across the left and right hemifields, parameter wλ (for more 
detailed information, see chapter 5.3.3, pp. 70 et seqq.). 
3.3.2. Advantages 
The TVA-based approach permits parametric estimates to be derived from performance in 
two psychophysical tasks that reflect both, aspects of processing capacity (e.g., perceptual 
processing speed C and VSTM storage capacity K), assessed by a whole report task, and spa-
tial (parameter laterality of attentional weighting wλ) as well as task-related (parameter top-
down control α) aspects of attentional weighting, evaluated by a partial report experiment. 
In both highly identical paradigms (identical stimuli, similar tasks), subjects are simply asked 
to „Report as many letters as possible‟ (whole report) and to „Report red (target) letters only‟ 
(partial report), respectively, with the experimenter typing in all reported letters. Even cogni-
tively severely impaired patients like neglect patients (Bublak et al., 2005; Duncan et al., 
1999) or Huntington‟s disease patients (Finke et al., 2006) were able to complete both, the 
whole and partial report task. 
In general, whole and partial report can be considered as simple psychophysical tasks which 
were already successfully applied to several clinical populations like focal brain-damaged pa-
tients including partly subjects with subclinical attention deficits (Bublak et al., 2005; Gerlach 
et al., 2005; Habekost & Bundesen, 2003; Habekost & Rostrup, 2006; Peers et al., 2005), neg-
lect patients (Bublak et al., 2005; Duncan et al., 1999), patients suffering from simultanagno-
sia (Duncan et al., 2003), Huntington‟s disease (Finke et al., 2006) as well as MCI and AD 
(Bublak et al., 2006). Central conclusions arising out of TVA-based investigations (i.e. stu-
dies mentioned above) point at four central strengths of this tool for attentional assessment – 
the quality criteria sensitivity, specificity, reliability and validity. 
Notably, TVA-based attentional assessment completely abandons RT-based measurement. 
Thus, confounds by motor dysfunction are ruled out. Accordingly, parameters are derived 
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from raw data accuracy measurement of correctly reported letters. Therefore, interpretation of 
all parameter values is legitimate even if e.g. slowing of mental processing speed would be 
the underlying symptom of a patient.  
A further advantage of both paradigms is the fact that task difficulty is adapted to each of the 
subjects by individual adjustment of exposure duration which permits to control for compara-
ble task demands, for instance, when assessing healthy subjects, MCI and AD patients within 
one scope of research question, as presented in this dissertation. 
4. Study 1: Visual processing capacity in MCI and AD – 4.1. Abstract 31 
4. Study 1: Visual processing capacity in MCI and AD 
In this study, attentional functions of visual information intake and processing capacity were 
analyzed in a whole report task (WR) in patients with amnestic mild cognitive impairment 
(MCI) and Alzheimer‟s disease (AD). 
4.1. Abstract 
The present study analyzed visual information uptake based on Bundesen‟s (1990) theory of 
visual attention (TVA) in 18 subjects with probable Alzheimer‟s disease (AD), 18 subjects 
with amnestic mild cognitive impairment (MCI), and 18 healthy elderly control subjects. 
Groups were matched for gender, age, and education. From a whole report task requiring ver-
bal report of briefly presented letters, four parameters were derived, characterizing different 
aspects of visual processing capacity: perceptual threshold t0, iconic memory μ, processing 
speed C, and visual short-term memory (VSTM) storage capacity K.  
Comparison of these attentional parameters between groups revealed an elevation of the per-
ceptual threshold already in MCI subjects, while processing speed and VSTM storage capaci-
ty showed a significant decline for AD patients, only. AD patients on medication with acetyl-
choline esterase inhibitors had higher processing speed, but were still below the level of MCI 
patients. Perceptual threshold values were significantly correlated with disease duration, but 
not with cognitive measures. Conversely, speed and VSTM were significantly related to cog-
nitive scores, but not to disease duration. In particular, VSTM storage was related to neurop-
sychological tasks applying visual material (picture naming and visuo-construction), while 
speed showed an additional relationship also to measures of verbal memory. 
These results indicate a staged pattern of deficits affecting pre-attentive visual processing in 
MCI, and attentive processing in AD. They fit into the amyloid cascade hypothesis according 
to which the neuropathology of AD is characterized by a net accumulation and deposition of 
β-amyloid (Aβ) in the initial phase, giving rise to neuronal and neuritic dysfunction. Later, 
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gradual neuronal loss and transmitter disturbances finally cause the increasing intellectual de-
cline during further progression of the disease. A threshold elevation may thus be considered 
as a possible index of impaired neuronal functioning prior to cell death, while speed and 
VSTM deficits may be indicative already of a substantial loss of neuronal cell assemblies and 
a degeneration of neurotransmitter systems. 
4.2. Introduction and aim of the study 
Alzheimer‟s disease (AD) is the most frequent cause of dementia and has a prevalence that 
exponentially increases with age, so that up to one third of individuals aged above 80 years 
are affected (Blennow et al., 2006). It takes a slowly progressive course, typically with epi-
sodic memory impairment as the first ostensible cognitive sign. AD neuropathology is charac-
terized by an increasing load of senile plaques and neurofibrillary tangles in the brain, due to 
an imbalance between the production and clearance of β-amyloid (Aβ).  
 
Figure 2:  Amyloid cascade hypothesis in Alzheimer‟s disease 
“According to this hypothesis, the central event in the disease pathogenesis is an imbalance between Aβ pro-
duction and clearance, with increased Aβ production in familial disease and decreased Aβ clearance in sporadic 
disease. Aβ oligomers could directly inhibit hippocampal long-term potentiation and impair synaptic function, in 
addition to the inflammatory and oxidative stress caused by aggregated and deposited Aβ. These processes 
impair neuronal and synaptic function with resulting neurotransmitter deficits and cognitive symptoms. Tau pa-
thology with tangle formation is regarded as a downstream event, but could contribute to neuronal dysfunction 
and cognitive symptoms” (see p. 4 in Blennow et al., 2006; see also Hardy & Selkoe, 2002). 
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The amyloid cascade hypothesis (Hardy & Selkoe, 2002) assumes that rising plaque and tan-
gle burden invokes loss of nerve cells through direct and indirect effects on synaptic, neuronal 
and neuritic function (see e.g. Cirrito et al., 2005), resulting in progressive intellectual decline 
(see Figure 2). Presumably, the pathological load starts years before the clinical onset but re-
mains undetected until a critical threshold is reached and the first symptoms arise (Gauthier et 
al., 2006; Nestor, Scheltens, & Hodges, 2004). This transitional stage, when slight cognitive 
deficits already exist but do not yet exert adverse effects on activities of daily living, is termed 
“mild cognitive impairment” (MCI). MCI not necessarily leads to dementia, with some sub-
jects remaining stable or even returning to normal over time. However, it represents an at-risk 
state with more than half of the subjects converting to dementia within five years (Gauthier et 
al., 2006; Levey et al., 2006; Nestor et al., 2004). In particular, for AD the amnestic type of 
MCI is known to bear a high risk for progression to dementia, especially so, if additional defi-
cits of non-memory domains are also present (Alexopoulos et al., 2006; Alladi et al., 2006; 
Gauthier et al., 2006).  
Attention is one of the cognitive domains most likely to be affected already at early stages of 
AD (Foldi et al., 2002; Perry & Hodges, 1999, 2003). This is allegeable considering several 
important features of AD neuropathology. For example, large cortical neurons get preferen-
tially lost, inducing a cortico-cortical disconnection (Delatour, Blanchard, Pradier, & Duyck-
aerts, 2004) that not only affects hippocampal functions, but also destroys the neural network 
nodes supporting attentional functions (Sorg et al., 2007). In particular, accumulation of pla-
ques and tangles in visual association areas (Braak, Braak, & Kalus, 1989) may underlie defi-
cits of visual attention. Finally, degeneration of the basal nucleus results in decline of cortico-
petal cholinergic input (Coyle, Price, & DeLong, 1983; Mesulam, 2004). As cholinergic pro-
jections attain to virtually all cortical regions and are able to modulate the processing of 
sensory stimuli (Sarter & Bruno, 2000; Sarter, Hasselmo, Bruno, & Givens, 2005), their loss 
additionally contributes not only to learning, but also to attentional deficits. Importantly, all 
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these features described can already be found in MCI patients (Herholz, 2008; Herholz et al., 
2005; McKee et al., 2006). Thus, sensitive biomarkers loading functionally on the neural alte-
rations invoked by AD from early on, might improve the possibility to identify at risk subjects 
in time, providing a chance for effective treatment (Shah et al., 2008). The present study ex-
amines whether cognitive parameters for estimating the capacity of visual attention might 
serve that purpose. 
A decisive progress in this direction has already been made by the assessment of visual per-
ceptual speed based on the so-called inspection time paradigm (Deary, 2001; Vickers, Nettel-
beck, & Willson, 1972). In this task, subjects are presented with, for example, a π-like shape 
that has two arms of different lengths, and have to decide which one (left or right) is the long-
er. By assessing performance accuracy as a function of presentation time in this task, an esti-
mation of the speed of visual information uptake is derived. Inspection time (IT) has been 
shown to be significantly increased in Parkinson‟s disease (Johnson et al., 2004), and in both 
subjects with AD (Deary, Hunter, Langan, & Goodwin, 1991) and with MCI (Bonney et al., 
2006). Pharmacological studies have confirmed a strong relationship between perceptual 
speed, as assessed by IT, and the functional state of the cholinergic system (Hutchison, Na-
than, Mrazek, & Stough, 2001; Nathan & Stough, 2001; Stough, Thompson, Bates, & Nathan, 
2001). 
However, studies using the IT approach have also raised some unresolved issues. For exam-
ple, although a relationship to intelligence is well established (Deary, 2001; Grudnik & 
Kranzler, 2001; Schweizer & Koch, 2003), the exact role of the cognitive mechanisms re-
flected by IT is not sufficiently understood (Burns & Nettelbeck, 2003; Deary, 2000). In addi-
tion, it has become increasingly clear that IT has a more complex psychological nature than 
initially thought and might encompass not only a pure speed component, but also other as-
pects such as perceptual thresholds or even higher-level functions related to memory, atten-
tion, and cognitive control (Nettelbeck, 2001). 
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A theoretical framework that is more explicit with respect to the integration of different com-
ponents of visual information intake is the theory of visual attention (TVA) proposed by Bun-
desen (1990, 1998). TVA is a computational model of visual selective attention with a strong 
association to the biased competition framework (Desimone, 1998; Desimone & Duncan, 
1995; Duncan et al., 1997). According to TVA, visual information intake is a process by 
which evidence is accumulated that a visual object “x” belongs to a certain category “i” (e.g. 
red objects) and bears a certain feature “j” (e.g. shape). As a result of this process the object 
can be identified, which in TVA is synonymous with its selection or – in TVA terms – encod-
ing into a visual short-term memory (VSTM) store. When a single object is considered, the 
probability of correct identification is a function of exposure duration. It can be modeled by 
an exponential growth function originating from a threshold value t0, beneath which nothing 
is perceived, rising steeply with increasing presentation time, and approaching an asymptote 
when additional presentation time does not yield any further effect on report probability. The 
slope of this function at its origin reflects processing speed which is determined by the availa-
ble capacity of attention (see Kyllingsbaek, 2006, for a mathematical description). 
In the case of multiple objects present in the visual field, two limiting factors emerge: a) the 
amount of the attentional capacity available and b) the capacity of the VSTM store (about 4 
objects in healthy young subjects; see Cowan, 2001). The first constraint implies allocation of 
attention across all objects, which reduces the capacity each object receives and thereby de-
creases the processing speed for each object. The second constraint relates to the termination 
of the selection process, which occurs when the VSTM store is completely filled.  
Thus, according to TVA, which considers the competition between multiple objects for selec-
tion as a race towards VSTM, the efficiency of visual processing is primarily characterized by 
two components: visual processing speed and the VSTM storage capacity. These components 
can be assessed by a whole report task, in which letter arrays are briefly presented, either 
masked or unmasked, and subjects have to report as many letters as possible. A subject‟s per-
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formance can then be modeled by four parameters: processing speed (i.e. the slope of the ex-
ponential growth function), VSTM storage capacity (i.e. the asymptote of the function), a per-
ceptual threshold, and an estimation of iconic memory (or visual persistence) derived from 
unmasked displays (Kyllingsbaek, 2006). 
TVA is able to account for a broad range of data from the experimental psychological litera-
ture on visual selective attention. It also bridges the gap to neurophysiology by explaining a 
wide range of attentional effects derived from single cell recordings, and by making explicit 
assumptions about a neural interpretation of its parameters. For example, processing speed is 
assumed to reflect the number and activation of cortical neurons representing visual objects, 
while VSTM storage is thought to represent the function of neuronal populations arranged in 
a feedback circuitry to actively maintain object representations (Bundesen et al., 2005).  
In recent years, the TVA based approach has been successfully applied to several clinical 
populations (Bublak et al., 2005; Duncan et al., 1999; Gerlach et al., 2005; Habekost & Bun-
desen, 2003; Habekost & Rostrup, 2006, 2007; Peers et al., 2005). In particular, in a previous 
study assessing the subcortical dementia of Huntington‟s disease, both the speed of 
processing and the VSTM storage capacity were reduced and this decline was significantly re-
lated to the disease stage (Finke et al., 2006).  
In the present study, the same methodology was applied to AD as a cortical dementia, in order 
to examine whether there would be a systematic decrease of processing capacity at different 
stages of the disease, that is, amnestic MCI and dementia. In addition, perceptual threshold 
and iconic memory parameters were also assessed, so as to obtain a more complete picture of 
the factors contributing to the purported impairment of visual information intake during the 
course of AD. In general, for all aspects, an incremental decline in MCI compared to healthy 
subjects was expected, and in AD compared to MCI subjects. 
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4.3. Method 
4.3.1. Subjects 
Overall, 54 subjects – 18 patients with probable AD, 18 MCI patients, and 18 healthy control 
subjects – participated in this study. The three groups were matched for gender (χ2(2)= .15; p 
> .90), age (F(2, 53) = .35; p > .70), and education (F(2, 53) = 1.09; p > .30). Disease duration 
(time since symptom onset) tended to be longer in AD than in MCI subjects (t(34) = 1.87, p < 
.10). Demographic data are summarized in Table 1. Patients were recruited from the Memory 
Clinic of the Department of Psychiatry, Technical University, Munich, Germany; control sub-
jects by word-of-mouth and notice board advertising.  
All patients underwent a standardized diagnostic assessment comprising medical history (both 
patient and informant interview); medical, neurological, and psychiatric examination; neurop-
sychological assessment using the test battery of the Consortium to Establish a Registry for 
Alzheimer‟s Disease (CERAD-NP, German version; Thalmann and Monsch (1997); see Test 
1, pp. 141 et seqq.), which includes the Mini-Mental State Examination (MMSE; Folstein, 
Folstein, & McHugh, 1975) and the Clock Drawing Test (CDT; Shulmann et al. (1993), see 
Test 2, pp. 155 et seq.), rating of the overall severity of cognitive deficits using the Clinical 
Dementia Rating scale (CDR; Morris (1993), see Test 3, pp.157 et seqq.), structural brain im-
aging (MRI), and blood tests. The results of the neuropsychological testing are also provided 
in Table 1. Details for individual MCI and AD subjects are provided in Table 8 (p. 128). 
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Table 1:  WR: Demographic and neuropsychological data for MCI and AD patients and 
healthy controls 
See also Table 8 (p. 128). 
Values represent mean scores (and standard deviations). 
AD: subjects with probable Alzheimer‟s disease; MCI: subjects with mild cognitive impairment; HC: healthy con-
trol subjects; CDR: clinical dementia rating; MMSE: Mini Mental State Examination; CERAD: Consortium to Es-
tablish a Registry for Alzheimer‟s Disease; n.a.: not applied. 
**: AD versus MCI, p < .01; *: AD versus MCI, p < .05; +: AD versus MCI, p < .08 
§§
: MCI versus HC, p < .01; 
a
: Values represent median (and range); 
b
: Norm values taken from the CERAD manual. 
c
: Cut-off score 
 AD MCI HC 
Gender (male / female) 7 / 11 8 / 10 7 / 11 
Age (years) 68.3 (9.0) 69.8 (5.0) 68.0 (6.0) 
Education (years) 9.9 (1.5) 10.8 (1.9) 10.6 (2.0) 
MMSE (max. 30) 22.5 (2.4)
**
 27.4 (1.2)
§§
 29.0 (1.1) 
Disease duration (years) 3.4 (1.9)
+
 2.5 (1.2) - 
CDR sum score
a
 4.3 (3.5-7.0)
**
 2.0 (0.5-3.5) - 
CERAD total score 66.0 (10.8)
**
 83.5 (13.0) n.a. 
Category Fluency (animals) 13.9 (5.7)
**
 18.3 (5.7) 21.3 (5.5)
b
 
Boston Naming (max. 15) 12.6 (2.2) 13.0 (2.4) 14.0 (1.1)
b
 
Word list learning (max. 30) 10.8 (2.8)
**
 15.2 (3.9) 20.1 (3.7)
b
 
Delayed recall (max. 10) 1.4 (1.2)
**
 3.9 (1.6) 6.9 (2.0)
b
 
Recognition (max. 20) 16.8 (1.7)
**
 18.3 (1.8) 19.4 (0.9)
b
 
Visuoconstruction (max. 11) 8.3 (1.7)
*
 9.7 (1.7) 10.4 (0.9)
b
 
Clock drawing (max. 6)
a
 4.0 (1-5)
**
 2.0 (1-4) 3
c
 
 
Diagnosis of probable AD was made following the diagnostic criteria of the ICD-10 classifi-
cation of mental and behavioral disorders for dementia (Bramer, 1988), and the NINCDS-
ADRDA criteria (see list of abbreviations, p. VIII) for the diagnosis of AD (McKhann et al., 
1984). Diagnosis of MCI met the criteria for amnestic MCI (Gauthier et al., 2006; see also 
Sorg et al., 2007), which include reported and neuropsychologically assessed memory im-
pairments, largely preserved activities of daily living (B-ADL; Hindmarch, Lehfeld, de Jongh, 
& Erzigkeit, 1998), excluded dementia according to ICD-10 criteria, and CDR (global score) 
of 0.5 (questionable dementia). Exclusion criteria for entry into the study were other neuro-
logical, psychiatric, or systemic diseases (e.g. stroke, depression, alcoholism), or clinically 
notable MRI (e.g. stroke lesions) which could be related to cognitive impairment. None of the 
subjects had diabetes mellitus, and none received antidepressant medication. Two MCI sub-
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jects received anti-hypertensive medication. Eleven of the subjects with probable AD were 
treated with acetylcholine esterase inhibitors (AChEI). All patients were able to fixate ade-
quately, understand, and follow verbal instructions, and concentrate on the task for the dura-
tion of the experiment. All healthy control subjects were without memory complaints, were 
unrelated to the patients, and had no history of neurological or psychiatric disease.  
All patients and control subjects taking part in this study were right-handed (according to the 
Edinburgh Handedness Inventory, Oldfield, 1971), and had normal or corrected to normal vi-
sion. Subjects were treated in full agreement with the Declaration of Helsinki II, and gave 
written informed consent in accordance with the Human Research Committee guidelines of 
the Klinikum Rechts der Isar, Technical University, Munich. 
4.3.2. Whole report paradigm 
The whole report paradigm was applied in a manner analogous to that introduced by Duncan 
et al. (1999) and adopted in several previous studies of our own group (Bublak et al., 2005; 
Finke et al., 2006; Finke et al., 2005). 
4.3.2.1. Task 
A schematic illustration of an experimental trial is shown in Figure 3. On each trial, subjects 
were briefly presented with five equidistant target letters. They were arranged in a vertical 
column, which was displayed to either the left or the right of a fixation cross (see Figure 3). 
Subjects were instructed to maintain fixation and, after the letters had been presented, to ver-
bally report all the letters they were fairly sure they had recognized. Letters could be reported 
in any order, and there was no emphasis on speed of report. The experimenter entered the re-
ported letter(s) on the computer keyboard and initiated the next trial after the subject had indi-
cated that he/she was ready. For detailed information on test instructions, see Instruction 1 
and Instruction 2 (p. 126). 
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Figure 3:  WR: Schematic illustration of the whole report task 
Different trial types with presentation of five equidistant letters (either red or green, respectively) in columns on 
the left or the right of the fixation cross are shown. 
4.3.2.2. Procedure 
The letter arrays were presented for three different exposure durations, and were either 
masked or unmasked. Owing to visual persistence, the actual exposure durations are usually 
prolonged in unmasked as compared to masked conditions (Sperling, 1960). Thus, by ortho-
gonally combining the three exposure durations with the two masking conditions, six different 
„effective‟ exposure durations resulted. These were expected to generate a broad range of per-
formance, so that coverage of the whole curve relating report accuracy to effective exposure 
duration would be possible. 
The three exposure durations were determined individually for each subject in a pre-test phase 
and then introduced into the experimental assessment phase. This was done to permit adjust-
ment of baseline performance for all subjects, so as to support maximum validity of parameter 
estimation. Note that presentation time selection by itself is not a determinant of the parame-
ters obtained; rather, it provides just a means for optimal modeling of a subject‟s perfor-
mance. 
4. Study 1: Visual processing capacity in MCI and AD – 4.3. Method 41 
During the pre-test, the individual presentation time was determined at which a subject could 
report, on average, one letter per trial correctly (i.e. 20% report accuracy) in a series of 24 
masked trials (12 for each hemifield) presented with a fixed exposure duration (e.g. 300 ms). 
This presentation time was then used as the intermediate exposure duration in the experimen-
tal session, together with a shorter (about half as long, e.g. 157 ms) and longer (about twice as 
long, e.g., 600 ms), exposure duration (with each exposure duration adjusted to the screen re-
fresh rate). The average “short” presentation time was M = 140 ms (SD = 29.1) for healthy 
control subjects, M = 162 ms (SD = 56.9) for MCI subjects, and M = 198 ms (SD = 64.4) for 
AD subjects. “Intermediate” presentation times were on average M = 274 ms (SD = 61.0) for 
healthy subjects, M = 317 ms (SD = 117.8) for MCI subjects, and M = 387 ms (SD = 134.0) 
for AD subjects. And “long” presentation times were M = 547 ms (SD = 127.2) for healthy 
control subjects, M = 597 ms (SD = 188.7) for MCI subjects, and M = 713 ms (SD = 172.1) 
for AD subjects. The most frequently used set of presentation times was (157 ms, 300 ms, 600 
ms), applied to about half of the subjects (13 healthy control subjects, 5 MCI subjects, and 10 
AD subjects). Individual exposure durations for all three subject groups are listed in Table 9 
(p. 129). 
The whole report task comprised 192 trials, separated into four blocks of 48 trials each. With-
in each block, the twelve different trial conditions (2 hemifields x 3 exposure durations x 2 
masking conditions) of the experiment were presented equally often and in randomized order. 
Each subject received the same letter displays in the same random order. The test lasted about 
half an hour, with breaks between blocks adapted to a subject‟s needs. 
4.3.2.3. Stimuli 
The letters presented on each trial were either all red or all green and appeared at high contrast 
on a black background. For a given trial display, letters were randomly chosen from the al-
phabet excluding „C, D, G, I, O, Q, U, V‟, with a particular letter appearing only once. Letter 
size was 0.5 of visual angel in height and 0.4 in width. Masks consisted of letter-sized 
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squares (of 0.5) filled with a “+” and an “” and presented for 500 ms at each letter location. 
The distance of the letter column from the vertical meridian was 2.5° of visual angle. 
4.3.2.4. Apparatus 
The whole report task was conducted in a dimly lit room. Stimuli were presented on a person-
al computer with a 17‟‟ monitor (1024 x 768 pixel screen resolution; 70 Hz refresh rate). 
Viewing distance was about 50 cm. All patients were tested on location in the Memory Clinic, 
while the control subjects were assessed in an external psychology lab under identical condi-
tions.  
4.3.3. Estimation of TVA parameters 
Parameters were estimated applying the algorithms described in detail by Kyllingsbaek 
(2006) and used in several recent studies (Bublak et al., 2005; Duncan et al., 1999; Finke et 
al., 2006; Finke et al., 2005; Habekost & Bundesen, 2003). Generally, based on the basic equ-
ations (see sections 3.1.2.1 and 3.1.2.2, pp. 24 et seqq.) provided by TVA (see Bundesen, 
1990; Bundesen et al., 2005; Kyllingsbaek, 2006), a subject‟s accuracy of letter report as a 
function of effective exposure duration is modeled by an exponential growth function, accord-
ing to a maximum likelihood method. Two defining characteristics of this function are the 
slope at its origin and its asymptote. They represent two important TVA parameters, the 
meaning of which is described below. 
According to TVA, in masked conditions, the effective exposure duration of the stimulus dis-
play is the difference t–t0, with t being the display presentation time and t0 the estimated mi-
nimal effective exposure duration below which information uptake from the display is as-
sumed to be zero. Under non-masked stimulus conditions, owing to visual persistence, an ef-
fective exposure duration of µ milliseconds is added to t–t0. TVA assumes that, for a given 
subject, t0 and µ are constant across experimental conditions (see e.g. Bundesen, 1990). 
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Thus, essentially, fitting of the raw data is based on estimating four parameters which define 
the exponential growth function: a) parameter t0 (expressed in milliseconds), the estimated 
threshold value (minimum presentation time) beneath which nothing is perceived (i.e. proba-
bility of report equals 0); b) parameter μ (also expressed in milliseconds), the iconic memory 
buffer estimated from the difference in accuracy between unmasked and masked displays; c) 
parameter C, an estimation of visual processing speed (rate of information uptake, expressed 
in numbers of elements processed per second), reflecting the slope of the exponential growth 
function at its origin at the coordinate (t0, 0); and d) parameter K, an estimation of VSTM sto-
rage capacity (the maximum number of objects that can be represented simultaneously at a 
time in VSTM, expressed in number of elements), reflecting the asymptote of the exponential 
growth function. 
4.4. Results 
4.4.1. Raw data 
Figure 4 illustrates the qualitative pattern of performance for three representative subjects, one 
for each of the three groups. As indicated by the histograms (Figure 4 A-C), for each subject, 
the number of letters reported correctly increased systematically with increasing exposure du-
ration. However, both the AD and the MCI subject‟s letter identification performance was 
markedly reduced compared to the healthy control subject at the shortest exposure durations, 
with a relatively large proportion of zero letter reports. In the right panels of Figure 4 (D-F), 
the black dots represent the observed number of correctly reported letters [Mean(obs)] as a 
function of the effective exposure duration. As can be seen, within the earlier section of the 
ascending curve relating performance to presentation time, the performance increment with 
increasing stimulus exposure is more pronounced in the healthy subject, but less so especially 
in the AD patient. 
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4.4.2. TVA parameter estimates 
For each subject, the accuracy of letter report as a function of effective exposure duration was 
modeled by a TVA-based function representing the best fit of the raw data according to a 
maximum likelihood method (see e.g. Ross, 2000). This theoretically derived function is 
shown as a solid line for the representative subjects in Figure 4 [Mean(theo)]. 
A) 
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Figure 4:  WR: Whole report performance of a representative subject for each group: One 
healthy control subject (LA), one MCI patient (MM), and one AD patient (GE) 
The left panels (A–C) show the percentage of trials with 0, 1, 2, 3 or (in the AD patient) 4 correct letters re-
ported, plotted as a function of effective exposure duration. In the right panels (D–F), the mean number of cor-
rectly reported letters is shown as a function of effective exposure duration. Solid curves represent the best fits 
of the TVA-based model to the observed values. The resulting estimates of visual short-term memory storage 
capacity K are marked by a dashed horizontal line (asymptote of the curve), the estimates of visual perceptual 
processing speed C are shown as a dotted tilted line (slope of the curve at t0). Numerical values of these para-
meters, as well as of the estimated threshold t0 and of iconic memory duration μ are also provided.  
Overall, there was a close correspondence between the theoretically and the empirically ob-
tained mean scores in the three groups. Across subjects, the average Pearson product-moment 
correlation between the observed values and the TVA best data fits in each of the three groups 
was r = .93 (SD = .08) for the AD group, r = .96 (SD = .02) for the MCI group, and r = .95 
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(SD = .04) for the group of healthy control subjects. Thus, overall, the TVA model accounted 
for more than 86% of the variance in the performance of the whole report task. 
In Figure 4, the theoretically derived function [Mean(theo)] shows the typical course already 
known from previous studies (e.g. Duncan et al., 1999; Finke et al., 2005). However, in both 
patients, the function originates at a longer exposure duration compared to the healthy subject. 
Also, the slope of the function (dotted tilted line) at the point (t0, 0) is less steep in the AD pa-
tient compared to the other two subjects, indicative of a somewhat reduced processing speed 
C. As exposure duration increases to a few hundred milliseconds, though, all three curves ap-
proach a similar asymptotic level of about 3 reported letters. Accordingly, the three dashed 
horizontal lines indicating the subjects‟ predicted VSTM storage capacity K, are at about the 
same level.  
As for the representative cases shown in Figure 4, the four parameters (t0, μ, C and K) were 
derived individually for each of the 54 subjects tested by modeling his/ her performance in the 
whole report task. The numerical parameter estimates obtained in this way for each subject 
(see Table 10, pp. 130 et seq.) allowed for statistical analysis at the group level. Planned com-
parisons between groups (healthy control subjects versus MCI patients, and MCI versus AD 
patients) were conducted using t-tests for independent samples. 
4.4.2.1. Perceptual threshold: Parameter t0 
Figure 5 presents the group means for the threshold parameter t0, separately for each group. 
Subjects with MCI displayed a significantly elevated threshold compared to healthy control 
subjects (M = 106.1 ms, SD = 64.8 versus M = 75.5 ms, SD = 39.2; t(34) = -1.72, p < .05, 
one-tailed), but the difference between MCI subjects and AD subjects (M = 106.1 ms, SD = 
64.8) versus M = 114.9 ms (SD = 51.1)) was non-significant (t(34) = .45, p > .30).  
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Figure 5:  WR: Mean values of the estimated perceptual threshold t0 for healthy controls 
(HC), MCI and AD subjects 
Error bars indicate the standard error of the mean. 
4.4.2.2. Iconic memory: Parameter μ 
Figure 6 shows group means for the iconic memory parameter μ. There were no statistically 
significant differences in this parameter, neither between MCI and healthy control subjects 
(M = 91.6 ms, SD = 31.8 versus M = 102.7 ms, SD = 39.5; t(34) = .93, p > .15), nor between 
MCI and AD subjects (M = 91.6 ms, SD = 31.8 versus M = 97.6 ms, SD = 62.9; t(34) = .36, p 
> .35).  
 
Figure 6:  WR: Mean values of the estimated iconic memory μ duration for healthy controls 
(HC), MCI and AD subjects 
Error bars indicate the standard error of the mean. 
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4.4.2.3. Processing speed: Parameter C 
Figure 7 presents the group means for the speed parameter C.  
 
Figure 7:  WR: Mean values of the estimated processing speed C for healthy controls (HC), 
MCI and AD subjects 
Error bars indicate the standard error of the mean. 
While MCI subjects were comparable to healthy control subjects in processing speed (M = 
17.5 elements/ sec, SD = 6.0 versus M = 19.9 elements/ sec, SD = 6.6; t(34) = 1.11, p > .10), 
they were able to process a significantly larger number of items per second than AD subjects 
(M = 17.6 elements/ sec, SD = 6.0 versus M = 11.0 elements/ sec, SD = 4.9; t(34) = -3.57, p < 
.01, one-tailed).  
4.4.2.4. VSTM storage capacity: Parameter K 
Figure 8 presents the group means for the VSTM parameter K. As for the speed parameter, 
MCI subjects did not differ significantly from healthy control subjects in terms of VSTM sto-
rage capacity (M = 2.9 elements, SD = .4 versus M = 3.0 elements, SD = .4; t(34) = .88, p > 
.15); however, MCI subjects‟ capacity was larger than that of AD subjects (M = 2.9 elements, 
SD = .4 versus M = 2.5 elements, SD = .6; t(34) = -1.89, p < .05, one-tailed).  
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Figure 8:  WR: Mean values of the estimated visual short-term memory storage capacity K 
for healthy controls (HC), MCI and AD subjects 
Error bars indicate the standard error of the mean. 
Taken together, analysis of the TVA parameters indicated an elevation of the perceptual thre-
shold already in MCI, but a significant decline in processing speed and VSTM storage capaci-
ty only in AD. 
4.4.3. Effect of acetylcholine esterase inhibitor medication 
As mentioned above, 11 AD subjects received acetylcholine esterase inhibitors (AChEI) at 
the time of testing. Therefore, medicated and non-medicated AD subjects were compared with 
respect to the two parameters for which significant differences had been found compared to 
MCI: processing speed C and VSTM storage capacity K. Medicated and non-medicated sub-
jects were comparable in terms of age (t(16) = 1.05, p > .30), gender (χ2(2) = .08; p > .75), 
and education (t(16) = -.20, p > .80). 
For processing speed C, there was a significant difference (Figure 9). Non-medicated AD pa-
tients had lower processing speed than AChEI-medicated patients (M = 8.1 elements/ sec, SD 
= 4.0 versus M = 12.9 elements/ sec, SD = 4.7; t(16) = -2.24, p < .05; two-tailed). Non-
medicated patients also exhibited lower VSTM storage capacity compared to medicated pa-
tients (M = 2.2 elements, SD = .7 versus M = 2.7 elements, SD = .5), though this difference 
was not statistically reliable (t(16) = -1.54, p > .15).  
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Figure 9:  WR: Mean values of the estimated processing speed C for medicated and non-
medicated subjects with probable Alzheimer‟s disease 
Medication refers to acetylcholine esterase inhibitors. Error bars indicate the standard error of the mean. (HC = 
level of healthy control subjects; MCI = level of MCI patients). 
With respect to processing speed, medicated AD patients still differed significantly from MCI 
subjects (t(27) = -2.20, p < .05; two-tailed). 
4.4.4. Relationship to disease duration 
Across both clinical groups (i.e. MCI and AD patients), correlations between the three af-
fected TVA parameters (t0, C, and K) and disease duration were calculated, that is, time since 
symptom onset.  
For t0, the correlation with disease duration was significant (r = .34, p < .05; two-tailed), indi-
cating a modest association that points to an increase of the perceptual threshold with longer 
lasting disease. In contrast, C and K were not associated with disease duration (r = .02, p > 
.90, and r = -.09, p > .55, respectively). 
4.4.5. Relationship to indices of cognitive function 
We also calculated correlations between the three affected TVA parameters (t0, C, and K) and 
three global cognitive measures – namely: CDR score, MMSE and CERAD total score (which 
does not include the MMSE; see Chandler et al., 2005) – across both clinical subject groups. 
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The perceptual threshold parameter t0 was not associated with any of these measures (all p 
>.40; two-tailed). However, processing speed C was significantly related to CDR (r = -.55, p 
< .01), the MMSE score (r = .59; p < .01) and the CERAD total score (r = .42, p < .05). 
VSTM storage capacity K was also significantly related to CDR (r = -.39, p < .05), and the 
CERAD total score (r = .40, p < .05), while the association to the MMSE score was somewhat 
weaker (r = .33, p < .06). 
Interestingly, with respect to the CERAD, VSTM storage capacity K was related only to those 
subtests providing visual material (i.e. picture naming and visuo-construction; r = .49, p < .01 
in both cases). In contrast, processing speed C was significantly correlated not only with these 
measures (r = .33, and r = .39, respectively, both p < .05), but also with the verbal memory 
measures (learning, delayed recall, and recognition; all r > .35, all p < .05). 
4.5. Discussion 
The present study analyzed visual information uptake based on Bundesen‟s (1990) theory of 
visual attention (TVA) in AD, MCI, and healthy elderly control subjects. From a whole report 
task requiring verbal report of briefly presented letters, four parameters were derived, charac-
terizing different aspects of visual processing capacity: perceptual threshold t0, iconic memory 
μ, processing speed C, and VSTM storage capacity K. Comparison of these attentional para-
meters between groups revealed an elevation of the perceptual threshold already in MCI sub-
jects, while processing speed and VSTM storage capacity showed a significant decline for AD 
patients only. The reduction in processing speed was especially pronounced in non-medicated 
AD patients, proving a strong relation of processing speed to the functional state of the choli-
nergic system. 
This staged pattern of performance deficits revealed in the present study is striking, because it 
is the first, to my knowledge, to assess basic aspects of visual information uptake in both MCI 
and AD patients. It is well established that AD is accompanied by abnormalities in attentional 
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processing of visual stimuli. For example, Schlotterer et al. (1984) found Alzheimer patients 
to require more time than age-matched controls to identify letters, and to be susceptible to in-
terference from a backward pattern mask for a longer time interval. Consistent with this, Gil-
more et al. (2005) have shown that AD patients have to rely on higher contrast stimuli than 
healthy subjects for identifying rapidly flashed masked letters with comparable accuracy. Al-
so, Kavcic & Duffy (2003) disclosed an impaired temporal dynamics of visual perceptual 
processing in the attentional-blink paradigm using rapid serial visual presentation of alpha-
numeric stimuli. However, MCI patients were not assessed in these studies, so that a direct 
comparison between deficits at different stages of AD was not possible. Conversely, Perry & 
Hodges (2003) found a normal attentional blink in MCI, while Bonney et al. (2006) reported 
prolonged inspection times in MCI subjects, but both studies had not included patients with 
dementia.  
Relying on the conceptual strength of TVA in the present study, qualitative as well as quantit-
ative differences could be described between MCI and AD subjects with respect to separable 
components of visual information intake. The data point to the possibility that the identified 
impairments follow an orderly progression, such that simpler aspects of visual processing like 
a perceptual threshold are affected at an earlier disease stage (MCI), and before significant 
cognitive decline has emerged, while more complex aspects like processing speed and short-
term storage decline at a later stage when intellectual functions have already deteriorated 
(dementia). Based on TVA and its neural interpretation (NTVA; Bundesen et al., 2005), this 
differentiation can be discussed with respect to deficits at early (pre-attentive) versus late (at-
tentive) stages of visual processing. 
4.5.1. Deficits of pre-attentive processing 
According to TVA, during the first stage of visual processing, perceptual units (objects) in the 
visual field are matched to representations in visual long-term memory (categories). This is a 
massively parallel process that results in the computation of evidence values, each providing a 
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measure for the degree of the match between a given object and a long-term memory repre-
sentation. This first stage does not enable object identification. For example, in whole report 
of letters, the strength of the evidence that a given letter is an „E‟ may equal the strength of 
the evidence that the letter is an „F‟. Evidence values are affected by the objective conditions 
of the visual environment like stimulus visibility (e.g. contrast), by the quality of the visual 
patterns to be matched, and by the reliability of long-term memory representations (this de-
scription follows Kyllingsbaek, 2006). As a result, pathology of both peripheral and central 
components of the retino-calcarine pathway could contribute to deficits arising at this first 
stage. 
With respect to peripheral pathology, an extensive neuro-ophthalmic investigation by Rizzo et 
al. (1992) has provided evidence that, compared to pathologic changes in visual association 
cortex, retinal or optic nerve pathology are negligible for explaining visual deficits in AD (see 
Rizzo, M., Anderson, Dawson, & Nawrot, 2000, for a similar conclusion). Recently, however, 
retinal abnormalities have been reported to occur in early AD (Berisha et al., 2007), so that it 
is conceivable that an elementary deficit like an elevated threshold would be related to such 
abnormalities. However, what argues against this assumption is that any retinal pathology 
would be expected to also affect iconic memory duration, which was not supported by the 
present results. Moreover, in the study of Berisha et al. (2007), retinal pathology was asso-
ciated with visual field defects. However, there was no evidence for the presence of scotoma 
in the participants of this study. Therefore, the identified elevation of the visual threshold is 
suggested to be related to central, rather than to peripheral, pathology.  
As regards central pathology, an elevated visual threshold could result from alterations in ear-
ly visual areas in and around the striate cortex. On this assumption, feature detectors that pro-
vide the „building-blocks‟ for constructing visual patterns would be degraded. Consequently, 
the patterns to be compared to visual long-term memory representations might be compro-
mised, impeding the matching process. This interpretation is compatible with the available 
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evidence that neurofibrillary tangle burden, although relatively minor in area 17, is considera-
ble in areas 18 and 19 (Braak et al., 1989; Lewis, Campbell, Terry, & Morrison, 1987). More-
over, this pathology is notable already in pre-clinical AD subjects (McKee et al., 2006), sup-
porting the present finding of a threshold increase in MCI patients.  
An alternative account could be that long-term memory representations of letters, assumed to 
reside in the fusiform gyrus of the left hemisphere (Polk et al., 2002), might be degraded di-
rectly. That is, the disturbance of the matching process would result from the memory rather 
than pattern construction. Consistent with this, tangle burden has been found to be particularly 
marked in infero-temporal areas (Lewis et al., 1987), and cortical degeneration to be more 
pronounced in the left hemisphere (Thompson et al., 2003). 
4.5.2. Deficits of attentive processing 
TVA conceives of the second stage of visual processing as a race in which categorizations de-
rived from the first stage compete for representation in VSTM. Entry to VSTM is synonym-
ous with selection. Its result is the identification of a subset of visual elements from the visual 
field (e.g. that a given letter is an „E‟). Thus, in terms of TVA, those elements are selected 
that won the race for VSTM representation as a result of receiving the highest processing rate 
(Bundesen et al., 2005; Kyllingsbaek, 2006). The processing rate for each element is a func-
tion of both the evidence value derived from the first stage and an attentional weight assigned 
to the element. The weights stem from the available (limited) attentional capacity that is dis-
tributed across all the elements in the visual field. Thus, under the conditions of a whole re-
port task where no element in the display is prioritized according to an a-priori criterion, it 
can be assumed that processing speed (i.e. the sum of the processing rates for each display 
element) essentially reflects the amount of available attentional capacity.  
According to the neural interpretation of TVA (NTVA; Bundesen et al., 2005), allocation of 
attentional capacity to a visual object is synonymous with the recruitment of cortical neuronal 
populations representing the object. While the number and activation levels of these neurons 
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reflect processing speed, VSTM storage is realized by feedback loops that sustain the activa-
tion of neural units representing a subset of objects within reverberatory circuits (Bundesen et 
al., 2005). Thus, from a neuroanatomical and neurophysiological perspective, these visual 
functions arise from both the pure number of available neurons and their responsiveness. 
Hence, while a rather local pathology could explain the threshold elevation discussed above, 
more widespread alterations are likely to underlie the decline of VSTM storage capacity and 
processing speed. Given this, it appears plausible that these aspects show significant decline 
at an advanced disease stage (as seen in the present study) when AD pathology has already 
paved the way for substantial loss of neurons, cortico-cortical and cortico-subcortical discon-
nection, as well as destruction of neurotransmitter systems. 
In line with this, in subjects with acquired brain damage, Habekost & Rostrup (2007) found 
severe reductions of processing speed and VSTM capacity after white matter lesions affecting 
long-range anterior-posterior or cortico-thalamic connections. In a study with patients suffer-
ing from focal brain lesions, Peers et al. (2005) reported damage to the temporo-parietal re-
gion to be associated with significant speed and VSTM deficits. This region is also known to 
be heavily affected by AD pathology during the course of the disease (Blennow et al., 2006). 
Moreover, temporo-parietal hypometabolism has been identified to predict progression from 
MCI to dementia with high accuracy (Chetelat et al., 2003). For VSTM storage, fMRI evi-
dence suggests that bilateral activity in posterior regions, more specifically in the intraparietal 
and the intraoccipital sulcus, is correlated with the number of objects held in VSTM (Todd & 
Marois, 2004). This suggests that the significant VSTM decline found in AD subjects in the 
present study is related to advanced cortical pathology in posterior, especially temporo-
parietal regions. For visual perceptual processing speed, on the other hand, there is also con-
clusive evidence that it heavily relies on the activity of the cholinergic system (Hutchison et 
al., 2001; Nathan & Stough, 2001; Stough et al., 2001). Interestingly, and in full agreement 
with this assumption, higher processing speed in AD patients on cholinomimetic medication 
4. Study 1: Visual processing capacity in MCI and AD – 4.5. Discussion 55 
was found. Nevertheless, these patients‟ speed was still below the level of the MCI patients. 
Thus, the speed decline identified in this study might reflect a deficit in cholinergic innerva-
tion, which is also known as a neuropathological hallmark of AD (Mesulam, 2004). 
4.5.3. Relationship to other clinical and cognitive measures 
The results of the analysis of correlations between disease-related TVA parameters and other 
clinical and cognitive measures are compatible with the suggested neurocognitive interpreta-
tion of the deficits. Although these correlations were only moderate, they showed a distinctive 
pattern: Perceptual threshold values were significantly (though moderately) correlated with 
disease duration, but not with cognitive measures; conversely, speed and VSTM were signifi-
cantly related to cognitive scores, but not to disease duration. This is what would be expected 
if measures of the perceptual threshold depicted the gradual accumulation of tangle and pla-
que deposits, which characterizes the pre-clinical stage of AD until the advent of MCI (Blen-
now et al., 2006). On the other hand, cognitive decline to dementia may follow a non-linear 
and perhaps less systematic trend due to several influencing risk and protective factors (Jarvik 
et al., 2008), so that other measures (processing speed and VSTM capacity) depicting the pro-
gressive degradation of the neural machinery underlying cognition are not closely associated 
with disease duration as such. In this regard, there may be a difference to a subcortical demen-
tia such as Huntington‟s disease, for which speed and VSTM measures were found to be 
linked to disease duration (Finke et al., 2006). In this case, onset of cortical pathology may 
occur at later stages of the disease, giving rise to the link between duration and cognitive de-
cline. 
We found significant associations with cognitive tasks, both within the visual domain and 
beyond. In particular, VSTM storage was related to neuropsychological tests involving visual 
material (picture naming and visuo-construction), while speed showed an additional relation-
ship to measures of verbal memory. Similar relationships have already been documented in 
earlier studies. For example Cronin-Golomb et al., (1995) reported that visual dysfunction oc-
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curs in conjunction with cognitive decline in AD. An extensive investigation in AD patients 
(Rizzo, M., Anderson, Dawson, & Nawrot, 2000) showed significant associations between 
overall cognitive status and the performance in both perceptual and attentional visual tasks. 
Finally, modest relationships between a measure of processing speed (inspection time) and 
verbal memory measures have also been revealed for MCI subjects (Bonney et al., 2006). 
Such an association between vision and cognition can be interpreted in one of three ways. 
First, it is possible that general cognitive decline, producing difficulties in performing any 
task, also gives rise to problems with visual tasks. However, this is unlikely to apply to the 
present findings, given the simplicity of the whole report task. This task, which does not need 
a complex instruction and does not require the subject to engage in a complex mapping of 
stimuli to (key press) responses, makes minimal cognitive demands and can even be per-
formed by patients with Huntington‟s disease at a progressed stage (Bublak et al., 2006; Finke 
et al., 2006). Moreover, the individual performance pattern (see Figure 4, p. 44 for examples) 
demonstrates that AD patients produce results that show a similar, systematic increase in per-
formance with longer presentation times as for healthy control subjects. This would not be 
expected in a cognitively demanding task that poses difficulties for subjects with intellectual 
decline.  
As a second possibility is that visual deficits could affect the performance of a variety of cog-
nitive tasks, especially if these tasks use visual stimulus material. Such an interpretation is 
supported by recent data of Cronin-Golomb et al. (2007) who demonstrated that simply en-
hancing stimulus strength can improve cognitive performance. This was true, however, only 
for relatively simple tasks with a clear visuo-cognitive component (picture naming, reading, 
face recognition), but not for a more complex reasoning task (Raven matrices). Such an ac-
count may also explain the current finding of an association between VSTM capacity and 
both picture naming and visuo-construction scores. VSTM storage may be required in these 
tasks for at least two reasons: either because more complex pictures comprising several com-
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ponents (e.g., drawing a wire cube) have to be processed, or because visual scanning is neces-
sary. Likewise, these functions may also depend on processing speed, consistent with the as-
sociation of the TVA speed parameter with the scores in these tasks. The association of speed 
to the verbal memory measures may then be due to the fact that subjects had to read the words 
during encoding. 
A third explanation may invoke common underlying pathology. On this account, correlations 
between certain parameters and tasks would result from the fact that both measures depend on 
the integrity of the same brain regions. For example, visuo-constructive tasks and picture 
naming may require spatial shifts of attention, so that performance involves posterior parietal 
functions in both cases. This region may also play a role in VSTM storage, as discussed 
above, and may be associated with these tasks for this reason. With regard to processing 
speed, if this function critically depends on the cholinergic system, as supported by the 
present results, then the association with memory could be explained by the fact that this sys-
tem also contributes to learning and memory formation (Mesulam, 2004). In addition, one 
would expect the speed parameter to be correlated with a broad range of cognitive functions, 
due to the widespread cortical effects of the cholinergic system. 
Thus, more generally, the TVA parameters assessed in the present study may just be consi-
dered as neurocognitive markers for the functional integrity of the different cerebral systems 
and regions that are most prominently affected by AD pathology: posterior cortical areas in 
the temporal, parietal, and occipital lobe, and the cholinergic corticopetal projection system. 
4.5.4. Limitations 
The current study has a number of limitations that are worth mentioning. First, the presenta-
tion of results focused on the main line of the effects. There were numerical differences that 
did not reach statistical significance (in particular, differences between MCI and healthy con-
trol subjects with respect to parameters C and K) which might have turned out significant with 
a larger sample of subjects. However, even if such effects reached significance, they would 
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not contradict the conclusions drawn so far. In fact, the gradual transition from the MCI to the 
dementia stage of AD would imply a substantial overlap between both groups, as was quite 
evident in the present patient samples as well. The current results merely suggest that an ele-
vated threshold marks the MCI stage, while a speed decline unambiguously indicates the de-
mentia stage, notwithstanding the fact that more subtle differences may also be present. Nev-
ertheless, the present findings would have to be replicated in further studies to underpin the 
robustness of the effects revealed. 
A second limitation of this study derives from the fact that it is based on a cross-sectional ap-
proach, comparing different groups of subjects at different stages of cognitive decline. This 
approach needs to be complemented by longitudinal studies to examine whether the staged 
pattern of deficits identified does also hold for the individual progression of the disease. 
Third, despite the significant group differences in the mean parameter estimates, there was al-
so substantial overlap between groups with respect to the individual parameter values. There-
fore, it remains an open issue whether parametric assessment based on TVA can be used for 
diagnostic decisions at the level of individual patients. Note, however, that the diagnostic po-
tential of this approach may significantly improve by taking into account additional measures 
– such as TVA-based assessment of attentional weighting (Bublak et al., 2005; Finke et al., 
2006; this was not examined in the present study), or functional neuroimaging (e.g., positron 
emission tomography, PET) data. 
4.5.5. Conclusions 
Besides the presence of a memory disorder, AD is also characterized by deficits in visual per-
ception and attention that can be related to the neuropathology predominantly affecting post-
erior cortical areas. Visuo-cognitive impairments have been revealed in a broad range of 
tasks, involving visual search (Tales, Haworth et al., 2005), visual short-term memory (Ales-
cio-Lautier et al., 2007), and visual perception (Rizzo, M., Anderson, Dawson, & Nawrot, 
2000). It has also been suggested that deficits in visual memory can predict the advent of AD 
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long before a diagnosis can be made (Kawas et al., 2003). Efficiency of visual information 
uptake may contribute critically to such deficits. The present study, which was designed to 
analyze different components of visual processing capacity, revealed an incremental pattern 
of modified parameters that was associated with different disease stages and could be ex-
plained by differential impairments of pre-attentive and, respectively, attentive stages of visu-
al processing. These findings are compatible with the amyloid cascade hypothesis of AD 
(Blennow et al., 2006; Hardy & Selkoe, 2002), according to which the AD neuropathology is 
characterized by a net accumulation and deposition of Aβ in the initial phase, giving rise to 
neuronal and neuritic dysfunction. At later stages, gradual neuronal loss and transmitter dis-
turbances finally cause the increasing intellectual decline during further progression of the 
disease. The threshold elevation found in this study may thus be considered as a possible in-
dex of impaired neuronal functioning prior to cell death, while speed and VSTM deficits may 
be indicative already of a substantial loss of neuronal cell assemblies and a degeneration of 
neurotransmitter systems, in particular the cholinergic system. Thus, TVA-based assessment 
could provide appropriate neurocognitive markers of both a dysfunctional and a degenerated 
cortex, tracking the cerebral decomposition over the course of Alzheimer‟s disease. 
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5. Study 2: Visual attentional selection in MCI and AD 
In the second study, visual attentional functions of spatial and task-related selection were in-
vestigated in a partial report task (PR) in patients with amnestic mild cognitive impairment 
(MCI) and Alzheimer‟s disease (AD). 
5.1. Abstract 
The present study investigated visual selective attention in 32 patients with amnestic mild 
cognitive impairment (MCI), 16 patients with probable Alzheimer‟s disease (AD), and 36 
healthy elderly control subjects. Groups were matched for age, gender and educational level. 
In combination with Bundesen‟s (1990) theory of visual attention (TVA), two mathematically 
independent and quantitative parameter estimates were derived from a partial report of briefly 
presented letter arrays: top-down control of attentional selection, representing task-related at-
tentional weighting for prioritizing relevant visual objects, and spatial distribution of atten-
tional weights across the left and right hemifield.  
Compared to controls, MCI patients showed significantly reduced top-down controlled selec-
tion which further deteriorated in AD subjects. Moreover, attentional weighting was signifi-
cantly unbalanced across hemifields in MCI and tended to be more lateralized in AD. The ma-
jority of patients was biased to the left. Across MCI and AD patients, carriers of the apolipo-
protein E ε4 allele (ApoE4) revealed a leftward spatial bias. The leftward bias was the more 
pronounced the younger the ApoE4-positive patients and the earlier disease onset. ApoE4-
negative subjects showed balanced attentional weighting.  
These results indicate that impaired top-down control may be linked to early dysfunction of 
cortico-cortical networks connecting parietal and frontal lobes. Accompanying, an early inter-
hemispheric asymmetry in temporo-parietal cortical interactions might cause a pathological 
spatial bias. As the inheritance of ApoE4 is associated with an interhemispheric imbalance in 
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parietal cortical interactions, a pathological spatial bias may function as early cognitive mark-
er for detecting subjects at risk for probable AD. 
5.2. Introduction and aim of the study 
Alzheimer‟s disease (AD) is the most frequent form of dementia characterized by progressive 
cortical degeneration starting in mediotemporal regions and proceeding to parietal and frontal 
areas (Braak & Braak, 1990; Braak, Braak, & Bohl, 1993; Whitwell et al., 2007). It appears 
both as a familial and a sporadic variant. The familial form is rare, with a prevalence below 
0.1%, and represents an autosomal dominant disorder with onset before age 65 years, mostly 
caused by mutations of the highly homologous presenilin genes. In the by far more frequent 
sporadic form, a genetic risk factor is also implicated, in that carriers of the apolipoprotein E 
ε4 allele (ApoE4) on chromosome 19 have a 3 (in heterozygotes) to 15 times (in homozy-
gotes) higher risk of developing the disease, compared to non-carriers. In both variants, the 
neuropathological basis of AD is an accumulation of β-amyloid (Aβ) either due to a life-long 
over-production (familial variant) or a failure of the clearance (sporadic form) of Aβ (Blen-
now et al., 2006).  
Mild cognitive impairment (MCI) is considered as the prodromal phase of dementia in most 
patients. It is defined as a transitional state between the normal alterations of cognitive and 
functional abilities in elderly subjects and the significant decline associated with probable 
dementia (Gauthier et al., 2006; Nestor et al., 2004). In particular, MCI of the amnestic type 
bears a high risk for subjects to develop AD (Gauthier et al., 2006). According to Petersen et 
al. (1999), it is diagnosed on presentation of subjective memory complaints, preferably corro-
borated by an informant, the presence of objective memory impairment, as assessed by neu-
ropsychological testing, essentially normal functional abilities, and the absence of dementia. It 
has been claimed by some authors that the initial memory disturbance in AD is at least ac-
companied if not preceded by early deficits of selective attention (Foldi et al., 2002; Perry & 
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Hodges, 1999). Thus, sensitive tools for assessing selective attention might serve as early 
cognitive markers in the course of AD and therefore enhance the identification rate of at-risk 
subjects at the MCI stage (Shah et al., 2008). The present study aims at examining whether at-
tentional parameters of visuospatial and task-related selection are appropriate means for that 
purpose. 
Deficits of visuospatial attention are well established in AD, and have been extensively stu-
died using spatial cueing and visual search tasks (for review, see Parasuraman, Greenwood, & 
Sunderland, 2002). AD patients have been shown to suffer from a reduced spatial attentional 
window (Rizzo, M., Anderson, Dawson, Myers et al., 2000) and to present difficulties in dis-
engaging attention from invalidly cued locations (Tales, Snowden, Haworth, & Wilcock, 
2005). Recently, Drago et al. (2008) reported that the capacity to reallocate spatial attention is 
especially hampered when it had been directed towards the left. Similarly, Foster et al. (1999) 
had already found that AD patients had more difficulty in detecting targets on the right in a 
visual search task. In fact, a lateral bias of spatial attention, either towards the left or the right 
hemifield, seems to occur in a substantial number of cases, with some studies even showing 
signs of hemispatial neglect (Bartolomeo et al., 1998; Ishiai et al., 2000; Mendez, Cherrier, & 
Cymerman, 1997; Venneri, Pentore, Cotticelli, & Della Sala, 1998). Typically, however, the 
spatial bias is more subtle and disclosed under conditions of double simultaneous stimulation 
only, when stimuli within both hemifields compete for selection (Bublak et al., 2006). It is an 
open issue whether a spatial bias of attention is already present at the MCI stage. Thus, the 
first aim of the current study was to investigate the evidence of spatially lateralized attentional 
processing in both MCI and AD subjects. 
Visual search tasks have also revealed impairments in task-related selection, that is, deficits of 
filtering out irrelevant distractors during target processing. For instance, Baddeley et al. 
(2001) found AD patients to be somewhat more susceptible to interference from similar dis-
tractors than control subjects. Amieva et al. (1998) have reported deficient inhibitory mechan-
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isms in the widely used trail making test, which may be the result of a profound impairment 
of executive functions in AD, present already at early stages (Amieva, Phillips, Della Sala, & 
Henry, 2004a; Levinoff, Li, Murtha, & Chertkow, 2004; Minati, Edginton, Bruzzone, & 
Giaccone, 2009). In contrast to inferences from rather indirect measures of task-related selec-
tion (defined by, e.g., distractor similarity or error type differences), the second goal was to 
analyze the effect of distractor interference by direct comparison of performance between tri-
als with a single target presented on its own and trials with an additional distractor. 
To investigate these issues, a task requiring partial report of briefly presented letters (i.e. re-
port only pre-defined target letters, but not distractor letters) was employed, based on Bunde-
sen‟s (1990) formal theory of visual attention (TVA). The TVA-based approach permits pa-
rametric estimates to be derived from performance in this simple psychophysical task that re-
flect both spatial and task-related aspects of attentional processing. In this way, comparability 
of conditions was ensured for interpreting separate aspects of selective attention in both MCI 
and AD subjects; for a recent summary for TVA-based studies with neurological and psychia-
tric patients, see Habekost and Starrfelt (2009). A further, critical advantage of this paradigm 
is that it does not rely on response time-based assessment (as many previous studies did), the-
reby eliminating a general slowing of motor performance as a potentially confounding factor. 
Thus, by individually adjusting the (brief) stimulus presentation times, a comparable task dif-
ficulty is ensured across subjects. In a previous study, this approach had already been, suc-
cessfully, applied to investigate patients with a subcortical type of dementia, Huntington‟s 
disease (Finke et al., 2006). Furthermore, a related TVA-based whole report paradigm (in 
which subjects had to report as many letters from a briefly presented array as possible) had 
proved to be sensitive to revealing visual attentional capacity reductions in both MCI and AD 
patients (Bublak et al., 2009). Therefore, this method deemed to be appropriate for assessing 
spatial and task-related aspects of attentional processing in subjects at different stages of cor-
tical degeneration, that is, amnestic MCI and probable AD. 
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TVA is a mathematical model with strong relations to the biased competition account of at-
tentional selection proposed by Desimone and Duncan (1995); for a detailed mathematical de-
scription of TVA, see Bundesen (1990, 1998), Duncan et al. (1999), or Kyllingsbæk (2006). 
For a neural interpretation of TVA, see Bundesen et al. (2005). On this account, visual objects 
in the visual field are processed in parallel and compete for selection, that is, „conscious‟ re-
presentation within the information processing system. The resulting race among objects can 
be biased such that some objects are favored for selection, based either on stimulus-driven, 
„bottom-up‟ or on intentional, „top-down‟ factors. In TVA, selection of a visual object is syn-
onymous with its encoding into a visual short-term memory (VSTM) store with limited ca-
pacity. The probability of selection is determined a) by an object‟s processing rate v, which 
depends on the attentional weight (w) it receives, and b) by the capacity of the VSTM store (if 
the store is filled, the selection process terminates). TVA provides parameters for characteriz-
ing specific aspects of attentional weighting, such as task-related weighting for prioritizing 
the processing of relevant visual objects (top-down control) and the spatial distribution of at-
tentional weights across the left and right hemifields. Independent quantitative estimates of 
these two aspects of attentional weighting are derived from subjects‟ performance in the par-
tial report task. In this task, subjects have to report target objects only, which are pre-specified 
(e.g., with respect to color), whilst ignoring distractors.  
Thus, the present study provides an extension of a previous TVA-based investigation of visual 
processing capacity in MCI and AD using a (non-selective) whole report task, which, howev-
er, does not allow for aspects of the selective weighting of stimuli to be examined (Bublak et 
al., 2009). The partial report paradigm was applied in patients with amnestic MCI, probable 
AD, and healthy control subjects. In patients, the possible influence of genetic risk on atten-
tional weighting was also assessed by comparing carriers and non-carriers of ApoE4 alleles. 
Using an identical TVA-based partial report paradigm, Finke et al. (2006) had found a close 
relationship between the severity of the underlying genetic pathology in another neurodege-
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nerative, namely Huntington‟s, disease and the direction and degree of spatial attentional 
weighting. Therefore, it was examined whether ApoE4 carriers in the present clinical groups 
might exhibit more pronounced deficits in spatial and/ or task-related attentional weighting 
than clinical non-carriers of the ApoE4 allele. 
5.3. Method 
5.3.1. Subjects 
48 patients with the clinical diagnosis of amnestic mild cognitive impairment (MCI) or prob-
able Alzheimer‟s disease (AD), respectively, were recruited from the Memory Clinic of the 
department of Psychiatry, Technische Universität München, Germany. 32 MCI patients (17 
male, 15 female; mean age 69.0 years; mean educational level 10.8 years) took part in the 
study. The AD patient group consisted of 5 men and 11 women (mean age 67.1 years; mean 
education 9.8 years). All patients were right-handed according to the Edinburgh Handedness 
Inventory (Oldfield, 1971). 
Written informed consent according to the Helsinki II declaration was obtained from all sub-
jects or, respectively, their legal representatives, and the study was formally approved by the 
ethics committee of the University of Munich. All subjects had normal or corrected-to-normal 
vision. All patients were able to fixate adequately, understand, and follow the verbal task in-
structions as well as work concentrated for about 30 minutes, and did not suffer from color 
blindness. No subjects in the clinical group displayed any salient and considerable visual defi-
cits typical of posterior cortical atrophy. 
All patients had undergone a standardized diagnostic assessment including medical history 
(both patient and informant interview), medical, neurological, and psychiatric examination, 
neuropsychological assessment using the test battery of the Consortium to Establish a Regi-
stry for Alzheimer‟s Disease - Neuropsychological Battery (CERAD-NP, German version; 
Thalmann and Monsch (1997); see Test 1, pp. 141 et seqq.) including the Mini-Mental State 
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Examination (MMSE; Folstein et al., 1975), and the Clock Drawing Test (CDT; Shulmann et 
al. (1993), see Test 2, pp. 155 et seq.) as well as rating the overall severity of cognitive defi-
cits with regard to activities of daily living using the Clinical Dementia Rating (CDR; Morris 
(1993), see Test 3, pp.157 et seqq.), structural brain imaging (MRI), and blood tests.  
All AD patients fulfilled the criteria of probable dementia (CDR global score ≥ 1) of the Alz-
heimer type based on the diagnostic criteria of the ICD-10 classification of mental and beha-
vioral disorders for dementia (Bramer, 1988), and the NINCDS-ADRDA criteria for the diag-
nosis of AD (McKhann et al., 1984). All MCI patients fulfilled the following inclusion crite-
ria: cognitive impairment affecting at least the memory domain (amnestic MCI patients, 
single or multiple domains) according to Petersen (2000; Petersen et al., 1999), largely pre-
served activities of daily living (Bayer ADL scale; Hindmarch et al., 1998), no dementia ac-
cording to ICD-10 criteria, and questionable dementia indicated by CDR global score of 0.5. 
Exclusion criteria for participation in this study were other neurological or systemic diseases 
like stroke or substance abuse or clinically notable MRI pointing to cognitive deficits.  
None of the MCI patients was medicated with antidementives, but 11 (69%) AD patients were 
treated with acetylcholine esterase inhibitors (AChEI). Due to mild symptoms of depression, 
9 MCI (28%) and 3 (19%) AD patients received antidepressant medication. Distributions of 
antidepressant medication in MCI patients resembled those in AD subjects (p > .45). Fur-
thermore, two MCI and three AD patients suffered from diabetes mellitus, 9 MCI and 6 AD 
patients received antihypertensive medication. 
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Table 2: PR: Overview of biographical and clinical details for MCI and AD patients and 
healthy controls 
See also Table 11 (pp. 132 et seq.). 
CDR: Clinical Dementia Rating Scale, global score (Morris, 1993); p: level of significance; M (SD): mean score 
and standard deviation; Age in years; Education in years; Handedness: according to the Edinburgh Handedness 
Inventory (Oldfield, 1971); R: right-hander; MMSE: Mini Mental State Examination (Folstein et al., 1975), 30-0 
points, cut-off ≤ 23; CERAD: The Consortium to Establish a Registry for Alzheimer‟s Disease (Thalmann & 
Monsch, 1997), total score; n.a.: not applied; CDT: Clock Drawing Test, 0-6 points, cut-off ≥ 3 (Shulman, Shed-
letsky, & Silver, 1986); CDR sum: sum of CDR category scores; Age at disease onset in years; Disease dura-
tion in years; ApoE4: apolipoprotein E4 genotype, positive (+), negative (-). 
 AD 
(n = 16, CDR ≥ 1) 
MCI 
(n = 32, CDR = 0.5) 
Control  
(n = 36) 
p 
Age,  
M (SD), range 
67.1 (8.6) 
55.8 – 81.5 
69.0 (7.6) 
45.9 – 79.9 
67.2 (6.6) 
50.0 – 82.0 
> .55 
Gender (male/ female) 5 / 11 17 / 15 16 / 20 > .35 
Education, 
M (SD), range 
9.8 (1.3) 
9 – 13 
10.8 (1.9) 
9 – 13 
10.5 (2.1) 
7 – 13 
> .20 
Handedness all R all R all R  
MMSE, 
M (SD), range 
22.8 (2.3) 
19 – 25 
27.4 (1.3) 
25 – 30 
29.0 (1.0) 
27 – 30 
< .01 
 
CERAD, 
M (SD), range 
68.0 (10.0) 
51 – 84 
82.9 (10.5) 
54 – 112 
n.a. < .01 
CDT, 
M (SD), range 
3.2 (1.1) 
1 – 5 
2.0 (.9) 
1 – 4 
n.a. < .01 
CDR sum, 
M (SD), range 
4.4 (.6) 
3.5 – 5.0 
2.0 (.7) 
1.0 – 3.5 
n.a. < .01 
Age at onset, 
M (SD), range 
64.5 (9.1) 
52.1 – 78.4 
66.2 (7.9) 
43.6 – 76.8 
- > .50 
Disease duration, 
M (SD), range 
3.3 (2.0) 
0.8 – 8.0 
2.7 (1.5) 
0.5 – 7.8 
- > .25 
ApoE4 genotype 10 +/ 4 - 
2 n.a. 
18 +/ 11 - 
3 n.a. 
n.a. > .75 
 
As can be seen in Table 2, ApoE4 genotype was assessed for a subset of 29 MCI (18 ApoE4 
carriers) and 14 AD (10 ApoE4 carriers) patients. Distributions of the ApoE4 genotype were 
comparable in MCI and AD patients. 
A control group of 36 healthy older subjects (16 male, 20 female; mean age 67.2 years; mean 
education 10.5 years; all right-handed) was recruited by word-of-mouth recommendation, 
flyers and notices. None of the control subjects reported a neurological or psychiatric history. 
All subjects had normal or corrected-to-normal vision. MCI and AD patients as well as con-
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trol subjects did not differ significantly from each other with regard to Age [F(2, 81) = .58, p 
> .55], Education [F(2, 81) = 1.50, p > .20] or Gender [χ2(2) = 2.08, p > .35]. 
Further biographical and detailed clinical information of each subject group is listed in Table 
2 (for details of individual MCI and AD subjects see Table 11, pp. 132 et seq.). All three 
groups differed significantly from each other with regard to MMSE score. Furthermore, MCI 
patients were significantly less impaired than AD patients in the overall level of functioning 
according to CERAD (total score excluding MMSE, Chandler et al., 2005), in the CDT and 
the CDR (sum of category scores). Estimates of disease onset (based on the date of the first 
documentation of the MCI diagnosis) and disease duration were comparable across patient 
groups. 
5.3.2. Partial report paradigm 
The stimuli and the general method were similar to those introduced by Duncan et al. (1999) 
and identical to several previous studies of our research group (Bublak et al., 2005; Finke et 
al., 2006; Finke et al., 2005).  
A) 
 
B) 
 
Figure 10:  PR: Illustration of (A) the partial report paradigm with (B) 16 different trial types 
4 single target (depicted as „T‟, always red), 8 target plus distractor (depicted as „D‟, always green) and 4 dual 
target conditions. 
5. Study 2: Visual attentional selection in MCI and AD – 5.3. Method 69 
5.3.2.1. Task 
In Figure 10, the sequence of events on an experimental trial (A) and the different trial types 
(B) are illustrated. Subjects were asked to maintain fixation before being presented with one 
or two letters on four possible equidistant positions round the fixation cross. The subjects‟ 
task was to verbally report only red target letters they felt relatively sure they had recognized, 
and to ignore green distractor letters. Verbal report of individual letters was performed in ar-
bitrary order and without stress on report speed. The experimenter entered the reported let-
ter(s) on the keyboard and then started the next trial as soon as the subject was ready. For de-
tailed information on test instructions, see Instruction 3 and Instruction 4 (p. 127). 
5.3.2.2. Procedure 
First, subjects were instructed to fixate a central white cross (0.3° visual angle) presented for 
300 ms (see Figure 10 A). Then, after a gap of 100 ms, red and/or green letters (0.5° high x 
0.4° wide) were presented on a black background for a predetermined exposure duration. Sub-
jects were instructed to maintain fixation on the fixation cross until the presentation of the let-
ter(s). Prior to the start of the experiment proper, a short practice session was conducted 
which served to determine the individual presentation durations (besides validating intact vis-
ual functions in all subjects). 
For the specification of the individual exposure durations, an initial test phase consisting of 32 
masked trials was used, aiming for about 80% accuracy on single letter trials. In the experi-
ment itself, all stimuli displays were presented for the individually adjusted exposure dura-
tion. A mean exposure duration of 452 ms (SD = 171, range: 100-743) was used for AD pa-
tients, of 330 ms (SD = 114, range 143-600) for MCI patients, and of 200 ms (SD = 69, range: 
71-357) for control subjects. Exposure durations of individual subjects are listed in Table 12 
(p. 134). 
The total number of trials was 288, divided into blocks of 48 trials each. Within each block, 
the sixteen different trial types of the experiment (4 single target, 8 target-plus-distractor, and 
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4 dual target conditions) were presented equally often (with 18 trials each) and in randomized 
order. On each trial, a single red target (letter), or a target plus a green distractor (letter), or 
two red targets (see Figure 10 B) were presented at the corners of an imaginary square with an 
edge length of 5°, centered on the screen. Two stimuli were presented either horizontally (row 
display) or vertically (column display), but never diagonally. Stimuli were displayed random-
ly at all possible positions in pre-specified combinations as well as with respect to visual he-
mifield in order to avoid anticipatory responses by the subjects.  
5.3.2.3. Stimuli 
The letters for a given trial were randomly chosen from the prefixed set 
„ABEFHJKLMNPRSTWXYZ‟, with the same letter appearing only once in a trial display. 
Each subject received the same letter displays in the same random order. Stimuli were all 
masked by squares of 0.5° filled with a „+‟ and an „x‟, which were presented for 500 ms at 
each stimulus location after stimulus presentation. 
5.3.2.4. Apparatus 
Stimuli were presented on a personal computer with a 17‟‟ monitor (1024 x 768 pixel screen 
resolution; 70 Hz refresh rate). Viewing distance was about 50 cm. The patients were tested in 
hospital, and the control subjects in a university laboratory. At all locations, experiments were 
conducted in a dimly lit room under identical conditions.  
5.3.3. Estimation of TVA-based parameters 
The individual assessment of performance accuracy across the different partial report condi-
tions (see Figure 10 B) was modeled by a TVA-based algorithm using a maximum likelihood 
method (e.g. Ross, 2000). Detailed descriptions of the model fitting procedure, which was 
largely identical with that used by Duncan et al. (1999), and the software used, can be found 
in Kyllingsbæk (2006). By fitting TVA to individual (partial report) raw data sets, several pa-
rameter estimates can be derived, in particular: parameters for characterizing specific aspects 
of attentional weighting, such as task-related weighting for prioritizing relevant visual objects 
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for processing (top-down control) and the spatial distribution of attentional weights across the 
left and right hemifields. Additionally, parameter estimates for sensory effectiveness reflect-
ing the processing rate for each hemifield are provided.  
The qualitative pattern of each group‟s performance was quantitatively described by a TVA-
based model that produced individual estimates of attentional weights wi separately for each 
of the four display locations and separately for targets and distractors. Similarly, individual 
estimates of sensory effectiveness Ai for each display location (irrespective of the displayed 
letter being a target or distractor) were derived. 
The mean scores for the different partial report conditions and those predicted based on the 
best fits of the TVA model parameters showed a high correspondence, with a mean correla-
tion of r = .87 (SD = .11) for controls, of r = .92 (SD = .11) for MCI patients and of r = .95 
(SD = .04) for AD patients. The predicted values accounted for r
2
 = 77% (SD = .17) of the va-
riance of the observed mean score in controls, for r
2
 = 85% (SD = .16) in MCI patients and r
2
 
= 91% (SD = .07) in AD patients.  
5.3.3.1. Task-related weighting 
Parameter α, reflecting the efficiency of top-down control, indicates whether attentional 
weights for targets (T) are greater than the weights for distractors (D; averaged across loca-
tions, respectively) and is defined as the ratio wD / wT. Thus, lower α values indicate more ef-
ficient top-down control. Unselective processing, by contrast, would give rise to equally 
weighted target and distractor processing, increasing α to approach 1. A value of α greater 
than 1 would indicate that the subject actually prioritizes the task-irrelevant distractors. 
5.3.3.2. Spatial weighting 
The spatial distribution of attentional weighting, wλ, is estimated from performance in condi-
tions in which subjects have to report stimuli presented either unilaterally, on either side of 
the visual field, or bilaterally, in the left and right visual hemifields. From the accuracy of tar-
get identification, separate attentional weights are derived for the left (wleft) and the right he-
5. Study 2: Visual attentional selection in MCI and AD – 5.3. Method 72 
mifield (wright). In TVA, the absolute attentional weighting has no meaning; only relative in-
tra-individual values can be compared. Therefore, a laterality index was computed from the 
raw data of the w estimates: parameter wλ, reflecting the laterality of the spatial distribution of 
attentional weights. The laterality index of attentional weighing wλ is defined as the ratio wleft / 
(wleft + wright). Hence, a value of wλ = 0.5 indicates balanced weighting (wleft = wright), values of 
wλ > 0.5 indicate a leftward and values of wλ < 0.5 a rightward spatial bias, because weights 
for objects to the left of fixation would be higher than those for objects to the right, or vice 
versa. As a result, for example a value of .63 would indicate a leftward spatial bias, a value of 
.37 would represent a spatial bias of comparable degree, however to the opposite, right, hemi-
field. In AD with bilateral neurodegenerative processes, single patients might show a dysbal-
ance to either hemifield, that reflects either predominantly right-sided or left-sided neural 
damage, rather than suffering from a systematic spatial bias to a specific hemifield. Thus, the 
absolute deviation of wλ from the optimum value 0.5 in any direction was also computed, 
Dev(wλ), as an index of the subject‟s general ability to attend equivalently to both hemifields 
(see also Finke et al., 2005). Note that in the two examples given above, this absolute devia-
tion from 0.5, the imbalance index of attentional weighting Dev(wλ), would be equally severe 
and indicated by a value of .13. 
5.3.3.3. Sensory effectiveness 
In TVA, the probability of identifying an object depends not only on its relative attentional 
weight (i.e. the weight allocated to a given object relative to the weights assigned to the other 
objects), but also on the sensory effectiveness A of an object (Duncan et al., 1999), which is 
independent of its attentional weight (rather, it depends on factors such as stimulus discrimi-
nability, contrast, and retinal eccentricity). Parameter A is assumed to reflect the total 
processing rate for each hemifield, rather than how capacity is divided between the different 
objects in a display. Conceptually, the estimates of A are measures of basic sensory effective-
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ness and thus are related to accuracy on a single element presented alone, rather than to per-
formance losses in multi-element displays.  
According to TVA, a spatial bias may be caused by attentional weights being reduced for one 
compared to the other hemifield (Duncan et al., 1999), unbalancing the competition between 
objects on left and the right side. Alternatively, a spatial bias might be due to basic sensory ef-
fectiveness being reduced for one hemifield, leading to an imbalance in sensory processing 
between hemifields (see equation 2, section 3.1.2.2, p. 25; Bundesen (1990)). To decide be-
tween these possibilities (analogously to the definition of wλ), values of Aright and Aleft are cal-
culated, that is, the mean values of sensory effectiveness for the upper and lower positions in 
the left and the right hemifield, respectively. In addition, a laterality index for sensory effec-
tiveness (Aλ) is computed as the ratio Aleft / (Aleft+Aright). Thus, a laterality value above 0.5 re-
flects a lateralization of sensory effectiveness to the left (i.e. higher effectiveness in the left 
hemifield), and a value below 0.5 a lateralization to the right visual hemifield. In order to test 
for sensory accuracy loss in either of the two hemifields, the absolute deviation of Aλ from the 
balanced value 0.5 in any direction was computed, Dev(Aλ), as an index of a given subject‟s 
general degree of balance/ imbalance in sensory effectiveness between the two hemifields. 
5.4. Results 
This section is divided into two subsections, the first presenting the results on task-related 
weighting and the second the findings on spatial weighting and associated sensory effective-
ness. Each subsection starts with a description of the qualitative pattern of performance pro-
duced by each subject group in the partial report task. Next, the TVA-model estimates of the 
parameters for top-down control of attention, for spatial laterality and balance/imbalance of 
attentional weighting, and for the corresponding sensory effectiveness parameters are pre-
sented for each subject group, and compared among groups. Subsequently, the inter-
correlations of both partial report parameters are reported for each subject group. For addi-
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tional information about the clinical relevance of the TVA parameters, their relationship with 
external clinical measures and cognitive tests is also documented. Furthermore, in order to as-
sess whether the parameters are related to possible underlying gene-associated pathology, the 
effect of ApoE4 genotype (carriers versus non-carriers) on the parameter values is examined. 
5.4.1. Task-related weighting 
In this section, findings are present which pertain to the ability to perform top-down con-
trolled visual selection under conditions in which distractor information is present, starting 
with the raw data results followed by the estimates of the corresponding (top-down control) 
parameter α. 
5.4.1.1. Raw data 
Top-down control of attention refers to the capability of task-related selection, that is, of pri-
oritizing the visual processing of targets over that of distractors. To illustrate top-down con-
trol, Figure 11 shows the mean proportion of target letters correctly identified, by patients and 
controls, separately for conditions with single target letters, targets accompanied by distrac-
tors, and targets accompanied by a second target. As the interest here is in a general estimate 
of top-down control in the whole visual field, averaged values across hemifields are pre-
sented. 
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A) 
 
B) 
 
C) 
 
Figure 11: PR: Mean proportion of correctly reported letters (in %) of (A) control subjects, 
(B) MCI subjects and (C) AD patients in the single target (none), the target + dis-
tractor (D), and the target + target (T) conditions across both hemifields 
Error bars show standard errors of the mean. 
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In order to compare the efficiency of top-down controlled selection across the three subject 
groups, the relative performance in the target plus distractor condition is critical. In normal 
subjects, performance in this condition nearly equals that for single targets (3% difference) 
and is clearly higher than that for dual targets (11%). Thus, they efficiently prioritize targets 
over distractors. In the MCI patients, the accuracy in the distractor condition further ap-
proaches that for dual targets (14% difference; in contrast to 11% difference to the single tar-
get condition), in contrast to controls. Thus, this group seems to attribute higher attentional 
weights to irrelevant distractors compared to normal controls. In AD patients finally, accuracy 
in distractor conditions nearly equals that in dual target conditions (7% difference; in contrast 
to 19% difference to the single target condition). Therefore, distractors and additional targets 
interfere with AD patients‟ performance to a comparable degree, indicative of rather non-
selective processing. 
As selectivity is reflected in performance on target plus distractor displays compared to the 
single target condition (baseline), a raw data selectivity index was calculated which equals the 
ratio of mean accuracy for target plus distractor arrays divided by the mean accuracy for sin-
gle target displays. The lower this ratio, the lower the relative performance in the target plus 
distractor condition and, hence, the lower the efficiency of top-down control. An ANOVA 
was conducted on these raw data selectivity indices, with the single (between-subject) factor 
Group (controls, MCI and AD patients). The Group effect was highly significant [F(2, 81) = 
21.42; p < .01]. T-tests revealed that controls (M = .97, SD = .05) and MCI patients (M = .88, 
SD = .10) differed significantly [t(66) = 4.74, p < .01], as well as MCI and AD patients (M = 
.80, SD = .14) [t(46) = 2.31, p < .05]. This staged decrease of the raw data selectivity index 
value points to a progressive deficit in prioritizing the processing of targets over that of dis-
tractors in MCI and, more markedly, AD patients. 
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5.4.1.2. TVA parameter estimates 
From the raw data of the w estimates (for more details see chapter 5.3.3.1, p. 71), the parame-
ter efficiency of top-down control α was calculated and compared across subject groups. 
 
Figure 12: PR: Mean values of parameter top-down control α for healthy controls (HC), MCI 
and AD patients 
Error bars represent standard errors of the mean. 
An ANOVA of the parameter efficiency of top-down control α with the between-subject fac-
tor Group (MCI, AD, HC) and the within-subject factor Side of Visual Field (left, right) re-
vealed a highly significant effect of Group [F(2, 81) = 12.37, p < .01]. The main effect of Side 
and the interaction were not significant [all p > .25]. As depicted in Figure 12, post-hoc tests 
revealed that top-down control was impaired in both, MCI [t(66) = 1.83, p < .05] and AD pa-
tients [t(50) = 2.97, p < .01], compared to healthy subjects. The decline was staged, i.e. values 
of AD patients were worse than that of MCI patients [t(46) = 2.19, p < .05]. Parameter esti-
mates for individual MCI and AD patients are provided in Table 13 (pp. 135 et seqq.). 
5.4.2. Spatial weighting and sensory effectiveness 
First, visual field differences related to the spatial laterality and imbalance indices of atten-
tional weighting are reported, as well as that of sensory effectiveness across the left and the 
right hemifields, starting with the presentation of raw data results followed by the parameter 
estimates. 
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5.4.2.1. Raw data 
A) 
 
B) 
 
C) 
 
Figure 13:  PR: Mean proportion of correctly reported letters (in %) of (A) control subjects, 
(B) MCI subjects and (C) AD patients in unilateral stimulus conditions (accompa-
nying stimulus: none/ ipsilateral) and bilateral stimulus conditions (contralateral) 
The white bars indicate the averaged individual hemifield differences in the respective conditions. Error bars 
represent standard errors of the mean. 
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To illustrate attentional weighting and sensory effectiveness across the two hemifields, Figure 
13 shows the mean proportion of target letters correctly identified by patients and controls in 
each hemifield, separately for experimental conditions with unilateral stimuli (average of sin-
gle targets and targets accompanied by ipsilateral targets or distractors) and bilateral stimuli 
(average accuracy of targets accompanied by a contralateral stimulus). 
Performance for unilateral stimulus conditions was examined to assess the general sensory ef-
fectiveness, that is, basic sensory efficiency of visual processing of a single target stimulus at 
a given exposure duration. In unilateral displays, this basic efficiency is assumed to be inde-
pendent of the spatial attentional weighting across the two hemifields. In the unilateral presen-
tation conditions (none, ipsilateral distractor, ipsilateral target), both controls and patients ex-
hibited only minor hemifield differences, indicating a balanced sensory effectiveness. 
The laterality of attentional weighting is a measure of the spatial distribution of attentional 
weights across the left versus the right visual hemifield. Therefore, the bilateral stimulus con-
ditions with (row) displays containing a stimulus in each hemifield are crucial for the TVA-
based estimation of the attentional weighting parameter. In these conditions, spatial attention-
al weights have to be distributed across the left and the right visual hemifield, with the weight 
allocation determined by a competitive process between the two hemifields. If attentional 
weights are biased towards one hemifield, performance in the bilateral (compared to the unila-
teral) target condition will suffer more for a target presented in the hemifield with relatively 
low attentional weights, compared to a target in the hemifield with high weights. In bilateral 
presentation conditions, healthy controls showed no obvious hemifield differences. In con-
trast, MCI patients showed slightly better performance in the left compared to the right hemi-
field, indicating that objects on the left side received higher attentional weight and affected 
accuracy for right side stimuli more than vice versa. AD patients showed an even more pro-
nounced leftward bias. 
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It is worth noting that the standard error of the mean in bilateral conditions was quite large in 
MCI patients, and even larger in AD patients, compared to healthy subjects, indicating a re-
markable variance in performance. In order to examine whether this variance reflects indivi-
dually enhanced spatial attentional biases either to the left or the right hemifield, the average 
accuracy differences between the left and the right hemifield, |accuracyleft – accuracyright|, 
were computed. These hemifield differences are illustrated, separately for each group and the 
different conditions, by the white bars in Figure 13. In unilateral conditions, no significant 
differences between groups were found [F(2, 81) = 1.11; p > .30]. In bilateral conditions, 
however, the groups differed significantly [F(2, 81) = 12.62; p < .01], with enhanced values in 
MCI [t(66) = 3.82 ; p < .01] and AD patients [t(50) = 3.66; p < .01] compared to controls.  
These results suggest that MCI and AD patients suffered from biased spatial attentional 
weighting (either directed to the left or to the right visual hemifield in the individual patients) 
in conditions with bilaterally presented stimuli. Since no comparably enhanced visual field 
differences were revealed in unilateral stimulus conditions, the basic sensory effectiveness of 
visual processing seemed to be non-lateralized. 
5.4.2.2. TVA parameter estimates 
Three laterality indices were computed from the raw data of the A and w estimates (for more 
details, see chapters 5.3.3.2 and 5.3.3.3, pp. 71 et seq.): the laterality index of sensory effec-
tiveness Aλ, the laterality index of attentional weighting wλ and the imbalance index of atten-
tional weighting Dev(wλ). For detailed parameter values in all subject groups, see Table 3. Pa-
rameter estimates for individual MCI and AD patients are provided in Table 13 (pp. 135 et 
seqq.). 
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Table 3:  PR: TVA partial report parameters of MCI and AD patients and controls 
See also Table 13 (pp. 135 et seqq.). 
Aleft/ Aright: basic sensory effectiveness in the left and right hemifield, respectively; Aλ: laterality index of sensory 
effectiveness; wλ: laterality index of attentional weighting; Dev(wλ): imbalance index of attentional weighting; **: 
highly significant difference compared to controls (p < .01). Values represent mean scores (and standard devia-
tions). 
 Aleft Aright Aλ wλ Dev(wλ) 
AD 3.08 (.81) 3.05 (1.04) .51 (.07) .56 (.19) .16 (.11)** 
MCI 3.20 (1.76) 2.83 (.91) .52 (.08) .51 (.14) .11 (.09)** 
Controls 2.79 (.92) 2.68 (.83) .51 (.05) .49 (.06) .05 (.04) 
 
An ANOVA of sensory effectiveness parameters A, with the between-subject factor Group 
(HC, MCI, AD) and the within-subject factor Side of Visual Field (left, right), revealed nei-
ther main effect to be significant, Group [F(2, 81) = .95, p > .35] and Side [F(1, 81) = 2.00, p 
> .15], nor the Group x Side interaction [F(2, 81) = .79, p > .45]. Similarly, the index for the 
laterality of sensory effectiveness Aλ did not differ significantly between subject groups [F(2, 
81) = .21; p > .80]. Neither the control group‟s nor the patients‟ index differed significantly 
from 0.5, which indicates equal sensory effectiveness on both sides (all p > .20).  
 
Figure 14:  PR: Mean values of the imbalance index of attentional weighting Dev(wλ) for 
healthy controls (HC), MCI and AD patients 
Error bars show standard errors of the mean. 
The parameter laterality of attentional weighting wλ did not differ significantly among groups 
[F(2, 81) = 1.95; p > .10], and none of the group mean values differed significantly from the 
unbiased value 0.5 (all p > .15). These results indicate that there was no specific bias in the 
sense of a general leftward or rightward preference in the patient groups. 
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However, a significant group effect was found for the deviation from the optimum value, that 
is, the imbalance index Dev(wλ) [F(2, 81) = 11.07, p < .01]. As depicted in Figure 14, post-
hoc comparisons revealed highly significant differences between healthy control subjects and 
both MCI [t(66) = 3.27, p < .01]) and AD patients [t(50) = 3.75, p < .01]). Furthermore, AD 
patients tended to show even more increased values compared to MCI patients [t(46) = 1.60, p 
< .06] indicating a more severe imbalance of attention. Thus, rather than suffering from a di-
rected imbalance towards one specific hemifield, the patients displayed a more general inabil-
ity to distribute attention across both hemifields, with a preference for the right or the left on 
the level of the single cases. 
Based on the range of the imbalance index Dev(wλ) in healthy subjects, the 90
th
 percentile was 
selected to indicate a pathological spatial imbalance (Dev(wλ) ≥ .11) in patients. On this crite-
rion, 12 MCI (38%; 7 left, 5 right) and 9 AD patients (56%; 7 left, 2 right) suffered from a pa-
thological imbalance of attentional weights, predominantly directed to the left visual hemi-
field (67%), though, to a smaller portion, also directed to the right (33%).  
In order to rule out probable sensory confounds with the imbalance index Dev(wλ), this index 
was correlated with the corresponding parameter indicating imbalance of sensory effective-
ness Dev(Aλ). Non-significant correlations were obtained for all subject groups (controls: r = -
.05, p > .75; MCI: r = -.17, p > .35; AD: r = -.02, p > .90). Thus, the pathological imbalance 
of spatial weighting is not attributable to a more fundamental sensory imbalance. 
5.4.3. Parameter inter-correlation 
No significant correlation was found between the imbalance index of attentional weighting 
Dev(wλ) and the efficiency of top-down control α within single groups (all p > .25). These re-
sults indicate that partial report parameters are independent of each other in healthy controls 
as well as in both clinical groups. 
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5.4.4. Relationship of partial report parameters to external clinical measures 
Furthermore, the relationship of both partial report parameters, imbalance index of attentional 
weighting Dev(wλ) and the efficiency of top-down control α, with external criteria was ex-
amined, including age, age at onset and disease duration since estimated symptom onset in 
both patient groups and across all patients. Neither of these correlations reached significance 
(all p > .10). 
5.4.5. Relationship of partial report parameters to measures of cognitive func-
tion 
Across both clinical groups, 46 MCI and AD patients (clinical indices of two AD patients 
were not available), Spearman correlations were calculated between the pathological imbal-
ance of spatial attentional weighting Dev(wλ) and the decreased efficiency of top-down con-
trol α, to external clinical criteria, the CERAD battery (total score excluding MMSE; see 
Chandler et al., 2005), the CDR sum of boxes score, MMSE, and CDT. After correction for 
multiple comparisons, a significant negative correlation between Dev(wλ) and the CERAD to-
tal score (rS = -.34, p < .05) was revealed. Thus, the more pronounced the general cognitive 
decline, the more severe the inability to pay equal attention to both visual hemifields. In con-
trast, parameter selectivity of top-down control α was significantly positively related to the 
CDR score (rS = .34, p < .05). This result suggests that the degree of impairment in top-down 
selection corresponds to the progressive stage of AD severity according to CDR. All other 
correlations were non-significant. 
5.4.6. Effect of ApoE4 genotype 
In order to test whether the partial report parameters are related to a possibly underlying gene-
associated pathology (as has been found for spatial attentional weighting in Huntington's dis-
ease, Finke et al., 2006) the effect of ApoE4 genotype (1-2 allele carriers denoted as ApoE4
+ 
versus ApoE4
-
) on the parameter values was analyzed.  
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ApoE4 status was available in 43 patients. For further analyses, the combined patient group 
was used in order to enhance sample size. The patients were divided into two subgroups, 28 
ApoE4
+
 and 15 ApoE4
-
 patients. Clinical details are reported in Table 4, separately for each 
of the groups under study.  
Table 4:  PR: Clinical characteristics of ApoE4 subgroups 
ApoE4
+
: ApoE4 gene carriers; ApoE4
-
: ApoE4 non-carriers; AChEI: acetylcholine esterase inhibitors; SSRI: se-
lective serotonin reuptake inhibitors; NaSSA: noradrenergic and specific serotonergic antidepressant; see also 
Table 2 (p. 67). 
 ApoE4
+
 (n = 28) ApoE4
-
 (n = 15) p 
Age,  
M (SD), range 
68.4 (6.2) 
56.1 – 79.0 
68.1 (10.1) 
45.9 – 81.5 
> .85 
Gender (male/ female) 12 / 16 9 / 6 > .25 
Education, 
M (SD), range 
10.6 (1.9) 
9 – 13 
10.2 (1.8) 
9 – 13 
> .45 
Diagnosis 18 MCI, 10 AD 11 MCI, 4 AD > .50 
Handedness all R all R  
MMSE, 
M (SD), range 
25.8 (2.4) 
20 – 29 
26.5 (2.7) 
19 – 30 
> .40 
CERAD, 
M (SD), range 
78.3 (9.1) 
54 – 90 
78.8 (16.4) 
51 – 112 
> .90 
CDT, 
M (SD), range 
2.4 (1.1) 
1 – 5 
2.3 (1.2) 
1 – 4 
> .75 
CDR sum, 
M (SD), range 
2.8 (1.3) 
1.0 – 5.0 
2.7 (1.3) 
1.0 – 5.0 
> .75 
Age at onset, 
M (SD), range 
65.3 (7.1) 
53.4 – 76.5 
65.2 (9.9) 
43.6 – 78.4 
> .95 
Disease duration, 
M (SD), range 
3.1 (2.0) 
.5 – 8.0 
2.9 (1.2) 
1.1 – 5.4 
> .70 
Medication: 
Antidementive 
19 AChEI 
(68%) 
13 AChEI 
(87%) 
> .15 
Medication: 
Antidepressant 
6 SSRI, 1 NaSSA  
(25%) 
1 SSRI, 1 NaSSA, 1 tricycli-
ca (20%) 
> .70 
 
ApoE4
+
 and ApoE4
-
 subgroups were matched with regard to all variables listed in Table 4 (all 
p > .15). A trend-level difference between ApoE4 subgroups was revealed with regard to the 
spatial laterality index of attention wλ [t(41) = 1.62, p < .06]. A significant deviation from the 
optimal unbiased wλ value 0.5 was only present in ApoE4
+
 patients [t(27) = 2.61, p < .01], in-
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dicating a pathological leftward spatial bias in contrast to the balanced distribution of atten-
tion in ApoE4
-
 patients [t(14) = .31, p > .75] (see Figure 15). 
 
Figure 15:  PR: Effect of ApoE4 genotype (ApoE4+: gene carrier; ApoE4-: non-carrier) on pa-
rameter laterality of attentional weighting wλ in a combined group of MCI and AD 
patients 
The dashed line represents the unbiased wλ value 0.5. Error bars indicate standard errors of the mean. 
As can be seen from Figure 16, age and the spatial laterality index of attention wλ were signif-
icantly correlated in ApoE4
+
 patients (n = 27, r = -.33, p < .05) and a trend level correlation 
was found between parameter wλ and disease onset (r = -.30, p < .07). These correlations indi-
cate that ApoE4
+
 patients with an early onset show a more pronounced leftward spatial bias. 
This result was revealed after the exclusion of one outlier value (3 standard deviations above 
mean) produced by MCI patient AW (wλ = .13).  
 
Figure 16:  PR: Scatterplot relating the spatial laterality index of attentional weighting wλ to 
age in ApoE4+ patients 
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5.5. Discussion 
The aim of the present study was to investigate the functions of spatial and task-related atten-
tional weighting by means of a partial report task based on Bundesen‟s (1990) theory of visu-
al attention (TVA) in amnestic MCI and probable AD patients compared to a healthy elderly 
control group. The partial report task required the verbal report of briefly presented target let-
ters (and to-be-ignored distractors) and allowed the derivation of two independent quantitative 
parameter estimates from the qualitative performance pattern: task-related efficiency of top-
down control α and spatial imbalance of attentional weighting Dev(wλ). MCI and AD patients 
were impaired in both attentional functions compared to healthy controls. Early deficits of 
both parameters α and Dev(wλ) at the MCI stage further deteriorated at the stage of AD. In 
apolipoprotein E ε4 allele (ApoE4) carriers, earlier disease onset was associated with a more 
pronounced leftward spatial bias wλ. 
Thus far, to my knowledge, there have been no reports of both spatial and task-related aspects 
of visual attentional weighting in MCI as well as AD patients, although it is widely accepted 
that early AD is marked by visuospatial (Parasuraman et al., 2002) and executive deficits 
(Perry & Hodges, 1999).  
The imbalance index of attentional weighting Dev(wλ) and the efficiency of top-down control 
α were uncorrelated for each group, indicating that these indices represent distinct attentional 
deficiencies with possibly different underlying neuropathological mechanisms. In support of 
this, Bublak et al. (2005), who employed the same partial report task, observed the following 
double dissociation: One patient with a right inferior parietal lesion suffered from impaired la-
terality of attentional weighting wλ, while efficiency of top-down control α was intact. The 
second patient with a superior frontal brain lesion displayed the reverse pattern, with impaired 
top-down control and balanced spatial weighting. 
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5.5.1. Impairments in task-related weighting 
Frontal lobe pathology is generally not seen in the early stages of AD (Braak & Braak, 1990; 
Braak et al., 1993; Whitwell et al., 2007). However, it has been repeatedly suggested that the 
frontal lobes might be functionally disconnected from other relevant extrastriate, parietal and 
hippocampal areas (see review by Delbeuck, Van der Linden, & Collette, 2003; Grady et al., 
2001; Sorg et al., 2007). Correspondingly, a number of studies suggest that impairment in top-
down processing might be even a very early feature in the course of AD (Azari et al., 1992; 
Perry & Hodges, 1999). The results of the present study were in line with this assumption. 
The task-related selection, that is, the efficiency of top-down control α, was impaired early at 
the MCI stage and deteriorated further in the later stages of disease progression. 
Neuropathology in AD is mainly characterized by neurofibrillary tangles and neuritic plaques. 
Neurofibrillary tangles are prevailing in associative areas, that is, the parietal and frontal 
lobes, and in large cortical neurons mediating cortico-cortical connections (Pearson et al., 
1985), while neuritic plaques seem to accumulate at the ends of cortico-cortical tracts (De La-
coste & White, 1993). Both pathological markers give rise to a selectively distributed neocor-
tical disconnection syndrome in AD (Delbeuck et al., 2003; Sorg et al., 2009), disrupting, 
among others, functional connectivity between frontal and parietal cortices in AD (Azari et 
al., 1992; Horwitz et al., 1987). The diminished anterior-posterior connectivity in AD was 
corroborated by Collette et al. (2002), who examined inhibitory processing and selective at-
tention in AD patients with either parietal and temporal hypometabolism or with additionally 
reduced metabolism in frontal areas. Both AD groups were impaired in all executive tasks, ir-
respective of the presence or absence of frontal lobe hypometabolism. Consequently, execu-
tive impairments in AD seem to be predominantly caused by disruptions of the fronto-parietal 
attention network, rather than frontal lobe dysfunction, and therefore might occur early, that 
is, at the MCI stage of the disease. At the later AD stage, increasing burden of neuritic pla-
ques and neurofibrillary tangles cause substantial loss of neuronal cell assemblies in parietal 
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and frontal cortex (Braak & Braak, 1990, 1991; Whitwell et al., 2007), which is in accordance 
with further deterioration of top-down control selectivity in AD compared to MCI patients. 
By using a comparable TVA partial report task, Peers et al. (2005) revealed that, in patients 
with frontal lobe lesions, deficits in the efficiency of top-down control α were predicted by le-
sion volume. Consequently, the staged decline of efficiency of top-down control α, as re-
vealed in the present study, might result from early cortico-cortical disconnection in the fron-
to-parietal attention network at the MCI stage and a later additional loss of nerve cells in cor-
responding association areas at the stage of AD. 
5.5.2. Impairments in spatial weighting 
In the current clinical samples, a pathological spatial deviation of attention Dev(wλ) to either 
hemifield was obtained in both MCI and AD patients, although the patients‟ performance was 
absolutely balanced across both hemifields in unilateral stimulus conditions. Any unilateral 
right- or left-sided sensory loss was excluded by a balanced laterality index of sensory effec-
tiveness Aλ across the left and right visual hemifield and non-significant correlations between 
imbalance of attentional weighting Dev(wλ) and the corresponding imbalance index of sen-
sory effectiveness Dev(Aλ) in all subject groups. Additionally, the spatial bias exhibited by the 
clinical groups in this study is also not attributable to an inability to maintain central fixation 
during the partial report task. Any systematic gaze deviation to either hemifield would have 
resulted in higher accuracy and enhanced values of sensory effectiveness of visual processing 
for one or the other hemifield and would, thus, have affected the absolute accuracy differenc-
es between the left and the right hemifield in unilateral conditions as well as the laterality in-
dex of sensory effectiveness Aλ.  
Significant accuracy asymmetries in patients were present in bilateral presentation conditions 
only, which accords with the view that visual extinction is at the basis of the patients‟ visuos-
patial bias, a symptom mainly found in unilaterally brain damaged patients. Extinction is de-
fined as the inability to process a stimulus in the right visual hemifield in presence of another 
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stimulus in the left hemispace, or vice versa, despite preserved visual sensory processing 
(Driver & Vuilleumier, 2001). In manifest neglect, the patient would be completely unaware 
of all stimuli presented in the contralesional hemifield.  
These findings are consistent with the assumption that parietal lobe degeneration in AD is bi-
lateral on the one hand (Braak & Braak, 1990), however, probably also not absolutely ba-
lanced in individual patient‟s brains. Neural degeneration in AD might be slightly intensified 
in the left compared to the right hemisphere, as indicated by various measures of brain activi-
ty (Desgranges et al., 1998; O'Brien et al., 1992; Volkow et al., 2002) and pre- (Thompson et 
al., 2003; Ueyama et al., 1994) and post-mortem (Li et al., 2000) brain volume measurements. 
Accordingly, Bartolomeo et al. (1998) and Venneri et al. (1998) reported visual spatial neg-
lect of the right hemifield in single cases with cortical atrophy and hypoperfusion predomi-
nantly in the left posterior regions. However, leftward neglect in patients with predominantly 
right-hemispheric degeneration has also been reported (Ishiai et al., 2000; Mendez et al., 
1997; Venneri et al., 1998). Group studies (Bublak et al., 2006; Ishiai et al., 2000; Maruff, 
Malone, & Currie, 1995; Meguro et al., 2001; Mendez et al., 1997) found left- or right-sided 
spatial bias in line bisection, reaction times, discrimination and visual search tasks in up to 
75% of AD patients. Since potential lateralizations at the early MCI stage of the disease are 
presumably even more subtle than those in the later AD phase, highly sensitive, experimental-
ly-based, paradigms are needed to reveal small but indicative deficits. The present TVA-based 
partial report results resembled these findings even at the early stage of the disease, since in 
38% of MCI and 56% of AD patients a pathological spatial bias prevailed. About 2/3 of these 
patients showed leftward spatial lateralization and about 1/3 a spatial bias towards the right 
visual field.  
Although AD does often not lead to clinically manifest hemineglect symptoms according to a 
classical test of figure copying, visual search paradigms using picture material can reveal he-
mispatial omissions in the majority of patients (i.e. Meguro et al., 2001). In this study, AD pa-
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tients‟ enhanced rightward omissions were correlated with lower parietal cerebral blood flow 
(CBF), as measured with single photon emission computed tomography (SPECT), in the left 
hemisphere compared to the right, and patients with predominantly leftward omissions 
showed the opposite CBF pattern. Accordingly, it is feasible that in the current clinical groups 
the present pathological laterality of spatial attention wλ might be associated with and result 
from an underlying interhemispheric imbalance in (temporo-)parietal cortical interactions in 
such a way that a more pronounced leftward spatial bias would be associated with distinct 
leftward parietal impairment and vice versa. Further imaging (e.g., positron emission tomo-
graphy, PET) studies are necessary to investigate this issue. The staged increase in pathologi-
cal spatial bias from MCI to AD patients in this study might result from an early imbalance in 
parietal cortical interactions and, at the later AD stage, additional parietal degeneration 
through neuronal loss. Support for the latter assumption is provided by a TVA-based partial 
report study by Peers et al. (2005). In this study, patients with parietal lobe lesions revealed a 
lateral spatial bias, which was associated with lesion volume. 
5.5.3. Effect of ApoE4 genotype 
One major influence on spatial attention in AD might stem from genetic influences. This is 
suggested by findings in several fluoro-deoxy-glucose PET (FDG-PET) studies in healthy 
subjects (Reiman et al., 1996; Small et al., 2000; Small, Mazziotta et al., 1995) as well as 
MCI and AD patients (Mosconi et al., 2005; Mosconi, Nacmias et al., 2004; Mosconi, Perani 
et al., 2004), which showed that the dose of ApoE4 allele influences the typical age-related 
decline in parietal, temporal and posterior cingulate cerebral glucose metabolism progresses. 
Healthy monozygous ApoE4
+ 
subjects with subjective memory impairments (Small, La Rue 
et al., 1995) as well as homozygous ApoE4
+
 subjects without memory complaints (Reiman et 
al., 1996) were found to display significantly lower parietal metabolism compared to ApoE4
- 
subjects and a significantly enhanced parietal asymmetry with a more pronounced hypometa-
bolism in the left hemisphere. Furthermore, in healthy subjects at genetic risk, lower baseline 
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metabolism in left posterior cingulate, inferior parietal and lateral temporal regions predicted 
the greatest portion of metabolic decline after two years (Small et al., 2000). Interestingly, us-
ing an identical partial report paradigm, Finke et al. (2006) had found a close relationship be-
tween the severity of the underlying gene-associated pathology in the neurodegenerative Hun-
tington‟s disease and the degree of leftward spatial attention. In the present study, the findings 
of Finke et al. (2006) could be replicated in a combined clinical group of MCI and AD pa-
tients, suggesting more pronounced leftward spatial bias in ApoE4
+
 patients with earlier dis-
ease onset. The correlation was lower in the present study, which is most probably related to 
the deeper impact of the underlying gene-associated pathology in Huntington‟s disease. Since 
interactive effects of ApoE4 genotype and (onset) age have been documented (Mosconi et al., 
2005; Mosconi, Sorbi et al., 2004), it would be important to examine systematically, in larger 
samples, whether distinct effects of ApoE4 genotype in patients with early and with late (on-
set) age would be found on, for instance, the parameter laterality of attention wλ.  
5.5.4. Limitations of the study 
As a cross-sectional study design was used, neither conclusions on the predictive value of one 
or both partial report parameters can be drawn with regard to conversion from MCI to AD nor 
on the course of partial report parameters in the individual progression of AD. Therefore, this 
survey needs to be complemented by longitudinal studies.  
5.5.5. Conclusions 
The TVA-based partial report task proved to be a sensitive tool for assessing selective visual 
attention already at an early stage of the progression to AD. Both, deficits in task-related se-
lection and a pathological attentional imbalance, are already present at the early MCI stage, 
besides the presence of memory impairments, and they increase further at a more advanced 
stage of the disease. These findings are compatible with the hypotheses that early impairments 
in task-related and spatial weighting result from a disconnection syndrome and an interhemis-
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pheric imbalance in cortical interactions, respectively, in the fronto-parietal attention network. 
At later stages, gradual neuronal loss causes further decline in selective attentional and intel-
lectual functions. The present results point to the efficiency of top-down control and to the 
spatial imbalance of visual attention as potential early cognitive markers. Both attentional pa-
rameters can be taken into account as sensitive measures of neuronal dysfunction prior to cell 
decline. The fact that the pathological spatial imbalance of attentional weighting was asso-
ciated with the presence of ApoE4 and early disease onset, may even determine the partial re-
port procedure as efficient diagnostic tool for early identification of subjects at risk for AD. 
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6. Study 3: Spatial weighting and interhemispheric metabolic im-
balance across MCI and AD 
In the third study, the relationship of the spatial distribution of attentional weights across the 
left and right hemifield was analyzed with regard to interhemispheric metabolic imbalances as 
measured by 
18
Fluoro-deoxy-glucose positron emission tomography (FDG-PET) in temporo-
parietal cortices (TPJ, temporo-parietal junction) in patients with mild cognitive impairment 
(MCI) and Alzheimer‟s disease (AD). 
6.1. Abstract 
In mild to moderate Alzheimer‟s disease (AD), deficits of visuospatial attention and task-
related selection are well established. Furthermore, the partial report paradigm based on the 
theory of visual attention (TVA) proved to be a sensitive tool for verifying that both, deficits 
in task-related selection and a pathological attentional imbalance, are already present at the 
early amnestic stage of mild cognitive impairment (MCI) and increase further at the AD stage 
(see second study, chapter 5, pp. 60 et seqq.). It was hypothesized that these deficiencies in 
selective attention may result from an early disconnection syndrome and an interhemispheric 
imbalance in cortical interactions, respectively, in the fronto-parietal attention network, before 
gradual neuronal loss leads to further decline in selective attentional and intellectual functions 
at later stages.  
In the present study, these hypotheses were tested by investigating the relationship of both 
partial report parameters, top-down control α and especially the laterality index of attentional 
weighting wλ, to regional glucose metabolism measured by resting-state positron emission 
tomography (PET) in a sample of 30 amnestic MCI or mild AD patients.  
Hypometabolism across all patients was slightly increased in the left hemisphere. Interesting-
ly, the more reduced the metabolism in the left temporo-parietal junction (TPJ) the more pro-
nounced was the top-down control deficit. Accordingly, hypometabolism in the left TPJ to-
gether with the left inferior parietal lobe (IPL) predicted the magnitude of the spatial bias. 
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Furthermore, relative hypometabolism in the left TPJ and left IPL as compared to the right 
TPJ and right IPL, respectively, was correlated with direction and degree of spatial bias. 
Taken together, PET imaging results support the hypotheses that, one the one hand, early def-
icits in task-related weighting may result from a fronto-parietal disconnection syndrome al-
ready at the stage of MCI. On the other hand, very early AD seems to be also associated with 
an interhemispheric imbalance of metabolism, particularly in the temporo-parietal cortices, 
resulting in a correspondingly directed and distinctive visuo-spatial attentional bias. 
6.2. Introduction and aim of the study 
In the latter study (see chapter 5, pp. 60 et seqq.), functions of spatial and task-related atten-
tional weighting were assessed by means of a partial report task based on Bundesen‟s (1990) 
theory of visual attention (TVA) in amnestic mild cognitive impairment (MCI) and probable 
Alzheimer‟s disease (AD) patients compared to healthy elderly controls. The TVA-based par-
tial report task proved to be a sensitive tool for assessing selective visual attention already at 
an early stage of the progression to AD. The findings of the latter study corroborated that pa-
tients in the early stage of MCI were impaired in both, task-related efficiency of top-down 
control α and spatial imbalance of attentional weighting Dev(wλ) compared to control sub-
jects. Thus, on the one hand, MCI subjects were impaired in their ability to prioritize pre-
specified target letters over task-irrelevant distractor letters. On the other hand, in MCI pa-
tients, a pathological spatial imbalance of attention towards either hemifield was revealed. 
Compared to healthy controls, most of these patients suffered from a pathological spatial bias 
directed to the left visual hemifield, though a smaller portion of patients showed a rightward 
spatial lateralization. 
The findings in view of parameter top-down control α are compatible with the hypothesis that 
early impairments in task-related weighting might result from a cortico-cortical disconnection 
syndrome (see e.g. Delbeuck et al., 2003; Sorg et al., 2009) in the fronto-parietal attention 
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network, which was corroborated by a 
18
fluoro-deoxy-glucose positron emission tomography 
(
18
FDG-PET) study by Collette et al. (2002). In this study, AD patients with either parietal 
and temporal hypometabolism or with additionally reduced metabolism in frontal areas were 
impaired in various executive tasks, irrespective of the presence or absence of frontal lobe hy-
pometabolism. As a result, cortico-cortical disconnectivity between frontal and parietal cor-
tices might be at the bottom of deficits in top-down controlled selection (see chapter 5.5.1, pp. 
87 et seq., for a detailed discussion). As a consequence, the first aim of the third study was to 
investigate whether the TVA-based assessment in combination with resting-state 
18
FDG-PET 
would reveal evidence for a functional disconnection syndrome between frontal and parietal 
cortices in early AD. 
The second and main goal of the present study was derived from the finding that already MCI 
patients suffered from impaired spatial allocation of attentional weights which was interpreted 
as being probably caused by an interhemispheric (temporo-)parietal imbalance in cortical inte-
ractions. In line with this hypothesis are findings of a visual search study by Meguro et al. 
(2001), revealing that AD patients‟ enhanced rightward omissions were correlated with lower 
parietal cerebral blood flow (CBF) in the left hemisphere compared to the right, and vice ver-
sa. The fact that temporo-parietal hypometabolism is a main indicator of AD (see e.g. review 
by Mosconi, 2005) supported the view of parameter laterality of attentional weighting wλ as 
potentially early cognitive marker of subjects at risk for AD. In this study, a more pronounced 
leftward spatial bias was expected to be associated with relative left-hemispheric hypometa-
bolism in (temporo-)parietal cortex compared to the metabolic rate in homologous right-
hemispheric regions and vice versa. For a more thorough discussion and detailed argumenta-
tion, see chapter 5.5.2 (pp. 88 et seqq.).  
Thus, the present study expands the investigation of the previously presented second study of 
this dissertation (see chapter 5, pp. 60 et seqq.) by relating TVA parameters for spatial and 
task-related attentional selection to 
18
FDG-PET imaging data. The TVA-based partial report 
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paradigm (and whole report paradigm) was applied in patients who were predominantly diag-
nosed with amnestic MCI – only some patients were diagnosed with probable AD – in order 
to be able to account for behavioral-metabolic coherences in early AD. 
6.3. Method 
6.3.1. Subjects 
A subgroup of those patients who participated in the second study (for details on diagnostic 
assessment, exclusion and diagnostic criteria, see chapter 5.3.1, pp. 65 et seq.) took part in 
this third study because only individuals of the original sample underwent FDG-PET imaging, 
resulting in 23 MCI and 7 AD patients (11 male, 19 female; mean age 67.5 years; mean edu-
cation 10.3 years; all right-handed). The patient sample was supposed to represent early AD 
because the majority (77%) consisted of MCI patients. None of the MCI patients was medi-
cated with antidementives, but 6 AD patients were treated with acetylcholine esterase inhibi-
tors (AChEI). Due to mild symptoms of depression, 8 MCI patients and 1 AD patient received 
antidepressant medication. Furthermore, 1 MCI patient suffered from diabetes mellitus, 5 
MCI and 2 AD patients received antihypertensive medication.  
The age, gender and education matched control group for the TVA-based (whole and) partial 
report assessment was identical to the group of control subjects assessed for the second study 
and consisted of 36 healthy older subjects (16 male, 20 female; mean age 67.2 years; mean 
education 10.5 years; all right-handed). All control subjects were neurologically and psychia-
trically healthy, were not medicated and had no cognitive symptoms. All subjects had normal 
or corrected-to-normal vision. Patients and control subjects did not differ significantly from 
each other with regard to Age [F(1, 65) = .04, p > .80], Education [F(1, 65) = .08, p > .75] or 
Gender [χ2(1) = .41, p > .50]. Further biographical and clinical information of each subject 
group is listed in Table 5 (for demographic details of individual MCI and AD subjects, see 
Table 14, p. 138).  
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Table 5: TVA-PET: Overview of biographical and clinical details across MCI and AD pa-
tients and healthy controls 
See also Table 14 (p. 138). 
CDR: Clinical Dementia Rating Scale, global score (Morris, 1993); p: level of significance; M (SD): mean score 
and standard deviation; Age in years; Education in years; Handedness: according to the Edinburgh Handedness 
Inventory (Oldfield, 1971); R: right-hander; MMSE: Mini Mental State Examination (Folstein et al., 1975), 30-0 
points, cut-off ≤ 23; CERAD: The Consortium to Establish a Registry for Alzheimer‟s Disease (Thalmann & 
Monsch, 1997), total score; n.a.: not applied; CDT: Clock Drawing Test, 0-6 points, cut-off ≥ 3 (Shulman et al., 
1986); CDR sum: sum of CDR category scores; Age at disease onset in years; Disease duration in years; 
ApoE4: apolipoprotein E4 genotype, positive (+), negative (-). 
 MCI and AD 
(n = 30, CDR ≥ .5) 
Control  
(n = 36) 
p 
Age,  
M (SD), range 
67.5 (7.9) 
45.9 – 79.9 
67.2 (6.6) 
50.0 – 82.0 
> .80 
Gender (male/ female) 11 / 19 16 / 20 > .50 
Education, 
M (SD), range 
10.3 (1.8) 
9 – 13 
10.5 (2.1) 
7 – 13 
> .75 
Handedness all R all R  
MMSE, 
M (SD), range 
26.2 (2.4) 
20 – 30 
29.0 (1.0) 
27 – 30 
< .01 
 
CERAD, 
M (SD), range 
81.1 (11.5) 
54 – 112 
n.a.  
CDT, 
M (SD), range 
2.4 (1.1) 
1 – 5 
n.a.  
CDR sum, 
M (SD), range 
2.6 (1.1) 
1.0 – 5.0 
n.a.  
Age at onset, 
M (SD), range 
64.7 (8.3) 
52.1 – 76.8 
-  
Disease duration, 
M (SD), range 
2.8 (1.6) 
0.5 – 7.8 
-  
ApoE4 genotype 19 +/ 8 -/ 3 n.a. n.a.  
 
All participants gave informed consent to taking part in the TVA-based assessment and rest-
ing-state 
18
FDG-PET. The ethics committee of the Technical University of Munich and the 
radiation protection authorities approved the study protocol. The TVA procedure and the PET 
acquisition were performed within an interval of a few days.  
For the comparison of patient baseline PET data with an age-matched control group a pre-
existing PET database of 23 healthy volunteers was applied. This group had been acquired 
previously for clinical and scientific purposes in the dementia research unit and consisted of 
subjects without cognitive symptoms, neurological, psychiatric, or systemic diseases. The eth-
ics committee of the Technical University of Munich and the radiation protection authorities 
6. Study 3: Spatial weighting and interhemispheric metabolic imbalance across MCI and AD – 6.3. Method 98 
approved the PET protocol for the healthy control group. PET examinations of the control 
group had been performed following the identical protocol as for the patient group. 
6.3.2. Whole and partial report paradigm 
Please note that the TVA-based whole report paradigm was primarily applied in order to con-
trol for possible non-lateralized influences of distinct components of processing capacity on 
aspects of both, task-related and spatial weighting. Task, procedure, stimuli and apparatus of 
the whole report assessment were identical to the testing in the first study described in this 
dissertation (see chapter 4.3.2, pp. 39 et seqq.). The average “short” presentation time used in 
the whole report paradigm was M = 167 ms (SD = 58) across MCI and AD patients and M = 
135 ms (SD = 29) for healthy control subjects. “Intermediate” presentation times were on av-
erage M = 325 ms (SD = 120) across MCI and AD patients, and M = 265 ms (SD = 58) for 
healthy subjects. And “long” presentation times were M = 618 ms (SD = 191) across MCI and 
AD patients, and M = 528 ms (SD = 188) for healthy subjects. Individual exposure durations 
for the combined patient group and control subjects are listed in Table 15 (p. 139). 
The main focus of this study was the partial report assessment which was identical to the ex-
amination in the second study (see chapter 5.3.2, pp. 68 et seqq.). A mean exposure duration 
of 360 ms (SD = 138) was used across MCI and AD patients, of 200 ms (SD = 69) for control 
subjects. Exposure durations of individual subjects are listed in Table 15 (p. 139). 
6.3.3. Estimation of TVA-based parameters 
Parameter estimates derived from the whole report, perceptual processing speed C and VSTM 
storage capacity K, were computed as presented in the first study (see chapter 4.3.3, pp. 42 et 
seq.). The estimation of the partial report parameters top-down control α, characterizing task-
related weighting for prioritizing relevant visual objects for processing, and the spatial distri-
bution of attentional weighting wλ across the left and right visual hemifield were conducted as 
described in the second study (see chapter 5.3.3, pp. 70 et seqq.). 
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6.3.4. 
18
FDG-PET measurement 
18
FDG-PET was used for data assessment in MCI and AD patients. An age-matched control 
group of healthy volunteers was composed of a pre-existing PET database. 
6.3.4.1. Between-group and between-hemisphere comparisons 
Images were acquired on a Siemens 951 R/31 PET scanner. For all patients, PET imaging be-
gan 30 minutes after injection of an intravenous bolus of 370 Megabecquerel (MBq) of 
18
FDG. Subjects were positioned with the head parallel to the canthomeatal line within the 
gantry. During data acquisition, patients were at rest with their eyes closed. Three frames of 
ten-minute duration were acquired and averaged to a single frame. Image data were acquired 
in 2-dimensional mode with a total axial field of view of 10.5 cm and no inter-plane gap 
space. Attenuation correction was performed by a standard ellipse-ﬁtting method. Details of 
the imaging procedure can be found in a report by Drzezga et al. (2005). Images were norma-
lized to a standard template in Montreal Neurological Institute (MNI) space using a non-linear 
algorithm implemented in Statistical Parametric Mapping (SPM) 5 
(http://www.fil.ion.ucl.ac.uk/spm/) and smoothed using a 12x12x12 mm
3
 Gaussian kernel. 
Individual global counts were proportionally scaled to a mean value of 50 mg/ 100 ml/ min. 
The smoothed images were further analyzed within the framework of the general linear model 
(Friston et al., 1995).  
In a first step, global effects of the presence of amnestic MCI and AD on glucose metabolism 
were investigated by comparing PET images from the combined patient group with images of 
23 healthy age-matched controls. A two-sample Student‟s t-test on each voxel was performed, 
accepting differences that passed a threshold of p < .01, false-discovery-rate-corrected (FDR-
corrected) for multiple comparisons, as significant. Regions differing between the groups 
were supposed to be those most affected by disease progression and expected any effects of 
clinical scores to be found within these areas. This was done mainly to ensure that the sample 
in this study was representative of MCI and AD in general. 
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Further, a group-level map of disease-mediated interhemispheric asymmetry was created. In 
order to be able to compare homologous structures in both hemispheres, PET images needed 
to be adjusted to make them symmetrical across the central commissure. For this purpose, all 
patients‟ images (which had previously been normalized to MNI space) were averaged to 
create a patient-specific template and averaged this template with a duplicate that had been 
flipped across the y-z-plane to make it symmetrical. The patients‟ and controls‟ native images 
were then normalized to this symmetrical template, effectively creating symmetrical images 
that still retained individual variations in metabolism. Again, a two-sample Student‟s t-test 
was used to find regions of significant hypometabolism (at p < .01, FDR-corrected, and a 
minimum of 200 contiguous voxels) in patients compared to controls. These hypometabolic 
areas were used as a mask within which to search for disease-related interhemispheric meta-
bolic asymmetry. To test for these imbalances in metabolism, a duplicate of each image was 
created that was then flipped along the y-z-plane and subtracted the original image from its 
flipped duplicate, yielding images of metabolic difference across hemispheres. Using these 
images, a one-sample t-test was performed on each voxel to find unbalanced regions (at p ≤ 
.05, FDR-corrected, and 50 contiguous voxels). 
6.3.4.2. Multiple regression model of PET-based measurements onto TVA parame-
ters 
As the next step, a multiple regression model of TVA parameters onto PET images was 
created. Although at least four main parameters (laterality of attention weighting wλ, top-down 
control α, perceptual processing speed C and visual short-term memory (VSTM) storage ca-
pacity K) can be derived from the TVA-based whole and partial report paradigms, the main 
interest was taken in the laterality index of attentional weighting wλ, which was expected to be 
related to hypometabolism in temporo-parietal regions (see Meguro et al., 2001). In addition, 
it was analyzed whether top-down control α might be predominantly associated with metabol-
ism in temporo-parietal cortex, besides frontal areas (see Collette et al., 2002; Delbeuck et al., 
2003). 
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Since the measure of spatial laterality of attention wλ ought to be used with as few confounds 
from other factors as possible, the contribution of the parameters processing speed C, VSTM 
storage capacity K and top-down control α to parameter wλ were extracted by using Gram-
Schmidt orthogonalization, yielding four orthogonal TVA regressors. Analogous procedures 
were executed with regard to parameter top-down control α. The participants' age was used as 
covariate of no interest. The hypothesis focused on the relationship between parameter wλ and 
metabolism in four homologous left and right temporo-parietal regions putatively related to 
impairments in spatial attention: the angular and supramarginal gyri of the parietal cortex 
(Ang-SMG) as well as the posterior middle temporal gyrus (pMTG) as representatives of the 
temporo-parietal junction (TPJ), along with the inferior parietal lobule (IPL) and the superior 
parietal lobule (SPL). TPJ was separated into two regions of interest (ROIs) to get more spa-
tially specific results. Initially, analyses were restricted to these regions by anatomically de-
fining ROIs using the Automated Anatomical Labeling (AAL) tool (Tzourio-Mazoyer et al., 
2002). Additionally, a whole-brain analysis was used to look for correlations outside of the 
ROIs defined in this study. Please note that whole-brain analyses were not corrected for mul-
tiple comparisons (p < .001, cluster threshold: minimum of 50 contiguous voxels). Conse-
quently, a larger alpha error (i.e. p > .05) cannot be excluded. Therefore, correlations revealed 
by whole-brain analyses might not be considered as rigorous and straight compared to ROI 
results.  
Next, in order to further evaluate the contribution of spatially non-lateralized attention me-
chanisms, analogous analyses were performed for the remaining TVA parameters perceptual 
processing speed C, VSTM storage capacity K, and top-down control α.  
6.3.4.3. Metabolic laterality index 
Finally, to test the hypothesis that it is the relative hypometabolism of one brain structure 
compared to its contralateral homologue, rather than metabolism of that single brain structure, 
which causes spatial lateralization towards one or the other hemifield, mean values from the 
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four ROIs in both hemispheres were extracted. For each ROI, a metabolic laterality index was 
created by dividing average metabolism in the right ROI by the sum of metabolism in left and 
right homologous ROIs, i.e. using the formula 
ROI laterality index =
right  ROI  metabolism
right  ROI  metabolism  + left  ROI  hypometabolism
. Then, it was checked up on 
significant relations between the ROI indices and the partial report laterality parameter of at-
tentional weighting wλ, using Pearson‟s correlations. To test whether the laterality parameter 
wλ is related to imbalanced metabolism in the visual system, the same procedure was per-
formed for primary visual areas along the calcarine sulcus, again as derived from the AAL 
tool.  
6.4. Results 
This chapter is divided in three sections, the first describing the results on pathological hypo-
metabolism across MCI and AD patients, the second presenting results on task-related 
weighting and the third on spatial weighting in relation to PET metabolism. Subsequently, the 
inter-correlations of the main four TVA parameters (wλ, α, C and K) and relevant metabolic 
laterality indices are reported for patients and healthy subjects. 
6.4.1. AD-typical hypometabolism across MCI and AD patients 
Regions of significant hypometabolism across MCI and AD patients compared to the normal 
controls‟ PET images are shown in Figure 17.  
6. Study 3: Spatial weighting and interhemispheric metabolic imbalance across MCI and AD – 6.4. Results 103 
 
Figure 17: TVA+PET: Regions of significant hypometabolism across MCI and AD patients 
as compared to healthy controls 
p < 0.01, FDR-corrected, cluster threshold: minimum of 200 contiguous voxels; 
Patients showed bilaterally distributed hypometabolism centered on posterior cingulate gyrus/ 
precuneus (largest group differences), lateral superior parietal lobes, dorsolateral frontal lobes 
and anterior cingulate cortex. 
6.4.2. Task-related weighting and frontal/ temporo-parietal hypometabolism 
Parameter top-down control α was negatively correlated with ROI-metabolism in the left 
Ang-SMG and the left pMTG, indicating reduced top-down controlled selection with dimi-
nished metabolism in left TPJ (see Figure 18 A).  
A) 
 
B) 
 
Figure 18: TVA+PET: Left-hemispheric hypometabolic regions showing a negative correla-
tion (A) in the ROI and (B) in the whole-brain analysis with parameter top-down 
control α across MCI and AD patients 
Whole-brain analysis: p < 0.001, uncorrected, cluster threshold: minimum of 50 contiguous voxels; 
Whole-brain analyses with a more liberal threshold were conducted to avoid excluding poten-
tially relevant regions and revealed the same left posterior maxima of correlation with para-
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meter α, as in the ROI analysis with further maxima found in the left inferior frontal cortex 
and the left precuneus (see Figure 18 B). The more reduced left-hemispheric metabolism in 
TPJ, inferior frontal lobe and precuneus, the more impaired was top-down control α.  
6.4.3. Spatial weighting and temporo-parietal hypometabolism 
A significant group effect was found for parameter laterality of attentional weighting wλ [t(64) 
= 2.83, p < .01]. Across MCI and AD patients (M = .55, SD = .11), parameter wλ deviated 
significantly from the optimal unbiased wλ value 0.5 [t(29) = 2.46, p < .05], indicating a pa-
thological leftward spatial bias. In contrast, healthy controls (M = .49, SD = .06) showed ba-
lanced spatial weighting [t(35) = 1.40, p > .15]. The laterality index of sensory effectiveness 
Aλ in the patient group (M = .52, SD = .08) did not differ significantly from the value 0.5 
[t(29) = 1.40, p > .15], which indicates equal sensory effectiveness on both sides of the visual 
field. Therefore, the pathological spatial bias wλ in the clinical group is not attributable to a 
more fundamental sensory bias. For detailed information concerning individual parameter 
values, see Table 16 (p. 140). 
In line with the behavioral results, six clusters of significant hemispheric differences were re-
vealed within those regions showing hypometabolism in the patient group. Five of these re-
gions were situated in the left hemisphere, indicating that metabolism in those left-
hemispheric structures was reduced compared to the same structures in the right hemisphere. 
The five clusters of left hypometabolism were in the posterior cingulate, the superior, middle, 
and inferior frontal gyri, and the inferior parietal lobule. The single cluster of relative right 
hypometabolism was in the precuneus.  
Furthermore, a significant negative correlation of parameter laterality of attentional weighting 
wλ with metabolism in the left pMTG was found, near the maximum for parameter top-down 
control α. Therefore, lower metabolism in the left TPJ was associated with a more pronounced 
leftward spatial bias. Parameter wλ did not correlate with the symmetrical right TPJ or with 
the inferior or superior parietal lobules of either hemisphere. In the whole-brain analysis (see 
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Figure 19), correlations with the laterality parameter wλ were restricted to the left temporal 
and parietal lobes, centered on TPJ (Ang-SMG and pMTG). No other areas showed any sig-
nificant correlations. Therefore, parameter laterality of attentional weighting wλ seemed not to 
be related to the metabolic rate of the visual system, for instance. 
 
Figure 19: TVA+PET: Left-hemispheric hypometabolic regions showing a negative correla-
tion with the spatial laterality index of attentional weighting wλ across MCI and AD 
patients 
p < 0.001, uncorrected, cluster threshold: minimum of 50 contiguous voxels; 
Finally, the relationship of parameter laterality of attentional weighting wλ to the laterality in-
dex of relative regional metabolism in ROIs was investigated across MCI and AD patients. 
The metabolic laterality index was significantly correlated with parameter wλ in the Ang-SMG 
and the pMTG (TPJ; r = .43, p < .01; see Figure 20 A), i.e. regions which were already identi-
fied to significantly correlate with parameter wλ in the unilateral analysis.  
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A) 
 
B) 
 
Figure 20: TVA+PET: Positive correlation of the spatial laterality index of attentional weight-
ing wλ to corresponding interhemispheric metabolic (A) TPJ and (B) IPL laterality 
indices across MCI and AD patients 
TPJ: temporo-parietal junction; TPJ laterality index =
right  TPJ  metabolism
right  TPJ  metabolism  + left  TPJ  metabolism
 ; IPL: inferior parietal lobe; 
IPL laterality index =
right  IPL  metabolism
right  IPL  metabolism  + left  IPL  metabolism
 ; 
Additionally, the metabolic laterality index for the IPLs correlated significantly with the late-
rality index of attention wλ (r = .35, p < .05; see Figure 20 B), even though the left IPL alone 
was not correlated with parameter wλ. The metabolic laterality index of the visual cortex was 
not correlated with parameter wλ, indicating that the spatial distribution of attention seems to 
be independent of interhemispheric metabolic imbalances in the visual system, but dependent 
on relative metabolism in homologous temporo-parietal cortical regions. 
6.4.4. Parameter inter-correlation 
Given the adjacent metabolic maxima in the left pMTG for both, parameter spatial laterality 
index of attention wλ and parameter top-down control α, a special interest was taken in inves-
tigating whether these parameters were associated with each other.  
No significant correlations were found between all TVA parameters (see Table 6), laterality 
index of attentional weighting wλ, top-down control α, perceptual processing speed C and vis-
ual short-term memory storage capacity K, in both, patients and healthy controls (all p > .13).  
In healthy subjects, two trend-level correlations between parameters wλ and C and parameters 
wλ and K, respectively, were revealed (all p < .10), indicating that a slight leftward spatial bias 
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was associated with enhanced general processing capacity, i.e. faster processing speed and 
higher VSTM storage capacity.  
Table 6: TVA-PET: TVA parameter inter-correlations and relationship to metabolic TPJ- 
and IPL laterality indices 
wλ: laterality index of attentional weighting; α: top-down control; C: perceptual processing speed (N elements/ 
sec); K: visual short-term memory storage capacity (N elements);  
TPJ: temporo-parietal junction; IPL: inferior parietal lobe; TPJ laterality index =
right  TPJ  metabolism
right  TPJ  metabolism  + left  TPJ  metabolism
 ; 
IPL laterality index =
right  IPL  metabolism
right  IPL  metabolism  + left  IPL  metabolism
 ; **: p < .01; *: p < .05; 
Parameter 
inter-correlations 
α C K TPJ laterality 
index 
IPL laterality 
index 
MCI and AD      
wλ -.06 -.15 -.19 .43** .35* 
α - .00 -.10 -.18 -.32 
C - - .28 -.25 -.06 
K - - - -.18 -.08 
TPJ laterality 
index 
- - - - .75** 
      
Controls      
wλ .14 .29 .28 - - 
α - .11 .05 - - 
C - - .10 - - 
 
Across MCI and AD patients (for individual parameter values, see Table 16, p. 140), signifi-
cant positive correlations were solely revealed between the laterality index of attentional 
weighting wλ and both, TPJ (Ang-SMG and pMTG) and IPL laterality indices. Both meta-
bolic indices were positively inter-correlated. This inter-correlation also subsisted when post-
erior cingulate metabolism was used as a covariate of no interest in order to control for dis-
ease severity. None of the other correlations calculated between TVA parameters and meta-
bolic indices reached the level of significance. These results indicate that direction and degree 
of the spatial laterality index of attentional weighting wλ rest upon analogous interhemispheric 
imbalances in both, TPJ and IPL regions, and are independent of non-lateralized attentional 
mechanisms such as task-related selection (top-down control α) and processing capacity, per-
ceptual processing speed C and VSTM storage capacity K. 
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Notably, parameters C and K were not correlated with any ROI and did not show significant 
correlations elsewhere in the whole-brain analysis. 
6.5. Discussion 
The present study was conducted to investigate the relationship between components of selec-
tive visual attention, as assessed by a partial report task based on Bundesen‟s (1990) theory of 
visual attention (TVA), and the regional 
18
FDG-PET metabolism in early AD patients (about 
80% amnestic MCI and 20% probable AD patients). From the partial report task, two inde-
pendent quantitative parameter estimates were derived: task-related efficiency of top-down 
control α and the spatial laterality index of attentional weighting wλ. In early AD, left-
hemispheric hypometabolism in temporo-parietal (and frontal) areas predicted deficient top-
down controlled selection. Furthermore, hypometabolism in the left temporo-parietal junction 
(TPJ) as well as interhemispheric metabolic imbalances in homologous regions of the TPJ and 
the inferior parietal lobe (IPL), respectively, were significantly correlated in degree and direc-
tion with spatial attentional weighting wλ.  
PET imaging data affirmed that the present clinical sample can be considered as representa-
tive group of early AD patients (majority of MCI patients), since hypometabolic regions in 
the current sample are typically anticipated at an early stage of the disease (Drzezga et al., 
2003; Drzezga et al., 2005; Herholz, 1995). Furthermore, TVA-based capacity-reflecting pa-
rameters, perceptual processing speed C and VSTM storage capacity K, were not correlated 
with any ROI and did not show significant correlations elsewhere in the whole-brain analysis, 
as expected due to the nonspecific regional character of lesions associated with structural li-
mitations in attentional processing capacity (Bundesen et al., 2005). Both parameters, C and 
K, had no effect on top-down control α or the spatial laterality index of attentional weighting 
wλ, nor on the metabolic measures. Previous findings are in line with the present results, attri-
buting deficits in general processing capacity mainly to lesion volume and wide-ranging dis-
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ruptions of white matter cortico-cortical fibers (Habekost & Rostrup, 2007; Habekost & Starr-
felt, 2009; Peers et al., 2005), instead of circumscribed (e.g. metabolic) alterations in distinct 
regions. Importantly, top-down control α and the laterality parameter wλ were uncorrelated for 
each group, corroborating (see also chapter 5.5, pp. 86 et seq.) that both parameters are 
present as distinct and independent attentional indices, reflecting possibly different underlying 
neuropathological mechanisms. This issue will be discussed in the next sections. 
6.5.1. Task-related weighting and frontal/ temporo-parietal hypometabolism 
Neurofibrillary tangles and neuritic plaques give rise to a selectively distributed neocortical 
disconnection syndrome in AD (Delbeuck et al., 2003; Sorg et al., 2009), disrupting, among 
others, functional connectivity between frontal and parietal cortices in AD (Azari et al., 1992; 
Horwitz et al., 1987). A FDG-PET study by Collette et al. (2002) was in line with the hypo-
thesis of diminished anterior-posterior connectivity. In this study, AD patients with either pa-
rietal and temporal hypometabolism or with additionally reduced metabolism in frontal areas 
were similarly impaired in several executive tasks, irrespective of the presence or absence of 
frontal lobe hypometabolism. The current results on the relationship of parameter top-down 
control α with hypometabolism in predominantly left-hemispheric posterior regions (left TPJ, 
composed of Ang-SMG and pMTG; and precuneus) preponderantly support this view, al-
though parameter top-down control α was also related to left inferior frontal cortex. Notably, 
associations between parameter α and hypometabolism in precuneus and especially left infe-
rior frontal cortex were revealed in the whole-brain analysis, only. In support of the fronto-
parietal disconnection hypothesis, these findings might not be as reliable as the ROI-based re-
lationship between parameter top-down control α and metabolism in left TPJ. Taken together, 
executive impairments in early AD could be the consequence arising out of a partial disrup-
tion of the fronto-parietal attention network. 
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6.5.2. Spatial weighting and temporo-parietal hypometabolism 
Across MCI and AD patients, a pathological spatial lateralization of attention wλ towards the 
left visual hemifield was revealed, while in healthy elderly controls visual spatial attention 
was balanced. In support of these behavioral results, 
18
FDG-PET imaging corroborated a left-
hemispheric hypometabolism in prefrontal, lateral parietal cortices and precuneus compared 
to homologous regions in the right hemisphere across patients. Consequently, neural degene-
ration in AD seems to be slightly intensified in the left compared to the right hemisphere (De-
sgranges et al., 1998; Li et al., 2000; O'Brien et al., 1992; Thompson et al., 2003; Ueyama et 
al., 1994; Volkow et al., 2002).  
In the patient group, the laterality parameter of attentional weighting wλ was more directed to 
the left visual hemifield the lower the metabolism in the left TPJ. Parameter wλ was neither 
associated with metabolism in right TPJ, other parietal regions, nor the occipital cortex. In 
addition, spatial lateralization of attention wλ was not related to imbalanced metabolism be-
tween left and right primary visual cortex, which excludes primary visual-sensory deficits to 
be the cause of the pathological leftward spatial bias. Behavioral data complies with the PET 
data, revealing no significant correlation between the spatial laterality index of attentional 
weighting wλ and the corresponding index of sensory effectiveness Aλ, indicating that the pa-
thological leftward lateralization does not originate from an unilateral right- or left-sided sen-
sory loss.  
In contrast, the spatial laterality index wλ seemed to stem from hypometabolism in left TPJ 
and an interhemispheric metabolic imbalance between the left and right TPJ and IPL, respec-
tively (TPJ and IPL laterality index). The more reduced the metabolism in left TPJ and IPL 
compared to the right-hemispheric homologous regions, the more pronounced the leftward 
spatial bias. These results replicate recent findings by Meguro et al. (2001). In this SPECT 
study, AD patients‟ enhanced rightward omissions in a visual search task were correlated with 
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lower parietal cerebral blood flow (CBF) in the left hemisphere compared to the right, and pa-
tients with predominantly leftward omissions showed the opposite CBF pattern. 
6.5.3. Parameter inter-relations 
Despite the fact that both partial report parameters, top-down control α and the laterality pa-
rameter wλ, were related to corresponding cortical regions in the left pMTG (TPJ), they were 
not correlated with each other in both groups, patients and controls. Hence, they were present 
independently from each other. The same results were revealed for all other possible TVA-
based parameter inter-correlations.  
Interestingly, in the clinical group, significant positive correlations were solely revealed be-
tween the laterality index of attentional weighting wλ and both, TPJ and IPL laterality indices. 
Both metabolic indices were positively inter-correlated, which has been reported before (Cor-
betta, Patel, & Shulman, 2008; Vandenberghe & Gillebert, 2009). Consequently, direction 
and degree of the spatial laterality index wλ seem to be caused by interhemispheric metabolic 
imbalances in both, TPJ and IPL regions. However, this relationship is independent of non-
lateralized attentional mechanisms such as task-related selection (top-down control α) and 
processing capacity, i.e. perceptual processing speed C and VSTM storage capacity K. 
According to a recent review article by Vandenberghe and Gillebert (2009), activation in 
intraparietal sulcus (IPS) is related to selection tasks of multiple competing stimuli, i.e. targets 
and distractors, such as in the TVA-based partial report task. Complemented by the computa-
tional view based on NTVA (Bundesen et al., 2005), the relationship of parameter laterality 
index of attentional weighting wλ and the metabolic IPL index (IPL is adjacent to IPS) seems 
to correspond with the hypothesis that in IPL (and IPS, respectively) relative attentional 
weights are allocated and contralateral saliency maps are generated (Vandenberghe & Gille-
bert, 2009) in such a way that in the present sample of early AD patients, an imbalance in glu-
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cose metabolism and probably also in cortical activity between left and right IPL resulted in a 
spatial bias. 
Analogous, the relationship between parameter wλ and the metabolic TPJ index might origi-
nate from a deficit in the appropriate reallocation of attentional weights (i.e. processing capac-
ity) in this early AD sample, as attentional reallocation seems to be mediated by left and right 
TPJ regions (Vandenberghe & Gillebert, 2009). Both, IPL and TPJ metabolic indices, were 
highly inter-correlated, indicating that TPJ-mediated reallocation of attentional weights may 
support the instantiation of saliency maps in IPLs. Noteworthy, parameter top-down control α 
was in the whole-brain analysis loosely (see chapters 6.3.4.2, pp. 100 et seq. and 6.4.2, pp. 
103 et seq.) associated with left TPJ and left inferior frontal lobe (apart from left precuneus). 
Therefore, top-down controlled reallocation of attentional weights to task-relevant target sti-
muli in presence of task-irrelevant distractors might be modulated by inferior frontal lobe.  
In terms of the biased competition model of attentional selection proposed by Desimone and 
Duncan (Desimone, 1998; Desimone & Duncan, 1995; Duncan et al., 1997), which is strongly 
related to TVA (Bundesen, 1990), the process of attentional (re)allocation might be unders-
tood as interactions among neurons representing all stimuli which are currently present in the 
visual field. Competition between object representations are biased in favor of task-relevant 
stimuli in healthy subjects (Desimone & Duncan, 1995) but may be pathologically imba-
lanced in the current early AD sample. Reductions of neuronal activity in left IPL and TPJ 
compared to right IPL and TPJ, or vice versa, seem to cause a corresponding pathological 
spatial bias towards the left and right visual hemifield, respectively. In addition, decreased ac-
tivity in inferior frontal lobe might underlie impairments in top-down controlled selection of 
neuronal representations of objects relevant to current behavior or, considered from another 
angle, might result in altered suppression of behaviorally irrelevant stimuli. 
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6.5.4. Limitations of the study 
The present study has several limitations. First, this is a correlation study between resting 
state PET measures and cognitive performance and therefore a cautious interpretation is 
needed (Tulving et al., 1999). In addition, conclusions on „activated‟ or relatively „deacti-
vated‟ cortical regions could be questioned, although previous studies using voxel-based 
mapping of correlations between cognitive performance and resting-state regional glucose 
metabolism have demonstrated the sensitivity of this approach in unraveling the neural sub-
strates of cognitive impairment in AD (Bracco et al., 2007).  
Second, the pattern of cognitive-metabolic correlations might vary according to disease sever-
ity (Bracco et al., 2007). Despite the fact that posterior cingulate metabolism was used as a 
covariate of no interest in order to control for disease severity in the analysis of parameter in-
ter-correlations, the present findings ought to be investigated further, i.e. by opposing MCI 
and AD patient groups.  
Third, it was not feasible to assess both, resting FDG-PET and TVA-based tasks in one single 
sample of healthy elderly controls. Thus, it was impossible to directly compare the relation-
ship of the partial report parameters to patterns of metabolic correlates in both, patients and 
healthy controls. Therefore, this survey needs to be complemented by further studies (e.g. 
PET and fMRI). 
6.5.5. Conclusions 
The TVA-based partial report task proved to be a sensitive tool for reflecting underlying me-
tabolic dysfunctions at an early stage of AD. Deficits in task-related selection as well as a pa-
thological spatial bias, qualitatively distinct and quantifiable, were shown to be related to left-
hemispheric hypometabolism and interhemispheric metabolic imbalances in predominantly 
posterior regions of the fronto-parietal attention network. These results support the hypotheses 
that early impairments in task-related as well as spatial weighting may be caused by a cortico-
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cortical disconnection of fronto-parietal cortices on the one hand and by an imbalance in in-
terhemispheric temporo-parietal interactions on the other hand.  
As temporo-parietal hypometabolism is now considered a reliable hallmark of AD (Mosconi, 
2005) and a sensitive tool for reflecting pathological interhemispheric metabolic imbalances, 
i.e. the TVA-based partial report paradigm, might be indicative of subjects at risk for AD. 
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7. General conclusions and perspectives 
This dissertation intended to investigate the probable valuable contribution of the TVA-based 
whole and partial report of briefly presented letter arrays based on Bundesen‟s theory of visu-
al attention (TVA; Bundesen, 1990, 1998; Bundesen et al., 2005) in assessing amnestic MCI 
and AD patients in comparison to healthy elderly control subjects. 
The results of the three presented studies suggest a staging model of visual selective atten-
tional impairments in MCI and AD (see Table 7). Deficits of pre-attentive processing (percep-
tual threshold t0), task-related (top-down control α) and spatial weighting (laterality index of 
attentional weighting wλ) were already detectable in MCI patients, while aspects of processing 
capacity (perceptual processing speed C and VSTM storage capacity K) were still intact. At a 
later stage of the disease, further deterioration of top-down control α and increasing lateraliza-
tion of spatial weighting wλ accompanied impairments in perceptual processing speed C and 
VSTM storage capacity K.  
Table 7: WR-PR: Pattern of impaired and intact TVA-based attentional components in MCI 
and AD patients compared to healthy controls 
↓: impaired attentional parameter; ↓↓: further deterioration; √: intact attentional component; 
Group Perceptual thre-
shold t0 
Spatial 
weighting wλ 
Top-down 
control α 
Processing 
speed C 
VSTM storage 
capacity K 
MCI ↓ ↓ ↓ √ √ 
AD ↓ ↓↓ ↓↓ ↓ ↓ 
 
It is a fact that not all subjects diagnosed with MCI will develop dementia, although the am-
nestic subtype bears a high prognostic value (Gauthier et al., 2006). Needless to say, this as-
sumption merits further investigation. A longitudinal study would be required to address the 
question whether one or several TVA-based parameters (i.e. perceptual threshold t0, top-down 
control α and the laterality index of attentional weighting wλ) might predict which MCI pa-
tients convert to AD.  
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Further specific questions for future studies arise from several particular findings. Notably, 
perceptual processing speed C differed significantly between AD patients receiving acetyl-
choline esterase inhibitors (AChEI) and those non-medicated AD patients. Medicated AD pa-
tients exhibited higher processing speed compared to non-medicated patients, indicating that 
parameter C might bear the potential of reflecting medication effects, maybe even at the early 
MCI stage. Dedicated medication studies using AChEI might answer this question.  
Furthermore, it would be of interest to contrast samples of AD patients with and without post-
erior cortical atrophy in order to investigate whether decreasing processing speed C might be 
a general factor in AD or whether it is more attributable to atrophy in specific posterior re-
gions. Analogous to a study by Finke et al. (2007) in Huntington‟s disease patients showing 
impaired simultaneous perception, symptoms of simultanagnosia could be investigated in AD 
subgroups by a simultaneous perception task of visual objects presented under varying levels 
of difficulty. Besides a conceivable common relationship between parameter C and simulta-
neous perception of objects, both disease variants in AD might differ with regard to other 
TVA-based parameters and might potentially exhibit a characteristic pattern of intact and dis-
turbed attentional aspects. In addition, these research questions should also be surveyed in 
MCI patients. 
With regard to the pinpointed relationship between increasing leftward spatial bias and earlier 
disease onset in clinical carriers of the ApoE4 allele, the effect of ApoE4 genotype and dis-
ease onset on parameter wλ should be investigated in more detail. Unfortunately, the present 
clinical sample or rather corresponding subgroups were not large enough to conduct an analy-
sis of a possible Genotype x Disease onset interaction effect. 
Finally, it would be desirable to further investigate the probable neuronal correlates of para-
meter top-down control α and the laterality index of attentional weighting wλ, respectively, as 
it was not feasible to assess both partial report components together with the PET imaging da-
ta in one and the same group of healthy elderly controls. Two different control groups had to 
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be applied which prevented the direct comparison of cognitive-metabolic coherences in the 
clinical and the healthy sample. On the same subject, the influence of the level of alertness on 
spatial (laterality parameter of attentional weighting wλ) and non-spatial (i.e. perceptual 
processing speed C) components of visual attention should be explored. Matthias et al. (2009) 
demonstrated the relevance of alertness to spatial attentional asymmetries, similar to those 
that were discovered in the present work in amnestic MCI and AD patients. 
In conclusion, the TVA-based assessment of selective visual attention proved to be a sensitive 
diagnostic tool for revealing subtle deficits already at the stage of MCI which might exhibit 
the capability of an early cognitive marker for the identification of subjects at risk of AD. 
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8. Deutsche Zusammenfassung (German synopsis) 
Die vorliegende Dissertation mit dem Titel „Erfassung visueller Aufmerksamkeitsleistungen 
bei Patienten mit ‚Mild Cognitive Impairment‟ und Alzheimer Demenz basierend auf der 
Theorie der visuellen Aufmerksamkeit“ (englischer Originaltitel: „Visual attentional assess-
ment in mild cognitive impairment and Alzheimer‟s disease based on a theory of visual atten-
tion“) gliedert sich in drei Studien, welche unterschiedliche Aspekte der selektiven visuellen 
Aufmerksamkeit untersuchten, und zwar an Patienten mit einer amnestischen Form von ‚Mild 
Cognitive Impairment‟ (MCI; deutsch: leichte kognitive Störung) und an Patienten, die mut-
maßlich an einer Alzheimerdemenz (AD) erkrankt sind. 
Die Erforschung des gesunden aber v.a. auch pathologischen Alterns, bedingt durch z.B. ver-
schiedene Formen der Demenz, nimmt mittlerweile einen hohen Stellenwert in unserer Ge-
sellschaft ein, da mit steigender Lebenserwartung ein stetig wachsendes Risiko einhergeht, an 
einer neurodegenerativen Erkrankung wie der Alzheimerdemenz zu erkranken. Diese gesell-
schaftspolitisch relevante Entwicklung rückt immer mehr in den Fokus der Wissenschaft und 
der Forschung. 
Die vorliegende Forschungsarbeit geht von der Annahme aus, dass bereits in einem frühen 
Stadium der AD-Erkrankung Defizite der selektiven visuellen Aufmerksamkeit auftreten 
(Foldi et al., 2002) und diese möglicherweise als erste Beeinträchtigungen (neben Gedächt-
nisproblemen; Perry & Hodges, 1999) im frühen Prodromalstadium MCI (Petersen et al., 
1999) nachweisbar sind. Ziel dieser Dissertation war es, die Fragestellung zu untersuchen, 
inwiefern bestimmte Komponenten der selektiven visuellen Aufmerksamkeit v.a. im frühen 
MCI-Stadium bereits beeinträchtigt bzw. noch intakt sind. In diesem Zusammenhang sollte 
auch untersucht werden, ob sich bei MCI-Patienten bestimmte Aufmerksamkeitsfunktionen 
qualitativ und/ oder quantitativ von Aufmerksamkeitsleistungen bei AD-Patienten auf der ei-
nen und bei gesunden älteren Kontrollprobanden auf der anderen Seite unterscheiden.  
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Die Theorie der visuellen Aufmerksamkeit (TVA) von Bundesen (1990, 1998) diente hierzu 
als theoretische Grundlage und ermöglichte es, latente, mathematisch unabhängige und quan-
tifizierbare Parameter zu schätzen. Diese Parameterwerte leiten sich ab von zwei sehr ähnli-
chen Paradigmen, dem computergestützten Ganzbericht und Teilbericht mit kurz dargebote-
nen visuellen Buchstabenanordnungen. Zahlreiche TVA-basierte Untersuchungen (z.B. Bub-
lak et al., 2005; Bublak et al., 2006; Duncan et al., 1999; Duncan et al., 2003; Finke et al., 
2006; Gerlach et al., 2005; Habekost & Bundesen, 2003; Habekost & Rostrup, 2006; Peers et 
al., 2005) konnten zeigen, dass das Ganz- und Teilberichtsverfahren als Diagnostikum für se-
lektive Aufmerksamkeitsleistungen vier große Stärken aufweist: die Gütekriterien der Sensi-
tivität, Spezifizität, Reliabilität und Validität sind in hohem Maße gegeben. 
8.1. Studie 1 
Die Amyloid-Kaskaden-Hypothese (Hardy & Selkoe, 2002) nimmt in Bezug auf die AD-
Erkrankung an, dass eine Zunahme von β-Amyloid (Aβ) Plaques und Neurofibrillen durch di-
rekte und indirekte Wirkung auf synaptische, neuronale und neuritische Funktionen langfris-
tig zu kortikalem Zelltod (z.B. Cirrito et al., 2005) sowie fortschreitendem intellektuellem 
Verfall führt. Folglich könnte die Erforschung von sensitiven Biomarkern, welche die neuro-
degenerativen Veränderungen der AD widerspiegeln, die Möglichkeit bieten, Personen mit 
erhöhtem AD-Risiko möglichst früh zu diagnostizieren und somit die Chance einer wirksa-
men Behandlung zu eröffnen (Shah et al., 2008). Die erste Studie (Kapitel 4, S. 31 ff.) unter-
suchte die Fragestellung, ob kognitive Parameter zur Erfassung visueller Aufmerksamkeits-
kapazität diesem Anspruch gerecht werden können. 
Basierend auf der TVA von Bundesen (1990, 1998) wurde die Fähigkeit zur visuellen Infor-
mationsaufnahme von 18 Patienten mit mutmaßlicher AD, 18 amnestischen MCI-Patienten 
und 18 gesunden älteren Kontrollprobanden untersucht. Die Gruppen waren hinsichtlich des 
Alters, des Geschlechts und des Bildungsniveaus vergleichbar. Alle Probanden bearbeiteten 
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ein Ganzberichtsverfahren, in dem möglichst viele Buchstaben benannt werden sollten, wel-
che kurzzeitig auf einem Computerbildschirm präsentiert wurden. Ausgehend von dieser 
Leistung konnten vier voneinander unabhängige Parameter ermittelt werden, welche ver-
schiedene Aspekte der visuellen Verarbeitungskapazität repräsentieren: perzeptuelle Verarbei-
tungsschwelle t0, ikonisches Gedächtnis µ, perzeptuelle Verarbeitungsgeschwindigkeit C und 
visuelle Speicherkapazität des Kurzzeitgedächtnisses (KZG) K.  
Im Gruppenvergleich wurde deutlich, dass die perzeptuelle Verarbeitungsschwelle t0 bereits 
im MCI-Stadium erhöht ist, wohingegen die Verarbeitungsgeschwindigkeit C und die KZG-
Speicherkapazität K nur bei den AD-Patienten signifikant reduziert vorlag. AD-Patienten, 
welche Acetylcholinesterasehemmer (AChEH) einnahmen, wiesen zwar eine höhere Verar-
beitungsgeschwindigkeit als AD-Patienten auf, die keine AChEH erhielten, jedoch erreichten 
erstere nicht das Leistungsniveau der MCI-Patienten. Der Parameter perzeptuelle Verarbei-
tungsschwelle t0 war signifikant mit der Krankheitsdauer korreliert, jedoch nicht mit anderen 
kognitiven Kennwerten. Im Gegensatz dazu wiesen die Verarbeitungsgeschwindigkeit C und 
die KZG-Speicherkapazität K zwar einen signifikanten Zusammenhang mit eben jenen kogni-
tiven Maßen auf, nicht aber mit der Dauer der Erkrankung. Insbesondere zeigte sich ein Zu-
sammenhang zwischen der KZG-Speicherkapazität K und neuropsychologischen Tests, die 
primär auf visuellem Material beruhen, wie z.B. Bildbenennung und Visuokonstruktion. Im 
Hinblick auf die Verarbeitungsgeschwindigkeit konnte zudem noch ein Zusammenhang mit 
verbalen Gedächtnismaßen belegt werden.  
Diese Ergebnisse deuten darauf hin, dass im frühen MCI-Stadium Defizite der präattentiven 
visuellen Verarbeitung vorliegen, wohingegen bei AD-Patienten zudem die attentive Verar-
beitung beeinträchtigt scheint. Eine gestufte attentionale Kapazitätsabnahme im Verlauf der 
AD-Erkrankung steht im Einklang mit der Amyloid-Kaskaden-Hypothese, welche besagt, 
dass die AD-Neuropathologie in der Frühphase vor allem durch die netzartige Anhäufung und 
Ablagerung von Aβ beschrieben werden kann. Dies führt zu neuronalen und neuritischen 
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Funktionsstörungen. Im weiteren Krankheitsverlauf bewirken der allmähliche Verlust von 
Neuronen und Störungen in Transmittersystemen den zunehmenden geistigen Verfall. In die-
sem Zusammenhang könnte die Erhöhung der perzeptuellen Wahrnehmungsschwelle als 
möglicher Indikator für neuronale Funktionsstörungen vor dem Zelltod in Betracht gezogen 
werden. Im Gegensatz dazu könnten Defizite der Verarbeitungsgeschwindigkeit und der 
KZG-Speicherkapazität bereits Hinweise geben auf einen massiven Verlust neuronaler Zell-
verbände in Verbindung mit Beeinträchtigungen in Neurotransmittersystemen. 
8.2. Studie 2 
Die häufigste Form von Demenz ist die AD, die zum einen als erbliche, familiär gehäufte Er-
krankung auftritt, doch viel häufiger in sporadischer Form in Erscheinung tritt. Auch die spo-
radische Form von AD wird mit einem genetischen Risikofaktor in Verbindung gebracht: 
Träger des Apolipoprotein E ε4 Allels (ApoE4) haben im Vergleich zu ApoE4-negativen Per-
sonen ein 3- bis 15-fach höheres Risiko, an AD zu erkranken (Blennow et al., 2006). Finke et 
al. (2006) konnten mit demselben TVA-basierten Teilberichtsparadigma wie in dieser Studie 
bei Chorea Huntington Patienten eine enge Beziehung belegen zwischen dem Schweregrad 
der genetischen Pathologie der neurodegenerativen Erkrankung sowie der Ausrichtung und 
dem Ausmaß räumlicher Aufmerksamkeitslateralisierung. Sensitive Tests zur Messung selek-
tiver visueller Aufmerksamkeit könnten als frühe kognitive Marker der AD zum Einsatz 
kommen und somit eine frühe Diagnose von Risikopersonen im MCI-Stadium ermöglichen 
(Shah et al., 2008), als auch von Personen mit zugrundeliegendem genetischem Risiko 
(ApoE4). Die Zielsetzung der zweiten Studie (Kapitel 5, S. 60 ff.) richtete sich auf die Frage-
stellung, ob Parameter der visuell-räumlichen und aufgabenbezogenen selektiven Aufmerk-
samkeit als frühe kognitive Marker in Betracht kommen.  
Zur Erfassung der selektiven Aufmerksamkeitsleistungen bei 32 amnestischen MCI-
Patienten, 16 AD-Patienten und 36 gesunden älteren Kontrollprobanden wurde ein TVA-
8. Deutsche Zusammenfassung (German synopsis) 122 
basiertes Teilberichtsverfahren (Bundesen, 1990, 1998) eingesetzt. Die Aufgabe der Proban-
den bestand darin, kurzzeitig präsentierte Buchstaben zu benennen. Ausgehend von dieser 
Leistung wurden zwei mathematisch unabhängige und quantifizierbare Parameterwerte be-
rechnet. Der Parameter Top-down Kontrolle α ist ein Maß für die Fähigkeit, Zielreize im Ge-
gensatz zu Distraktoren bevorzugt zu verarbeiten. Der Parameter räumliche Aufmerksam-
keitsgewichtung wλ spiegelt die Verteilung der Aufmerksamkeit über das linke und rechte vi-
suelle Halbfeld wider.  
Im Vergleich zu einer nach Alter, Geschlecht und Bildung vergleichbaren Kontrollgruppe 
zeigten MCI-Patienten signifikante Defizite in der Top-down Kontrolle α, die sich im AD-
Stadium noch weiter verschlechterten. Zudem wiesen MCI-Patienten eine pathologische 
räumliche Aufmerksamkeitslateralisierung wλ auf, die bei AD-Patienten tendenziell noch stär-
ker ausgeprägt war. Überwiegend zeigte die Gruppe der Patienten eine Aufmerksamkeitsver-
schiebung wλ zum linken Halbfeld. Träger des ApoE4 Allels in der klinischen Gruppe wiesen 
darüber hinaus eine linksseitige Aufmerksamkeitslateralisierung auf. Diese linksgerichtete 
Aufmerksamkeitsverschiebung war bei jüngeren ApoE4 Patienten bzw. ApoE4 Trägern mit 
früherem Krankheitsbeginn stärker ausgeprägt. ApoE4-negative Patienten konnten die Auf-
merksamkeit gleichmäßig auf beide visuelle Halbfelder ausrichten. 
Diese Befunde deuten darauf hin, dass Defizite in der Top-down Kontrolle α auf frühe Beein-
trächtigungen in kortiko-kortikalen Faserverbindungen zwischen parietalen und frontalen 
Arealen zurückgeführt werden können. Zudem scheinen begleitend interhemisphärische 
Asymmetrien im temporo-parietalen Aufmerksamkeitsnetzwerk aufzutreten, welche einer pa-
thologischen räumlichen Aufmerksamkeitsverschiebung wλ zugrunde liegen können. Da die 
Erblichkeit von ApoE4 in Verbindung steht mit einem interhemisphärischen Ungleichgewicht 
in parietalen kortikalen Interaktionen, könnte eine pathologische linksseitige Aufmerksam-
keitsverschiebung wλ als früher kognitiver Marker dienen, um Personen mit erhöhtem Risiko 
an einer Alzheimerdemenz zu erkranken, möglichst früh zu diagnostizieren. 
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8.3. Studie 3 
In der vorangegangenen Studie zeigte sich, dass das TVA-basierte Teilberichtsparadigma bei 
amnestischen MCI-Patienten als sensitives Verfahren zur frühen Diagnose von Beeinträchti-
gungen in der aufgabenbezogenen Selektionsfähigkeit als auch hinsichtlich eines pathologi-
schen Ungleichgewichts in der Aufmerksamkeitsverteilung im Raum herangezogen werden 
kann (Kapitel 5, S. 60 ff.). Es wurden die Hypothesen aufgestellt, dass diese Beeinträchtigun-
gen in der selektiven Aufmerksamkeit auf ein frühes Diskonnektions-Syndrom und ein inter-
hemisphärisches Ungleichgewicht kortikaler Interaktionen im fronto-parietalen Aufmerksam-
keitsnetzwerk zurückzuführen sind. In einem späteren Stadium der Krankheit kommt es dann 
durch ein allmähliches Absterben von Nervenzellen zu einer weiteren Verschlechterung der 
selektiven Aufmerksamkeitsleistungen sowie auch der geistigen Fähigkeiten. 
In der dritten Studie (Kapitel 6, S. 93 ff.) wurden diese Hypothesen geprüft, indem der Zu-
sammenhang zwischen den beiden Teilberichtsparametern, Top-down Kontrolle α und v.a. 
der räumlichen Aufmerksamkeitsgewichtung wλ, und dem lokalen Glukosestoffwechsel mit-
tels Positronen-Emissions-Tomographie (PET) in einer klinischen Gruppe mit 30 amnesti-
schen MCI- oder AD-Patienten untersucht wurde.  
Bei allen Patienten fand sich ein leicht verringerter Glukosestoffwechsel in verschiedenen 
Arealen der linken Hemisphäre. Interessanterweise ergab sich folgender Zusammenhang: je 
deutlicher der Metabolismus im linken temporo-parietalen Übergansbereich reduziert war 
(temporo-parietal junction, TPJ), desto schlechter war die Top-down Kontrolle α. Vergleich-
bare Ergebnisse zeigten sich in Bezug auf den Parameter räumlichen Aufmerksamkeitsge-
wichtung wλ: ein verringerter Stoffwechsel im linken TPJ-Areal diente als Prädiktor für das 
Ausmaß der räumlichen Lateralisierung wλ. Darüber hinaus korrelierte ein verringerter Gluko-
sestoffwechsel im linken TPJ-Areal bzw. dem linken inferioren Parietallappen (IPL) im Ver-
gleich zu rechtshemisphärischem TPJ-Areal bzw. IPL mit der Ausrichtung und der Stärke der 
räumlichen Aufmerksamkeitslateralisierung wλ.  
8. Deutsche Zusammenfassung (German synopsis) 124 
Zusammenfassend kann man schließen, dass die PET-basierten Bildgebungsdaten die ein-
gangs aufgestellten Hypothesen untermauern. Einerseits konnte gezeigt werden, dass eine 
frühe Beeinträchtigung der Top-down Kontrolle α bereits auf ein fronto-parietales Diskonnek-
tions-Syndrom im MCI-Stadium zurückgeführt werden kann. Andererseits scheint auch ein 
interhemisphärisches metabolisches Ungleichgewicht in homologen temporo-parietalen Area-
len vorherrschend zu sein, welches einer entsprechend ausgerichteten und ausgeprägten visu-
ell-räumlichen Aufmerksamkeitslateralisierung zugrunde liegt. 
8.4. Schlussfolgerungen und Ausblick 
Die vorliegende Dissertation hatte es sich zum Ziel gesetzt, den Beitrag des Ganz- und Teil-
berichts basierend auf Bundesen‟s Theorie der visuellen Aufmerksamkeit (TVA; Bundesen, 
1990, 1998; Bundesen et al., 2005) als mögliches sensitives Verfahren zur Diagnostik von se-
lektiven Aufmerksamkeitsdefiziten bei amnestischen MCI- und AD-Patienten zu untersuchen 
und den Aufmerksamkeitsleistungen von gesunden Kontrollprobanden gegenüberzustellen. 
Die Ergebnisse der drei hier vorgestellten Studien weisen darauf hin, dass sich visuelle selek-
tive Aufmerksamkeitsleistungen über das MCI- bis hin zum AD-Stadium graduell verschlech-
tern. Beeinträchtigungen in der präattentiven Verarbeitung (perzeptuelle Wahrnehmungs-
schwelle t0), der aufgabenbezogenen attentionalen Gewichtung (Top-down Kontrolle α) sowie 
der räumlichen Gewichtung der Aufmerksamkeit (wλ) konnten bereits bei MCI-Patienten 
nachgewiesen werden. Komponenten der Verarbeitungskapazität (perzeptuelle Verarbei-
tungsgeschwindigkeit C und KZG-Speicherkapazität K) waren hingegen im MCI-Stadium 
noch intakt. Im weiteren Verlauf der neurodegenerativen Erkrankung zeigte sich eine zuneh-
mende Verschlechterungen der Top-down Kontrolle und eine stärker ausgeprägte Lateralisie-
rung der räumlichen Aufmerksamkeit. Begleitend traten zusätzlich Defizite in der Verarbei-
tungsgeschwindigkeit als auch in der KZG-Speicherkapazität auf. 
8. Deutsche Zusammenfassung (German synopsis) 125 
Die vorliegende Arbeit konnte aufzeigen, dass sich die TVA-basierte Untersuchung der selek-
tiven visuellen Aufmerksamkeit als sensitives Diagnostikum bewährt hat, da mit diesem Ver-
fahren schon im frühen MCI-Stadium subtile Defizite aufgedeckt werden konnten. Mögli-
cherweise kommt dieses Aufmerksamkeitsdiagnostikum als früher kognitiver Marker in Be-
tracht, um eine Früherkennung von MCI-Patienten mit erhöhtem Risiko, an AD zu erkranken, 
zu unterstützen. Längsschnittstudien müssen zeigen, ob die TVA-basierte Aufmerksamkeits-
diagnostik prognostischen Wert hat. 
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Supplement A: Test instructions 
 
Test instructions were provided in written form. The experimenter made sure that every single 
subject understood the instruction by requesting and further verbal explanation of the task, if ne-
cessary (especially with regard to patient data assessment). 
Instruction 1:  Whole report instruction: German original version and English translation for 
healthy subjects in phase I (pre-test) and phase II (experiment) 
In the pre-test the individual exposure duration was determined at which the subject could report, on average, 
one letter correctly (20%). This value was used as the middle exposure duration (together with a shorter and a 
longer presentation duration) in the main experiment (phase II). Masked and unmasked trials were balanced 
and were used for all participants. 
„Sie sehen gleich für kurze Zeit in der Mitte des Bildschirms ein Kreuz aufleuchten. Bitte fixie-
ren Sie dieses Kreuz. Wenig später verschwindet es wieder. Danach erscheinen für sehr kurze 
Zeit fünf rote oder fünf grüne Buchstaben. Ihre Aufgabe ist es, möglichst viele dieser Buchsta-
ben zu benennen. Die Reihenfolge spielt keine Rolle. Da die Präsentationszeit sehr kurz ist, ist es 
völlig normal, wenn Sie nicht alle Buchstaben erkennen. Versuchen Sie einfach, die Aufgabe so 
gut wie möglich zu machen und nennen Sie alle Buchstaben, von denen Sie sich ziemlich sicher 
sind, sie erkannt zu haben. Ich werde die von Ihnen genannten Buchstaben eingeben und dann 
folgt ein neuer Durchgang mit neuen Buchstaben.“ 
 
“Now, in a moment you will see a cross briefly presented at the middle of the screen. Please fix-
ate this cross and keep your fixation on its position. After the cross has disappeared, five red or 
five green letters will appear in a column in the centre of the screen. Your task is to name, in any 
order you wish, as many letters as possible. As the presentation time is very short, it is absolutely 
normal if you are unable to recognize all of them. Just try to do your best and report only those 
letters of which you are quite sure you have seen them. I will type in the letters you report and 
then the next trial follows including a new set of letters.” 
Instruction 2:  Whole report instruction: German original version and English translation for MCI 
and AD patients in phase I (pre-test) and phase II (experiment) 
In the pre-test the individual exposure duration was determined at which the subject could report, on average, 
one letter correctly (20%). This value was used as the middle exposure duration (together with a shorter and a 
longer presentation duration) in the main experiment (phase II). Masked and unmasked trials were balanced 
and were used for all participants. 
„Auf dem Bildschirm erscheint zuerst ein Kreuz. Schauen Sie dorthin, wo das Kreuz ist. Dann 
erscheinen fünf Buchstaben. Benennen Sie alle Buchstaben, die Sie sehen können. Die Buchsta-
ben erscheinen nur ganz kurz. Es ist normal, dass Sie nicht alle Buchstaben erkennen werden. 
Nennen Sie einfach alle Buchstaben, die Sie erkannt haben.“ 
 
“First you will see a cross at the screen. Fixate this cross. After the cross has disappeared, five 
letters will appear. Name as many letters as possible. Presentation time is very short. Therefore, 
it is normal that you are unable to recognize all letters. Just report all letters that you have seen.” 
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Instruction 3:  Partial report instruction: German original version and English translation for 
healthy subjects in phase I (pre-test) and phase II (experiment) 
The pre-test was applied to determine the individual exposure duration for the experiment itself (phase II), aim-
ing for about 80% accuracy in single letter trials and for about 20% totally correct dual target trials (based on tri-
als with two correctly named targets, only). Masked trials were used for all participants. 
„Sie sehen gleich für kurze Zeit in der Mitte des Bildschirms ein Kreuz aufleuchten. Bitte fixie-
ren Sie dieses Kreuz. Wenig später verschwindet es wieder. Dann erscheint für sehr kurze Zeit 
entweder ein einzelner roter Buchstabe oder es erscheinen zwei Buchstaben: entweder zwei rote 
Buchstaben, oder ein roter und ein grüner Buchstabe. Ihre Aufgabe ist es, nur auf die roten 
Buchstaben zu achten und diese zu benennen. Die Reihenfolge spielt keine Rolle. Da die Präsen-
tationszeit sehr kurz ist, ist es völlig normal, wenn Sie nicht alle roten Buchstaben erkennen. 
Versuchen Sie einfach, die Aufgabe so gut wie möglich zu machen und nennen Sie alle roten 
Buchstaben, von denen Sie sich ziemlich sicher sind, sie erkannt zu haben. Ich werde die von Ih-
nen genannten Buchstaben eingeben und dann folgt ein neuer Durchgang mit einem oder zwei 
neuen Buchstaben.“ 
 
“Now, in a moment you will see a cross briefly presented at the middle of the screen. Please fix-
ate this cross and keep your fixation on its position. After the cross has disappeared, either a sin-
gle red letter or two letters appear. There might be two red letters or one red letter together with 
one green letter. Your task is to attend to and report red letters only, whilst ignoring the green 
ones. As the presentation time is very short, it is absolutely normal if you are unable to recognize 
all the red letters. Just try to do your best and report only those red letters of which you are quite 
sure you have seen them. I will type in the letters you report and then the next trial follows in-
cluding one or two new letters.” 
Instruction 4:  Partial report instruction: German original version and English translation for MCI 
and AD patients in phase I (pre-test) and phase II (experiment) 
The pre-test was applied to determine the individual exposure duration for the experiment itself (phase II), aim-
ing for about 80% accuracy in single letter trials and for about 20% totally correct dual target trials (based on tri-
als with two correctly named targets, only). Masked trials were used for all participants. 
„Auf dem Bildschirm erscheint zuerst ein Kreuz. Schauen Sie dorthin, wo das Kreuz ist. Danach 
erscheinen rote oder grüne Buchstaben. Nur die roten Buchstaben sind wichtig. Benennen Sie 
nur die roten Buchstaben. Die grünen Buchstaben brauchen Sie nicht zu benennen. Die Buchsta-
ben erscheinen nur ganz kurz. Es ist normal, dass Sie nicht alle roten Buchstaben erkennen wer-
den. Nennen Sie einfach alle roten Buchstaben, die Sie erkannt haben.“ 
 
“First you will see a cross at the screen. Fixate this cross. After the cross has disappeared, either 
red or green letters will appear. Name the red letters only. Only the red letters are of importance. 
You do not have to report the green letters. Presentation time is very short. Therefore, it is nor-
mal that you are unable to recognize all red letters. Just report all red letters that you have seen.” 
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Supplement B: Whole report data (study 1) 
 
Table 8:  WR: Demographic and neuropsychological data for individual MCI and AD patients 
CDR: Clinical Dementia Rating Scale, global score (Morris, 1993); p: level of significance; M (SD): mean score and 
standard deviation; Age in years; Education in years; MMSE: Mini Mental State Examination (Folstein et al., 1975), 
30-0 points, cut-off ≤ 23; CERAD: The Consortium to Establish a Registry for Alzheimer‟s Disease (Thalmann & 
Monsch, 1997), total score; CDT: Clock Drawing Test, 0-6 points, cut-off ≥ 3 (Shulman et al., 1986); CDR sum: sum 
of CDR category scores; Age at disease onset in years; Disease duration in years; ApoE4: apolipoprotein E4 geno-
type, positive (24, 34, 44), negative (23, 33); n.a.: not applied; AChEI: acetylcholine esterase inhibitors. All subjects 
were right-handers, according to the Edinburgh Handedness Inventory (Oldfield, 1971). 
Nr. Patient Age Gender Education MMSE CERAD 
total 
score 
CDT CDR 
sum 
Age at 
disease 
onset 
Disease 
duration 
ApoE4 
genotype 
Medication 
Dementia Depression 
MCI patients            
1 KK 71.9 m 9 28 79 3 1.5 70.3 1.5 34 - - 
2 BD 75.6 f 13 28 83 2 2.0 73.5 2.2 34 - - 
3 HM 59.0 f 9 28 87 3 2.0 56.4 2.6 n.a. - - 
4 SE 69.1 f 10 28 91 3 1.0 65.9 3.2 33 - - 
5 LE 74.7 f 10 25 79 3 3.0 73.1 1.5 34 - - 
6 TJ 61.3 m 10 28 100 1 0.5 58.1 3.2 33 - - 
7 FF 67.7 m 13 27 96 1 3.5 65.1 2.5 33 - - 
8 RB 66.4 m 13 27 112 2 2.5 63.3 3.1 33 - - 
9 BU 73.3 f 9 26 90 1 2.0 72.2 1.1 34 - - 
10 SB 71.0 f 13 27 54 3 2.0 70.5 0.5 44 - - 
11 LM 66.1 f 10 28 86 1 2.0 61.6 4.5 34 - - 
12 BW 79.0 f 9 29 80 1 1.0 76.5 2.4 34 - - 
13 MM 70.8 f 9 26 86 3 1.0 67.2 3.5 34 - - 
14 JR 68.2 m 9 27 70 3 3.0 66.8 1.4 33 - - 
15 HF 71.0 m 13 28 89 2 2.0 66.9 4.1 23 - - 
16 AW 67.5 m 13 27 79 2 3.0 63.3 4.2 44 - - 
17 NS 68.4 m 9 30 76 1 1.5 66.3 2.1 33 - - 
18 HI 74.8 f 13 26 66 4 3.0 73.7 1.1 34 - - 
 Mean 
(SD) 
69.8 
(5.0) 
8 m, 
10 f 
10.8 
(1.9) 
27.4 
(1.2) 
83.5 
(13.0) 
2.2 
(1.0) 
2.0 
(.8) 
67.3 
(5.5) 
2.5 
(1.2) 
10+, 7-, 
1 n.a. 
un-
medicated 
un-
medicated 
              
AD patients             
1 OK 71.4 m 9 25 71 1 4.5 65.9 5.5 34 AChEI - 
2 VA 78.2 m 10 24 52 4 7.0 66.9 4.1 34 AChEI - 
3 SAa 80.9 m 10 24 74 3 4.0 - - 34 - - 
4 RB 55.8 f 9 25 63 4 4.5 52.1 3.7 33 AChEI - 
5 WG 65.9 m 13 24 64 3 3.5 64.3 1.6 33 AChEI - 
6 MW 67.1 m 13 n.a. n.a. n.a. 5.0 59.1 8 44 AChEI - 
7 SU 60.0 f 10 23 72 4 4.0 58.3 1.8 24 AChEI - 
8 LL 79.1 f 9 25 62 3 4.0 78.0 1.1 33 - - 
9 FA 75.0 f 9 19 54 4 5.5 71.9 3.1 44 AChEI - 
10 JH 62.0 f 10 23 70 4 4.0 58.1 3.8 33 AChEI - 
11 CI 65.6 f 9 20 71 5 5.0 59.2 6.4 34 AChEI - 
12 SAb 68.2 f 9 25 84 2 3.5 66.1 2.1 34 AChEI - 
13 HJW 57.0 m 10 n.a. n.a. n.a. n.a. - - n.a. - - 
14 KB 60.6 f 9 22 83 3 3.5 58.4 2.2 44 AChEI - 
15 GT 63.2 m 13 24 76 2 4.0 59.2 3.9 44 - - 
16 UB 57.1 f 9 19 58 4 5.0 55.3 1.8 44 - - 
17 GE 80.6 f 9 19 51 4 5.0 78.4 2.1 n.a. - - 
18 EM 81.5 f 9 19 51 4 5.0 78.4 3.2 33 - - 
 Mean 
(SD) 
68.3 
(9.0) 
7 m, 
11 f 
9.9 
(1.5) 
22.5 
(2.4) 
66.0 
(10.8) 
3.4 
(1.0) 
4.5 
(.89) 
64.4 
(8.5) 
3.4 
(1.9) 
11+, 5-, 
2 n.a. 
11 AChEI, 7 
unmedicated 
un-
medicated 
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Table 9:  WR: Exposure durations of individual MCI and AD patients and healthy controls 
50% of the trials were masked. 
Nr. AD 
patients 
Exposure 
durations (ms) 
Nr. MCI 
patients 
Exposure 
durations (ms) 
Nr. Controls Exposure 
durations (ms) 
1 OK 157 300 600 1 KK 157 300 600 1 ED 157 300 600 
2 VA 300 600 1000 2 BD 157 300 600 2 BA 157 300 600 
3 SAa 157 300 600 3 HM 86 157 300 3 SJ 157 300 600 
4 RB 157 300 600 4 SE 300 600 1000 4 LA 157 300 600 
5 WG 157 300 600 5 LE 157 300 600 5 SE 157 300 600 
6 MW 157 300 600 6 TJ 157 300 600 6 FU 157 300 600 
7 SU 157 300 600 7 FF 86 157 300 7 EA 157 300 600 
8 LL 157 300 600 8 RB 200 400 700 8 SS 157 300 600 
9 FA 300 600 1000 9 BU 86 157 300 9 DG 157 300 600 
10 JH 200 400 700 10 SB 157 300 600 10 LK 157 300 600 
11 CI 157 300 600 11 LM 100 200 400 11 SI 157 300 600 
12 SAb 171 343 686 12 BW 129 257 514 12 UE 157 300 600 
13 HJW 157 300 600 13 MM 186 371 700 13 RML 86 157 300 
14 KB 200 400 700 14 JR 229 457 814 14 PDM 71 143 271 
15 GT 157 300 600 15 HF 229 457 800 15 BE 100 186 371 
16 UB 300 600 1100 16 AW 171 343 686 16 SH 157 386 786 
17 GE 171 343 686 17 NS 200 400 700 17 AW 114 229 457 
18 EM 343 686 957 18 HI 129 257 529 18 PD 114 229 457 
 
Mean 
(SD) 
198 
(64) 
387 
(134) 
713 
(172) 
 
Mean 
(SD) 
162 
(57) 
317 
(118) 
597 
(189) 
 
Mean 
(SD) 
140 
(29) 
274 
(61) 
547 
(127) 
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Table 10:  WR: Parameters of individual MCI and AD patients and healthy controls 
t0: perceptual threshold (ms); μ: iconic memory (ms); C: perceptual processing speed (N elements/ sec); K: visual 
short-term memory storage capacity (N elements). 
Nr. Patient t0 μ C K 
AD patients      
1 OK 118 147 17.6 2.96 
2 VA 181 1 4.2 1.25 
3 SAa 10 133 7.4 2.48 
4 RB 120 145 11.7 2.99 
5 WG 70 71 13.4 2.87 
6 MW 141 47 19.3 2.96 
7 SU 89 76 14.7 2.86 
8 LL 131 48 11.0 1.52 
9 FA 217 48 15.8 2.96 
10 JH 93 196 9.6 2.51 
11 CI 134 38 17.7 2.94 
12 SAb 96 119 8.3 2.53 
13 HJW 44 229 9.4 2.70 
14 KB 152 147 9.6 2.88 
15 GT 96 56 13.6 2.89 
16 UB 65 133 2.6 1.37 
17 GE 134 105 9.6 3.00 
18 EM 178 16 3.1 1.70 
 Mean (SD) 115 (51) 98 (63) 11.0 (4.9) 2.52 (.61) 
      
MCI patients      
1 KK 126 57 24.5 3.00 
2 BD 108 52 20.9 4.00 
3 HM 15 127 27.9 2.94 
4 SE 277 50 21.2 2.90 
5 LE 31 58 9.2 2.34 
6 TJ 136 141 22.3 3.00 
7 FF 63 128 17.5 2.96 
8 RB 127 126 12.1 2.93 
9 BU 23 89 12.0 2.40 
10 SB 92 123 18.5 3.00 
11 LM 80 91 25.8 2.84 
12 BW 30 32 15.8 1.93 
13 MM 119 96 12.9 3.00 
14 JR 149 107 8.2 2.95 
15 HF 195 79 10.4 2.86 
16 AW 114 84 22.5 3.00 
17 NS 137 109 19.6 2.94 
18 HI 88 98 14.5 2.32 
 Mean (SD) 106 (65) 92 (32) 17.5 (6.0) 2.85 (.42) 
 
See below for healthy control subjects. 
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Nr. Patient t0 μ C K 
Healthy controls     
1 ED 17 233 14.3 2.98 
2 BA 92 104 19.1 2.87 
3 SJ 92 95 22.1 2.93 
4 LA 79 111 17.3 3.00 
5 SE 107 112 25.5 3.00 
6 FU 40 124 15.1 3.78 
7 EA 119 96 17.1 2.98 
8 SS 138 64 36.2 2.90 
9 DG 112 63 32.9 3.00 
10 LK 78 77 17.4 3.94 
11 SI 98 90 16.0 2.81 
12 UE 74 64 25.3 2.96 
13 RML 52 121 12.8 2.47 
14 PDM 15 80 15.1 2.92 
15 BE 26 109 17.3 2.53 
16 SH 127 73 14.9 2.83 
17 AW 71 90 24.7 2.88 
18 PD 22 141 15.0 2.64 
 Mean (SD) 76 (39) 103 (39) 19.9 (6.6) 2.97 (.36) 
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Supplement C: Partial report data (study 2) 
 
Table 11:  PR: Demographic and neuropsychological data for individual MCI and AD patients 
CDR: Clinical Dementia Rating Scale, global score (Morris, 1993); p: level of significance; M (SD): mean score and 
standard deviation; Age in years; Education in years; MMSE: Mini Mental State Examination (Folstein et al., 1975), 
30-0 points, cut-off ≤ 23; CERAD: The Consortium to Establish a Registry for Alzheimer‟s Disease (Thalmann & 
Monsch, 1997), total score; CDT: Clock Drawing Test, 0-6 points, cut-off ≥ 3 (Shulman et al., 1986); CDR sum: sum 
of CDR category scores; Age at disease onset in years; Disease duration in years; ApoE4: apolipoprotein E4 geno-
type, positive (24, 34, 44), negative (23, 33); n.a.: not applied; AChEI: acetylcholine esterase inhibitors; SSRI: selec-
tive serotonin reuptake inhibitor; NaSSA: noradrenergic and specific serotonergic antidepressant; All subjects were 
right-handers, according to the Edinburgh Handedness Inventory (Oldfield, 1971). 
Nr. Patient Age Gender Education MMSE CERAD 
total 
score 
CDT CDR 
sum 
Age at 
disease 
onset 
Disease 
duration 
ApoE4 
genotype 
Medication 
Dementia Depression 
MCI patients            
1 ZF 58.5 m 13 27 85 1 1.5 54.3 4.2 34 - - 
2 KK 71.9 m 9 28 79 3 1.5 70.3 1.5 34 - - 
3 MC 78.1 m 13 27 71 1 1.5 76.0 2.1 23 - - 
4 RH 64.9 m 10 26 84 1 2.0 57.1 7.8 44 - SSRI 
5 RW 64.4 f 9 28 83 1 3.0 59.7 4.7 44 - SSRI 
6 BDa 75.6 f 13 28 83 2 2.0 73.5 2.2 34 - - 
7 RHB 65.8 m 13 29 85 2 2.0 64.1 1.7 24 - - 
8 HM 59.0 f 9 28 87 3 2.0 56.4 2.6 n.a. - - 
9 SE 69.1 f 10 28 91 3 1.0 65.9 3.2 33 - - 
10 LE 74.7 f 10 25 79 3 3.0 73.1 1.5 34 - - 
11 FA 65.4 m 13 28 84 2 2.0 62.0 3.4 23 - - 
12 WKH 57.2 m 9 27 93 2 1.5 55.6 1.6 23 - SSRI 
13 RHH 75.4 m 13 26 79 3 2.5 74.4 1.1 34 - - 
14 KJ 66.8 m 9 25 88 3 3.0 64.6 2.3 34 - SSRI 
15 TE 58.7 f 9 29 88 2 1.0 55.9 2.8 44 - SSRI 
16 BDb 77.0 m 13 28 86 2 1.5 73.8 3.2 34 - - 
17 ZU 78.9 f 13 27 89 1 1.5 76.8 2.1 n.a. - SSRI 
18 FF 67.7 m 13 27 96 1 3.5 65.1 2.5 33 - - 
19 PHa 45.9 m 9 26 93 2 2.5 43.6 2.4 33 - - 
20 RB 66.4 m 13 27 112 2 2.5 63.3 3.1 33 - - 
21 MR 76.2 f 9 30 86 1 1.5 72.0 4.2 33 - SSRI 
22 BU 73.3 f 9 26 90 1 2.0 72.2 1.1 34 - - 
23 SB 71.0 f 13 27 54 3 2.0 70.5 0.5 44 - - 
24 LM 66.1 f 10 28 86 1 2.0 61.6 4.5 34 - - 
25 TO 79.9 m 9 28 64 1 2.5 74.5 5.4 23 - tricyclica 
26 BW 79.0 f 9 29 80 1 1.0 76.5 2.4 34 - - 
27 MM 70.8 f 9 26 86 3 1.0 67.2 3.5 34 - - 
28 JR 68.2 m 9 27 70 3 3.0 66.8 1.4 33 - - 
29 PHb 69.9 f 9 29 81 2 2.0 68.8 1.1 n.a. - SSRI 
30 AW 67.5 m 13 27 79 2 3.0 63.3 4.2 44 - - 
31 NS 68.4 m 9 30 76 1 1.5 66.3 2.1 33 - - 
32 HI 74.8 f 13 26 66 4 3.0 73.7 1.1 34 - - 
 
Mean 
(SD) 
69.9 
(7.6) 
17 m, 
15 f 
10.8 
(1.9) 
27.4 
(1.3) 
82.9 
(10.5) 
2.0 
(.9) 
2.0 
(.7) 
66.2 
(7.9) 
2.7 
(1.5) 
18+, 11-, 
3 n.a. 
un-
medicated 
8 SSRI, 1 
tricyclica, 23 
unmedicated 
 
See below for AD patients. 
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Nr. Patient Age Gender Education MMSE CERAD 
total 
score 
CDT CDR 
sum 
Age at 
disease 
onset 
Disease 
duration 
ApoE4 
genotype 
Medication 
Dementia Dementia 
AD patients             
1 OK 71.4 m 9 25 71 1 4.5 65.9 5.5 34 AChEI - 
2 PA 56.1 m 9 21 71 3 5.0 53.4 2.8 44 AChEI SSRI 
3 RB 55.8 f 9 25 63 4 4.5 52.1 3.7 33 AChEI - 
4 MW 67.1 m 13 . . . 5.0 59.1 8.0 44 AChEI - 
5 SU 60.0 f 10 23 72 4 4.0 58.3 1.8 24 AChEI - 
6 LL 79.1 f 9 25 62 3 4.0 78.0 1.1 33 - - 
7 PM 73.0 f 10 25 60 3 5.0 70.8 2.1 34 AChEI SSRI 
8 MK 73.1 f 9 23 67 3 . 72.2 0.8 44 AChEI NaSSA 
9 JH 62.0 f 10 23 70 4 4.0 58.1 3.8 33 AChEI - 
10 CI 65.6 f 9 20 71 5 5.0 59.2 6.4 34 AChEI - 
11 SA 68.2 f 9 25 84 2 3.5 66.1 2.1 34 AChEI - 
12 HJW 57.0 m 10 . . . . . . n.a. - - 
13 KB 60.6 f 9 22 83 3 3.5 58.4 2.2 44 AChEI - 
14 GT 63.2 m 13 24 76 2 4.0 59.2 3.9 44 - - 
15 GE 80.6 f 9 19 51 4 5.0 78.4 2.1 n.a. - - 
16 EM 81.5 f 9 19 51 4 5.0 78.4 3.2 33 - - 
 
Mean 
(SD) 
67.1 
(8.6) 
5 m, 
11 f 
9.8 
(1.3) 
22.8 
(2.3) 
68.0 
(10.0) 
3.2 
(1.1) 
4.4 
(.6) 
64.5 
(9.1) 
3.3 
(2.0) 
10+, 4-, 
2 n.a. 
11 AChEI, 5 
unmedicated 
2 SSRI, 1 
NaSSA, 13 
unmedicated 
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Table 12:  PR: Exposure durations of individual MCI and AD patients and healthy controls 
All stimuli were masked. 
Nr. AD 
patients 
Exposure 
durations (ms) 
Nr. MCI 
patients 
Exposure 
durations (ms) 
Nr. Controls Exposure 
durations (ms) 
1 OK  300  1 ZF  300  1 WS  157  
2 PA  300  2 KK  300  2 MS  157  
3 RB  600  3 MC  157  3 ED  157  
4 MW  300  4 RH  300  4 HD  157  
5 SU  300  5 RW  200  5 EH  157  
6 LL  600  6 BDa  300  6 RR  129  
7 PM  500  7 RHB  300  7 BA  157  
8 MK  500  8 HM  157  8 SJ  300  
9 JH  586  9 SE  600  9 SK  300  
10 CI  500  10 LE  300  10 LA  300  
11 SA  400  11 FA  300  11 SE  300  
12 HJW  100  12 WKH  500  12 SHa  300  
13 KB  700  13 RHH  257  13 KB  71  
14 GT  371  14 KJ  300  14 FU  129  
15 GE  429  15 TE  300  15 EA  257  
16 EM  743  16 BDb  357  16 SS  157  
 Mean  452  17 ZU  600  17 DG  200  
 (SD)  (171)  18 FF  300  18 WK  157  
     19 PHa  143  19 LK  157  
     20 RB  400  20 SI  200  
     21 MR  529  21 RML  357  
     22 BU  257  22 PDM  114  
     23 SB  329  23 BU  157  
     24 LM  271  24 BE  200  
     25 TO  386  25 KC  357  
     26 BW  300  26 SHb  243  
     27 MM  414  27 AW  157  
     28 JR  457  28 PD  157  
     29 PHb  200  29 LD  186  
     30 AW  343  30 WH  186  
     31 NS  400  31 BH  243  
     32 HI  300  32 MH  200  
      Mean  330  33 HW  143  
      (SD)  (114)  34 ND  186  
          35 LS  229  
          36 BM  200  
           Mean  200  
           (SD)  (69)  
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Table 13:  PR: Parameters of individual MCI and AD patients and healthy controls 
Aleft/ Aright: basic sensory effectiveness in the left and right hemifield, respectively; Aλ: laterality index of sensory ef-
fectiveness; wλ: laterality index of attentional weighting; Dev(wλ): imbalance index of attentional weighting; 
Nr. Patient Aleft Aright Aλ wλ Dev(wλ) 
AD patients       
1 OK 2.97 4.25 .41 .55 .05 
2 PA 2.40 2.75 .47 .80 .30 
3 RB 3.83 2.75 .58 .53 .03 
4 MW 3.01 2.45 .55 .66 .16 
5 SU 3.14 2.06 .60 .74 .24 
6 LL 4.55 5.96 .43 .74 .24 
7 PM 3.63 2.34 .61 .57 .07 
8 MK 3.23 2.57 .56 .72 .22 
9 JH 2.71 3.12 .47 .14 .36 
10 CI 4.05 4.29 .49 .58 .08 
11 SA 2.32 2.06 .53 .43 .07 
12 HJW 2.01 2.09 .49 .61 .11 
13 KB 2.26 2.84 .44 .54 .04 
14 GT 4.46 3.46 .56 .64 .14 
15 GE 2.51 3.37 .43 .15 .35 
16 EM 2.21 2.44 .48 .59 .09 
 Mean (SD) 3.08 (.81) 3.05 (1.04) .51 (.07) .56 (.19) .16 (.11) 
 
See below for MCI patients. 
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Nr. Patient Aleft Aright Aλ wλ Dev(wλ) 
MCI patients       
1 ZF 2.11 2.19 .49 .51 .01 
2 KK 3.10 3.57 .46 .63 .13 
3 MC 1.89 1.28 .60 .66 .16 
4 RH 2.24 1.91 .54 .52 .02 
5 RW 1.49 1.32 .53 .57 .07 
6 BDa 2.95 4.45 .40 .46 .04 
7 RHB 1.68 2.20 .43 .55 .05 
8 HM 9.85 3.88 .72 .43 .07 
9 SE 5.21 2.64 .66 .46 .04 
10 LE 2.12 3.02 .41 .57 .07 
11 FA 2.06 2.95 .41 .72 .22 
12 WKH 3.85 2.87 .57 .31 .19 
13 RHH 2.79 2.82 .50 .37 .13 
14 KJ 2.04 2.90 .41 .47 .03 
15 TE 3.30 4.82 .41 .70 .20 
16 BDb 1.97 2.32 .46 .44 .06 
17 ZU 3.44 2.65 .56 .55 .05 
18 FF 2.50 2.61 .49 .49 .01 
19 PHa 2.51 2.77 .48 .49 .01 
20 RB 2.67 2.56 .51 .41 .09 
21 MR 2.30 2.45 .48 .34 .16 
22 BU 2.42 2.19 .53 .62 .12 
23 SB 3.56 2.31 .61 .46 .04 
24 LM 8.00 5.34 .60 .52 .02 
25 TO 2.93 3.69 .44 .68 .18 
26 BW 3.78 2.52 .60 .60 .10 
27 MM 2.90 2.56 .53 .79 .29 
28 JR 2.15 2.30 .48 .58 .08 
29 PHb 2.70 2.04 .57 .54 .04 
30 AW 4.68 4.00 .54 .18 .32 
31 NS 2.48 2.72 .48 .13 .37 
32 HI 4.73 2.59 .65 .60 .10 
 Mean (SD) 3.20 (1.76) 2.83 (.91) .52 (.08) .51 (.14) .11 (.09) 
 
See below for healthy control subjects. 
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Nr. Patient Aleft Aright Aλ wλ Dev(wλ) 
Healthy controls      
1 WS 2.05 1.75 .54 .41 .09 
2 MS 1.66 1.70 .49 .44 .06 
3 ED 3.64 3.77 .49 .53 .03 
4 HD 3.17 2.87 .52 .50 .00 
5 EH 1.47 1.81 .45 .45 .05 
6 RR 2.98 2.81 .51 .57 .07 
7 BA 1.44 1.66 .46 .51 .01 
8 SJ 2.40 3.67 .40 .48 .02 
9 SK 3.91 3.96 .50 .57 .07 
10 LA 2.23 3.29 .40 .57 .07 
11 SE 4.47 3.77 .54 .48 .02 
12 SHa 3.08 2.67 .54 .38 .12 
13 KB 2.20 1.93 .53 .48 .02 
14 FU 2.64 2.77 .49 .60 .10 
15 EA 3.23 3.15 .51 .53 .03 
16 SS 2.10 2.07 .50 .57 .07 
17 DG 3.54 3.06 .54 .53 .03 
18 WK 2.23 1.99 .53 .51 .01 
19 LK 2.74 2.56 .52 .47 .03 
20 SI 4.91 3.42 .59 .47 .03 
21 RML 3.22 3.75 .46 .48 .02 
22 PDM 2.77 1.91 .59 .43 .07 
23 BU 4.83 3.00 .62 .38 .12 
24 BE 3.93 3.31 .54 .48 .02 
25 KC 2.80 3.10 .47 .47 .03 
26 SHb 1.95 1.97 .50 .32 .18 
27 AW 2.38 3.06 .44 .54 .04 
28 PD 2.56 1.85 .58 .45 .05 
29 LD 4.03 5.00 .45 .55 .05 
30 WH 2.16 2.47 .47 .45 .05 
31 BH 2.21 1.71 .56 .50 .00 
32 MH 2.18 1.95 .53 .54 .04 
33 HW 3.21 2.90 .53 .45 .05 
34 ND 2.79 2.54 .52 .39 .11 
35 LS 1.78 1.78 .50 .54 .04 
36 BM 1.53 1.45 .51 .47 .03 
 Mean (SD) 2.79 (.92) 2.68 (.83) .51 (.05) .49 (.06) .05 (.04) 
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Supplement D: TVA-based data and PET imaging (study 3) 
 
Table 14:  TVA+PET: Demographic and neuropsychological data for individual MCI and AD pa-
tients 
CDR: Clinical Dementia Rating Scale, global score (Morris, 1993); p: level of significance; M (SD): mean score and 
standard deviation; Age in years; Education in years; MMSE: Mini Mental State Examination (Folstein et al., 1975), 
30-0 points, cut-off ≤ 23; CERAD: The Consortium to Establish a Registry for Alzheimer‟s Disease (Thalmann & 
Monsch, 1997), total score; CDT: Clock Drawing Test, 0-6 points, cut-off ≥ 3 (Shulman et al., 1986); CDR sum: sum 
of CDR category scores; Age at disease onset in years; Disease duration in years; ApoE4: apolipoprotein E4 geno-
type, positive (24, 34, 44), negative (23, 33); n.a.: not applied; AChEI: acetylcholine esterase inhibitors; SSRI: selec-
tive serotonin reuptake inhibitor; All subjects were right-handers, according to the Edinburgh Handedness Inventory 
(Oldfield, 1971). 
Nr. Group Patient Age Gender Educa-
tion 
MMSE CERAD 
total 
score 
CDT CDR 
sum 
Age at 
disease 
onset 
Disease 
dura-
tion 
ApoE4 
genotype 
Medication 
Dementia Depression 
1 MCI RH 64.9 m 10 26 84 1 2.0 57.1 7.8 44 - SSRI 
2 MCI RW 64.4 f 9 28 83 1 3.0 59.7 4.7 44 - SSRI 
3 MCI BD 75.6 f 13 28 83 2 2.0 73.5 2.2 34 - - 
4 MCI RHB 65.8 m 13 29 85 2 2.0 64.1 1.7 24 - - 
5 MCI HM 59.0 f 9 28 87 3 2.0 56.4 2.6 n.a. - - 
6 MCI SE 69.1 f 10 28 91 3 1.0 65.9 3.2 33 - - 
7 MCI LE 74.7 f 10 25 79 3 3.0 73.1 1.5 34 - - 
8 MCI RHH 75.4 m 13 26 79 3 2.5 74.4 1.1 34 - - 
9 MCI KJ 66.8 m 9 25 88 3 3.0 64.6 2.3 34 - SSRI 
10 MCI TE 58.7 f 9 29 88 2 1.0 55.9 2.8 44 - SSRI 
11 MCI ZU 78.9 f 13 27 89 1 1.5 76.8 2.1 n.a. - SSRI 
12 MCI FF 67.7 m 13 27 96 1 3.5 65.1 2.5 33 - - 
13 MCI PHa 45.9 m 9 26 93 2 2.5 43.6 2.4 33 - - 
14 MCI RB 66.4 m 13 27 112 2 2.5 63.3 3.1 33 - - 
15 MCI MR 76.2 f 9 30 86 1 1.5 72.0 4.2 33 - SSRI 
16 MCI BU 73.3 f 9 26 90 1 2.0 72.2 1.1 34 - - 
17 MCI SB 71.0 f 13 27 54 3 2.0 70.5 0.5 44 - - 
18 MCI TO 79.9 m 9 28 64 1 2.5 74.5 5.4 23 - tricyclica 
19 MCI BW 79.0 f 9 29 80 1 1.0 76.5 2.4 34 - - 
20 MCI MM 70.8 f 9 26 86 3 1.0 67.2 3.5 34 - - 
21 MCI JR 68.2 m 9 27 70 3 3.0 66.8 1.4 33 - - 
22 MCI PHb 69.9 f 9 29 81 2 2.0 68.8 1.1 n.a. - SSRI 
23 MCI HI 74.8 f 13 26 66 4 3.0 73.7 1.1 34 - - 
24 AD PA 56.1 m 9 21 71 3 5.0 53.4 2.8 44 AChEI SSRI 
25 AD RB 55.8 f 9 25 63 4 4.5 52.1 3.7 33 AChEI - 
26 AD SU 60.0 f 10 23 72 4 4.0 58.3 1.8 24 AChEI - 
27 AD CI 65.6 f 9 20 71 5 5.0 59.2 6.4 34 AChEI - 
28 AD SA 68.2 f 9 25 84 2 3.5 66.1 2.1 34 AChEI - 
29 AD KB 60.6 f 9 22 83 3 3.5 58.4 2.2 44 AChEI - 
30 AD GT 63.2 m 13 24 76 2 4.0 59.2 3.9 44 - - 
  
Mean 
(SD) 
67.5 
(7.9) 
11 m, 
19 f 
10.3 
(1.8) 
26.2 
(2.4) 
81.1 
(11.5) 
2.4 
(1.1) 
2.6 
(1.1) 
64.7 
(8.3) 
2.8 
(1.6) 
19+, 8-, 
3 n.a. 
6 AChEI, 
24 unme-
dicated 
8 SSRI, 1 
tricyclica, 
21 unme-
dicated 
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Table 15:  TVA+PET: Whole and partial report exposure durations of individual MCI and AD 
patients and healthy controls 
In the whole report task, 50% of the trials were masked. In the partial report task, all stimuli were masked. 
Nr. Diagnosis Patients Whole report 
exposure 
durations (ms) 
Partial report 
exposure 
durations (ms) 
Nr. Controls Whole report 
exposure 
durations (ms) 
Partial report 
exposure 
durations (ms) 
1 MCI RH 157 300 600 300 1 WS 157 300 600 157 
2 MCI RW 157 300 600 200 2 MS 157 300 600 157 
3 MCI BD 157 300 600 300 3 ED 157 300 600 157 
4 MCI RHB 157 300 600 300 4 HD 157 300 600 157 
5 MCI HM 86 157 300 157 5 EH 157 300 600 157 
6 MCI SE 300 600 1000 600 6 RR 157 300 600 129 
7 MCI LE 157 300 600 300 7 BA 157 300 600 157 
8 MCI RHH 157 300 600 257 8 SJ 157 300 600 300 
9 MCI KJ 157 300 600 300 9 SK 157 300 600 300 
10 MCI TE 157 300 600 300 10 LA 157 300 600 300 
11 MCI ZU 300 600 1000 600 11 SE 157 300 600 300 
12 MCI FF 86 157 300 300 12 SHa 157 300 600 300 
13 MCI PHa 43 86 157 143 13 KB 86 157 300 71 
14 MCI RB 200 400 700 400 14 FU 157 300 600 129 
15 MCI MR 300 600 1000 529 15 EA 157 300 600 257 
16 MCI BU 86 157 300 257 16 SS 157 300 600 157 
17 MCI SB 157 300 600 329 17 DG 157 300 600 200 
18 MCI TO 171 343 686 386 18 WK 86 157 300 157 
19 MCI BW 129 257 514 300 19 LK 157 300 600 157 
20 MCI MM 186 371 700 414 20 SI 157 300 600 200 
21 MCI JR 229 457 814 457 21 RML 86 157 300 357 
22 MCI PHb 186 371 743 200 22 PDM 71 129 271 114 
23 MCI HI 129 257 529 300 23 BU 114 229 457 157 
24 AD PA 157 300 600 300 24 BE 100 186 371 200 
25 AD RB 157 300 600 600 25 KC 129 257 500 357 
26 AD SU 157 300 600 300 26 SHb 157 386 786 243 
27 AD CI 157 300 600 500 27 AW 114 229 471 157 
28 AD SA 171 343 686 400 28 PD 114 229 457 157 
29 AD KB 200 400 700 700 29 LD 71 157 314 186 
30 AD GT 157 300 600 371 30 WH 114 243 486 186 
  Mean 167 325 618 360 31 BH 157 300 600 243 
  (SD) (58) (120) (191) (138) 32 MH 129 271 514 200 
       33 HW 143 286 571 143 
       34 ND 129 257 514 186 
       35 LS 100 214 429 229 
       36 BM 143 286 571 200 
        Mean 135 265 528 200 
        (SD) (29) (58) (118) (69) 
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Table 16:  TVA+PET: Whole and partial report as well as metabolic parameters of individual 
MCI and AD patients 
wλ: laterality index of attentional weighting; Aλ: laterality index of sensory effectiveness; TPJ: temporo-parietal junc-
tion; IPL: inferior parietal lobe; TPJ laterality index =
right  TPJ  metabolism
right  TPJ  metabolism  + left  TPJ  metabolism
 ; IPL laterality index =
right  IPL  metabolism
right  IPL  metabolism  + left  IPL  metabolism
 ;  
C: perceptual processing speed (N elements/ sec); K: visual short-term memory storage capacity (N elements). 
Nr. Diagnosis Patients wλ Aλ TPJ laterality 
index 
IPL laterality 
index 
C K 
1 MCI RH .52 .54 .497 .509 19.1 2.94 
2 MCI RW .57 .53 .506 .518 13.3 2.70 
3 MCI BD .46 .40 .488 .494 20.9 4.00 
4 MCI RHB .55 .43 .504 .510 11.0 2.48 
5 MCI HM .43 .72 .493 .506 27.9 2.94 
6 MCI SE .46 .66 .502 .490 21.2 2.90 
7 MCI LE .57 .41 .495 .496 9.2 2.34 
8 MCI RHH .37 .50 .492 .498 23.0 2.81 
9 MCI KJ .47 .41 .506 .515 13.7 2.94 
10 MCI TE .70 .41 .493 .489 17.7 2.83 
11 MCI ZU .55 .56 .501 .506 6.0 2.93 
12 MCI FF .49 .49 .498 .512 17.5 2.96 
13 MCI PHa .49 .48 .485 .491 35.4 2.92 
14 MCI RB .41 .51 .492 .500 12.1 2.93 
15 MCI MR .34 .48 .498 .487 5.0 2.92 
16 MCI BU .62 .53 .507 .506 12.0 2.40 
17 MCI SB .46 .61 .482 .486 18.4 3.00 
18 MCI TO .68 .44 .507 .492 8.5 2.51 
19 MCI BW .60 .60 .516 .528 15.7 1.93 
20 MCI MM .79 .53 .535 .541 12.9 3.00 
21 MCI JR .58 .48 .500 .515 8.2 2.95 
22 MCI PHb .54 .57 .496 .515 17.5 3.68 
23 MCI HI .60 .65 .483 .495 14.5 2.32 
24 AD PA .80 .47 .510 .493 18.2 2.98 
25 AD RB .53 .58 .516 .496 11.7 2.99 
26 AD SU .74 .60 .524 .528 14.7 2.86 
27 AD CI .58 .49 .460 .479 17.7 2.94 
28 AD SA .43 .53 .501 .489 8.3 2.53 
29 AD KB .54 .44 .473 .474 9.6 2.88 
30 AD GT .64 .56 .494 .497 13.5 2.89 
  
Mean 
(SD) 
.55 
(.11) 
.52 
(.08) 
.498 
(.015) 
.502 
(.015) 
15.2 
(6.5) 
2.85 
(.38) 
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Supplement E: Neuropsychological assessment 
Test 1: The Consortium to Establish a Registry for Alzheimer‟s Disease: Neuropsychologi-
cal test battery (CERAD-NP; Welsh et al., 1994) 
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Test 2:  Clock Drawing Test (CDT; Shulman et al., 1993) 
 
Der Uhren-Test (modifiziert nach Shulman 1993) 
 
Anweisungen zur Durchführung: 
1. Geben Sie dem Patienten ein Blatt Papier mit einem vorgezeichneten Kreis. Zei-
gen Sie ihm, wo oben und unten ist. 
2. Geben Sie dem Patienten folgende Anweisung: „Dies soll eine Uhr sein. Ich 
möchte Sie bitten, in diese Uhr die fehlenden Ziffern zu schreiben. Zeichnen Sie 
danach die Uhrzeit ‚10 nach 11„ ein.“ 
3. Machen Sie sich Notizen zur Ausführung der gestellten Aufgabe (Reihenfolge, 
Korrekturen etc.). 
4. Bewerten Sie die angefertigte Zeichnung gemäß der untenstehenden Kriterien. 
Notieren Sie den Score zusammen mit Datum und Namen des Patienten auf 
dem Zeichenblatt. 
5. Der validierte Cut-Off zur Unterscheidung zwischen Normalbefund einerseits und 
kognitiver Beeinträchtigung im Sinnes einer evtl. vorliegenden Demenz anderer-
seits liegt zwischen 2 und 3. Anders ausgedrückt: Ein Score von ≥ 3 Punkten ist 
als pathologisch anzusehen. 
_______________________________________________________________________ 
 
Bewertung (1 = ohne Fehler, 6 = keine Uhr erkennbar) 
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Test 3:  Clinical Dementia Rating Scale (CDR; Morris, 1993) 
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